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CONCEPTIONS OF “SUCCESS”:  
THE ETHICS AND RHETORIC OF HAND TRANSPLANTATION 
Emily Ruppel Herrington, PhD 
University of Pittsburgh, 2019 
Twenty years since the first modern attempts at human hand transplantation (HTX) in 1998 
and 1999, these operations are a fringe hybrid of the clinical specialties of reconstructive 
microsurgery and transplant immunology, offered only under experimental protocols in most 
cases. Despite having paved the way for face transplants, womb transplants, and penis transplants, 
fewer than 100 hand transplants have been performed so far, complicating clinical research efforts 
to parse results “objectively.” Through ethnographic oral history fieldwork and close rhetorical 
analysis of the medical literature on hand transplantation, my dissertation argues that despite its 
ubiquity across hand transplant rhetorics, “success” is a misnomer and a distracting frame for 
discussions of effectiveness in the science and ethics of this field since the reality of lived 
experience for patients involves lifelong unfolding tradeoffs of medications management, care 
activities, surveillance, managed complications, and relational upkeep which are never fully 
resolved. 
By placing the question of “success” in the frame of HTX patients’ self-reported 
experiences of dis/ability and the ongoing construction of their identity—rather than in 
medicalized notions of function or ability and progress-oriented histories of transplant science 
internationally—I show that parsing cause and effect in a many-faceted procedure like hand 
transplantation is a nuanced task that betrays the inherent subjectivity of data interpretation in 
medical science. Following in the stream of discourse on narrative medicine, person-centered 
v 
healthcare, and the social construction of disability, my dissertation challenges norms for doctors 
representing vulnerable others to their colleagues and the public. Along with empirical insights 
from the oral histories, my analysis of hand transplant literature contributes to knowledge in 
disability studies, rhetoric of science, feminist bioethics, and science and technology studies (STS) 
bringing novel substance to 21st century debates about the options that should or should not be 
made available to those navigating the personal and putative binaries of ability/disability, 
beauty/deformity, and health/illness.  
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 1.0 INTRODUCTION 
“Don’t turn a scientific problem into a common love story.” 
~ Andrei Tarkovsky, Solaris 
One night in February 2006, a chiropractor from Oklahoma was driving to a hunting trip 
with friends when his Suburban got trapped in a brush fire and its electrical systems failed, 
temporarily locking him inside the truck. Rich Edwards’s hands were severely burned in the fire, 
remaining gnarled and nonfunctional even after several reconstructive surgery attempts. Deeply 
depressed, and desperate to recapture some aspect of his former lifestyle and vocation, Rich and 
his wife, Cindy, agreed to participate in an experimental double hand transplant in Louisville, 
Kentucky. Rich’s singular desire was to go back to work as a chiropractor, stating in a post-
transplant interview that, “If I can just get 50% feeling back, I think I can go in there and develop 
[my professional skills again]” (Ruppel, 2011). 
Despite a surge of hope in the waiting period and a plethora of discreet functional gains 
per the hand grafts, Rich’s depression gradually returned as he and Cindy realized how inadequate 
the transplant hands would be in terms of affording the redevelopment of chiropractic technique. 
While some gains in independence, social acceptance, and physical sensation was deeply 
meaningful to Rich and Cindy (being able to hold hands together and to pray, more bathroom 
autonomy, among other affordances), Rich’s spirits again sunk to suicidal levels when he could 
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not return to work. At the end of summer 2015, Rich visited a gun range near his home and killed 
himself. Before his body was buried, Rich’s hand grafts were surgically removed by two of the 
doctors who had originally performed his transplant (they traveled from Pennsylvania and Texas, 
respectively, to retrieve the hands). The hands were then transported to Pittsburgh, to be studied 
by transplant biologists at the University of Pittsburgh Medical Center (UPMC).  
None of the speakers presented a robust picture of Rich and Cindy’s experiences at the 
2017 biannual congress of the International Society of Vascularized Composite 
Allotransplantation (ISVCA) in Salzburg, Austria—where almost every clinical thought leader 
researching hand transplantation was gathered, and at which I presented a poster on my oral history 
research with hand transplant patients and their caregivers. As a master’s student in bioethics 
concurrent with my doctoral research, I found lack of discussion of the negative sequelae of Rich 
and Cindy’s hand transplant questionable given the 2017 conference theme: “Defining Success.”  
My dissertation argues that the underappreciated and often, uncirculated narratives of hand 
transplantation (HTX) offer poignant complications to the media hype that tends to accompany 
any report of a hand transplant surgery. They also complement the abstract representation of 
experimental results as reported in academic case studies and review articles, where adverse 
consequences for patients can be obscured by the scientific tradition of discussing “objective” 
discreet and continuous variables like duration of transplant, grip function, and tissue health rather 
than holistically answering questions like: Did this operation confer satisfaction? Did it 
facilitate life? Because hand transplant surgeries are rare—highly active centers may average only 
one hand transplant every two years—practitioners trying to objectively compare methods and 
results find it difficult to generate statistically significant insights from published data. Disparate 
methodological approaches from center to center and high sociocultural variability among patients 
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internationally make the problem of evidence-based evaluation even more pronounced (Caplan et 
al, 2018). Nevertheless, a consistent refrain among hand transplant providers at conferences and 
in review articles is the “progress” of the HTX field and its evolution to other indications since the 
first modern cases in 1998 and 1999. Claims to successful hand transplantation in the academic 
literature are cited uncritically in sweeping retrospectives (Lanzetta et al, 2005; Gander et al, 2006; 
Elliott, Tintle, and Levin, 2014; Alolabi, Augustine, and Thoma, 2017; Cendales, 2017) and calls 
to further innovate (Baylis, 2004; Chambers, 2004; Brandacher, Lee, and Schneeberger, 2012; Ren 
and Laugel, 2013; Barker, Furr, Barrett, and Hardy, 2018). 
In my dissertation I argue that despite its ubiquity across hand transplant rhetorics, 
“success” is a misnomer and a distracting frame for discussions of effectiveness in the science and 
ethics of this field since the reality of lived experience for patients involves lifelong unfolding 
tradeoffs of medications management, care activities, surveillance, managed complications, and 
relational upkeep which are never fully resolved. Through ethnographic oral history fieldwork and 
close rhetorical analysis of the medical literature on hand transplantation, my dissertation helps to 
address questions left open in case reports and reviews on these operations, such as: “What 
happened?” and, “What was it like?” for participants seeking to regain a particular quality of life 
through hand transplantation. By placing the question of “success” in the frame of HTX patients’ 
self-reported experiences of dis/ability and the ongoing construction of their identity, I show 
through my research that parsing cause and effect in a many-faceted procedure like hand 
transplantation is a nuanced task that betrays the inherent subjectivity of data interpretation in 
medical science. Following in the stream of discourse on narrative medicine, person-centered 
healthcare, and disability studies—thinking especially through the concepts of 
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“biomedicalization” and the social model of disability—my dissertation challenges norms for 
doctors representing vulnerable others to their colleagues and the public.  
Background 
Since ancient times, physicians have attempted to repair dismembering injuries and 
illnesses in their patients using prosthetic substitutes and creative plastic surgery techniques. 
However, early surgeons were also aware that tissue from a stranger would “die” on the body of 
the recipient, a phenomenon they believed to be caused by the death of the donor’s soul (Hamilton, 
2012). Today, transplant immunology is a sophisticated field of research yielding drugs that 
suppress a transplant patient’s natural immune responses in order to facilitate acceptance of 
organ(s) from another person. Unfortunately, transplant drugs are toxic and many transplant 
patients die or get seriously ill every year not from organ failure but from opportunistic infections 
that would not likely have been health threats had they not been taking immunosuppressants 
(Hatrick and Tonkin, 2001; Chelmonksi, Jablecki, and Szajerska, 2011; Hamilton, 2012). 
Immunosuppressants also bring heightened risk of diabetes and some cancers and are usually 
paired in hand transplant patients with steroidal treatments that bring a slew of unwanted side 
effects (Baumeister et al, 2004; Boratynska et al, 2014). 
When I began working on this project in fall 2010, I spent time learning about the science 
of hand transplantation and familiarized myself with the history of these surgeries, which 
necessitated reading about the long period of public and professional debate on their ethical 
justification. While conducting research for my master’s thesis, I interviewed several doctors and 
patients about their goals and experiences, discovering that in each individual case of hand 
transplantation, the ethics are complicated, because all organ transplants are life-altering surgeries 
that carry serious health risks. Far more than even novel forms of brain-controlled prosthetics, a 
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hand transplant is a daring attempt to “replace like with like,” a phrase HTX doctors often quote, 
considered by many to be a basic principle of plastic surgery.  
Modern hand transplantation was pioneered in Louisville, Kentucky, my hometown. These 
operations and their medical progeny (face transplants, penis transplants, abdominal transplants, 
and womb transplants), have inspired countless national and international media stories—
including several on the prospect of a total head-body transplant, which is being envisioned by its 
proponents as a reasonable extension of the reconstructive transplant or “vascularized composite 
allotransplantation” (VCA) field (Ren and Laugel, 2012). The rapid evolution of VCA has 
occurred despite low numbers of patients internationally (N = <250) since 1998 and ongoing 
debate about the meaning of success for different VCA types including hand transplants. My 
dissertation will speak to and about these developments through my own observations and the 
words of experimental participants, making visible and accessible the human story of hand 
transplantation which is often elided in formal reports and histories.  
Influences and significance 
The problem of reduction in modern (western) medicine has received much attention from 
medical humanities, STS, and bioethics scholars in recent years. Stefen Timmermans and Marc 
Berg write, noting the increasing prevalence of “objective” measurements of effectiveness in the 
medical professions and the preference among clinicians for certain kinds of disembodied truth 
claims: 
According to the ideals of evidence-based medicine, clinical practice guidelines 
should be based on scientific evidence—preferably a meta-analysis of randomized 
clinical trials offering probability estimates of each outcome. Proponents of 
evidence-based medicine are wary of reasoning from basic principles or 
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experience; they distrust claims based on expertise or pathophysiological models. 
They prefer to remain agnostic as to the reason why something should or should 
not work—rather, they objectively measure whether or not it works in real-life 
settings. Yet such evidence is only rarely available to cover all the decision 
moments of a guideline (2010, p. 3). 
As Timmermans and Berg note, an attitude of resistance to non-quantifiable data has become 
deeply ingrained in the thought processes and protocols of western medical practice, yet high 
standards for what data “count” means some categories of knowledge of operations and outcomes 
may simply go unreported (for instance, the commonsense observations of patients or clinical staff 
members, as I argue in this dissertation).  
My dissertation will extend discussion of unnecessary/unproductive reductionism in 
medical science by showing why grounded, “subjective,” embodied data—which are discounted 
in strenuously quantitative clinical outcomes measurements—are crucial to the development of a 
more complete and accurate knowledge of relevant phenomena and events in the field of human 
hand transplantation. Without first-person representations of outcomes to balance biomedical 
accounts, I argue, the “mind’s eye” of readers of hand transplant case studies may unintentionally 
assume a “clinical gaze” that is more focused on dependent variables than on human recovery from 
traumatic events. The progression of chapters in my dissertation—from the historical framing of 
ethical questions and quandaries in chapter 1 through the richly descriptive oral history accounts 
in chapter 2 (affording knowledge of the unending/unfolding challenges of HTX from patient 
families’ perspective) to my final analysis of HTX “success” rhetorics in chapter 3—serves a 
performative function of “pulling back the curtain” on what it means for some aspects of hand 
transplantation to be emphasized over others in medical representations of success and failure.  
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Several scholars have recently investigated the media relationships and semiotic tools 
through which HTX and/or VCA doctors have represented themselves and their patients to the 
media (such as Fiona Kumari Campbell’s comprehensive 2004 media diagnostic, “The case of 
Clint Hallam’s wayward hand: Print media representations of the ‘uncooperative’ disabled 
patient”, Haavi Morreim’s 2004 article, “About Face: Downplaying the Role of the Press in Facial 
Transplantation Research”  and Marjorie Kruvand’s 2010 collaborative piece, “Face to face: How 
the Cleveland Clinic managed media relations for the first U.S. face transplant”). Other essays by 
medical humanities scholars and bioethicists have critically probed topics of meaning-making and 
value creation in VCA (such as Carson Strong’s 2004 paper, “Should we be putting a good face 
on facial transplantation?” and Samuel Taylor-Alexander’s 2013 article, “On face transplantation: 
Ethical slippage and quiet death in experimental biomedicine”). However, no books or papers on 
hand transplantation or VCA so far describe or theorize how “success” as a concept operates in 
the HTX literature, including what success is “doing” to afford or occasion certain ways of 
envisioning the goals and outcomes of hand transplantation as both the original VCA and as an 
emerging “standard of care” for upper extremity amputees (Breidenbach et al, 2015).  
Historical researcher Mary Jo Festle has attended to the ambiguities of defining “success” 
in transplant science in her 2012 oral history of lung transplantation, Second Wind. The problem 
of uncertainty in these procedures—and the difficulty of straightforward outcomes evaluation—is 
carefully highlighted. Festle writes, “How should we decide whether a medical procedure is 
worthwhile? If patients gain an additional year of life, does that constitute ‘success’ or should we 
expect longer? Should we also consider the quality of that added time?” (p. 4). Festle’s book 
outlines several issues impinging on success in lung transplantation, many of which are relevant 
to themes I explore in my dissertation. Where the value of Festle’s book lies in its exhaustive 
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encyclopedic documentation of firsthand patient experiences, more so than critique, my treatment 
will move chapter by chapter toward developing a theory of how “success” operates rhetorically 
in the literature on human hand transplantation and why “success” is a distracting and destructive 
term of value in the parlance of HTX professionals. 
As the first full length book project to focus on the rhetorical operations of success in hand 
transplantation/VCA, and to offer a view of these procedures from the “bottom up” utilizing data 
collected from patients’ own accounts, my dissertation challenges the status quo for representation 
of experimental outcomes by clinical researchers (especially those working with vulnerable 
populations). My dissertation will contribute to disability studies, medical humanities, 
communication, STS, bioethics, and rhetoric both a new empirical study of high-visibility 
developments in recent medical history and several concepts with which to parse related stories. 
Along with empirical insights from oral history interviews with hand graft recipients and their 
caregivers in chapter 2, my analysis of hand transplant ethics and rhetoric in chapter 3 will bring 
novel substance to debates about autonomy and paternalism in the medical care of vulnerable 
populations and the options that should or should not be made available to those navigating the 
personal and putative binaries of ability/disability, beauty/deformity, and health/illness in the 21st 
century. 
As disability scholar and literary theorist Rosemarie Garland-Thomson has written, in 
addition to directly manipulating our environment,  
Hands appear to help us conceptualize our world. Available items are on hand, 
handy, or in hand. Remarks can be made offhand. Disordered things are out of hand. 
Powerful people have the upper hand. … Human labor itself is signified by the 
hand. Workers are “hands.” Fate is “the hand of God.” The universe is “God’s 
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handiwork.” Hands do the work of humanity, but they also serve us as visual 
emblems” (2009, p. 120). 
The often breathtaking, sometimes brutally revealing words of scholars like Rosemarie Garland-
Thomson and others in the growing field of disability studies (notably Fiona Kumari Campbell) 
have been my constant companions in undertaking this project. In addition to their important work 
critiquing medicalized responses to physical and cognitive forms of difference, disability scholars 
have exemplified why there can be, “Nothing about us without us!” in authentic representations of 
dis/abled lives—no matter who is speaking or from what position of expertise.  
Oral historians, whom I consult for methodological tools for collecting and analyzing life 
stories (see chapter 2)—are similarly positioned towards esteeming the perspectives of people with 
firsthand experiences of an illness event or condition (rather than relying on top-down recitations 
of relevant factors). To develop my discussion of narrative forms and their value to ethical 
diagnosis, decision-making, and evaluation in hand transplantation I turn to feminist bioethicists 
such as Jackie Leach Scully and Margaret Shildrick, and scholars of narrative medicine and 
narrative ethics such as Rita Charon and Arthur Frank.  
Normative bioethics and descriptive qualitative methods like oral history offer very 
different tools for parsing perennial problems in healthcare and for understanding what gives rise 
to medical disagreements and disparities. In my home field of communication and rhetoric of 
science, scholars deploy a capacious portfolio of resources toward disentangling the motives 
behind or interests served by explicit statements of surgeons and scientists. Together these tools 
and approaches are well suited to my analysis of HTX success claims in chapters 1 and 3, in which 
I re-present statements and publications of hand transplant professionals in light of what patients, 
themselves, have said is most important.  
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Other questions raised in my dissertation include: What are the challenges and 
opportunities of identity formation and preservation in the transition from “healthy” amputee to 
lifelong transplant “patient”? What is the intended or actual effect of the term “non-compliant” in 
medical parlance (especially in experimental settings)? What role do partners and caregivers play 
in the preparation and decision-making process for participation in hand transplantation (perhaps 
shedding light on the impact of critical support networks in procedures that are similarly high-
risk/intensity)? How does the perceived need to be both “normal” and an “individual” in western 
society contribute to justifications for the biomedical restoration, transformation, or enhancement 
of bodies that have been amputated or physically disfigured?  
Structure of the dissertation 
Chapter 1 of my dissertation traces the discursive developments leading to the modern era 
of hand transplantation/VCA, introducing the problem of “success” and its characterization in the 
field since the late 1990s. The greatest academic innovation in the development of human hand 
transplantation, I argue, was the knowledge created through unprecedented collaboration of 
experts in transplant immunology/psychology and reconstructive plastic surgery in terms of 
sharing information relevant to the already-existing technical feasibility of performing a human 
hand graft. This is significant because the experimental permissibility of performing a “successful” 
hand transplant had to be constructed rhetorically by early HTX advocates, rather than emerging 
from a material kairotic moment afforded via discovery of a new drug or surgical strategy. The 
world’s first modern hand transplants were thus produced through dialogical work in which 
appeals to beneficence and “quality of life” of disadvantaged patients played a crucial role. The 
last half of chapter 1 relates key events and academic representations of the first modern attempts 
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at hand transplantation and explores how these early cases figured in the establishment of hand 
transplantation as a field.   
Chapter 2 complicates the picture drawn by hand transplant clinicians through eight oral 
history narratives, together offering an intimate portrait of life before and after hand 
transplantation. Part 1 of chapter 2 gives an introduction to my methodology, situating narrative 
oral history methods and grounded analysis of interview content within the context of qualitative 
research in medicine and medical humanities more broadly. Part 2 of chapter 2 is my empirical 
contribution to the literature on outcomes in hand transplantation in the form of eight narratives of 
hand transplantation based on my interpretation of oral history interviews, illuminated with quotes 
from narrators. Part 3 of chapter 2 gives a brief thematic extension to the oral histories by relating 
several noteworthy themes and concepts that arose through grounded analysis of collected data, 
most importantly the idea that “success” in hand transplantation begins with an accurate concept 
of the—in some ways, more limited—futures that are possible with and through hand 
transplantation.  
Chapter 3 offers my view of the “rhetoric of success” in the medical literature on hand 
transplantation, arguing that success claims in this field are a distraction from the more pressing 
question of the specific tradeoffs experienced by patients and the effects of hand transplantation 
on their health and quality of life (QoL). In chapter 3, I bring together voices from disability studies 
and STS to support my final arguments on why patients’ experiences are represented some ways 
and not others and why, in medical interventions where enhancing “quality of life” is the healers’ 
sole commitment, “success” is a meaningless if not destructive term unless accessed within the 
framework of patients’ own values and their conceptions of what it is or means. The grounded, 
infrastructurally-oriented critiques of STS scholars on major developments in medical science are 
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enlightening in terms of what values and material developments have facilitated different empirical 
commitments by clinicians and researchers. I argue in my treatment that critical understanding of 
the “rhetoric of success” in hand transplantation is aided by viewing hand transplantation as the 
biomedicalization of upper extremity disability where persons invest in a multi-level/multivalent 
process of self-transformation and I turn to disability scholars to unpack what this means for people 
who have lost a hand or both hands. Historically, chapter 3 picks up where chapter 1 leaves off, 
tracing recent movements in hand transplant ethics via close analysis of published editorials, case 
studies, and review articles, as well as talks by field leaders braced against my own observations.  
I conclude the argument of my dissertation by calling for strategies to increase transparency 
among competitive research programs in the hand transplant field, and for the establishment of a 
formal patient advocacy and support network for HTX/VCA recipients and prospective candidates. 
As I argue in chapter 1, hand transplants were the original VCA promising life-altering “quality of 
life” improvements for patients despite immunosuppression—yet the nature of QoL effects in the 
lives of patient families are far more challenging, person-specific, complicated, and drawn-out 
than medical case studies and reviews represent (as I demonstrate in chapter 2 through my 
interpretation of patient narratives). The effect of these gaps in knowledge and even conflicting 
views on the range of outcomes for HTX has been almost nonexistent in terms of slowing 
professional enthusiasm for performing hand transplants and declaring their contributions to 
medical “progress” (chapter 3). It is therefore imperative that bioethicists, medical humanities 
scholars, and thought leaders in hand transplantation/VCA institute a new rhetorical standard for 
the representation of patients in their field; these efforts would in my opinion begin with the 
establishment of a patient advocacy and support group as well as field-wide agreements on 
strategies to improve data sharing and transparency.       
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2.0  A BRIEF AND DISQUIETING HISTORY OF HUMAN HAND 
TRANSPLANTATION 
“Our patients aren’t going to be concert pianists, you know.” 
~ Repeated saying among hand transplant 
researchers in Louisville KY, 2010-2011 
In July 2016, two news articles about hand transplantation were published in international 
media outlets in England and the U.S. The first was from the BBC, “Double hand transplant: UK's 
first operation a 'tremendous' success,” the second from TIME magazine, “I can do absolutely 
nothing: The first American with a double hand transplant wants them removed.” The publication 
of these (albeit indirectly) contrasting headlines within days of each other suggests hand transplant 
outcomes or the claims connected with these surgeries may be highly variable case by case.  
September 2018 marked 20 years since the first modern attempt at human hand 
transplantation. When I first began reading about these rare and complicated surgeries, I was a 
college student studying English and writing in Louisville, Kentucky. Hand transplants were a 
recurring topic in Louisville’s Courier-Journal newspaper at the time, since several of the first 
modern attempts at hand transplantation were performed in Louisville in the late 90’s and early 
00’s, and because Louisville doctor-researchers were pivotal to the establishment of the field. As 
a new orientation for organ transplantation presenting unique but risky rehabilitative opportunities 
for amputees, the possibility of carrying out life-changing reconstructive allografts brought novel 
ethical quandaries for transplant scientists and surgeons.  
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In this chapter of my dissertation I argue that, unlike the introduction of lifesaving solid 
organ transplants, it was primarily rhetorical, not scientific, invention which gave birth to the field 
of hand transplantation (HTX). In the first half of this chapter I trace transformations in the 
possibility and permissibility of hand transplantation as constructed by field “pioneers,” noting 
key moments in the discourse on HTX where dialogue and textual intervention occasioned new 
ways of imagining medical responses to hand loss. First, I attend to the unprecedented 
interdisciplinary cooperation which illuminated previously cloistered knowledges of 
transplantologists and hand surgeons, and how as a unified group these hand transplant hopefuls 
performed the rhetorical and ekphrastic work of visualizing HTX operations as dramatic 
improvements to future recipients’ quality of life (QoL) where monumental gains to QoL could be 
conceived as outweighing the drawbacks of immunosuppression. The second half of the chapter 
covers the establishment of hand transplantation as a field of medical research, including 
discussion on the mixed outcomes of early experimental HTX cases and the way these were 
interpreted as evidence that hand transplants can be successful. The very notion that “quality of 
life” could be a site of intervention for organ transplantation has been called “a quiet revolution in 
organ transplant ethics” by prominent bioethics scholars. Because almost all of the rhetorical heavy 
lifting giving rise to and sustaining the field of hand transplantation relies on the promise of 
“beneficence,” or the idea that HTX present an opportunity to improve the QoL of a vulnerable 
population of care seekers despite the known burdens of immunosuppression and steroids, I argue 
in the conclusion of this chapter that in-depth first-person, qualitative research is needed to 
illuminate tradeoffs for patients. 
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2.1 TRANSPLANTING HUMAN HANDS: PRECLINICAL OBSTACLES AND 
OPPORTUNITIES 
Organ transplantation has for many years been the standard of care for life-threatening 
conditions such as heart, liver, and kidney failure, because statistically significant longitudinal 
studies of tens of thousands of organ transplants since the late-1900’s have depicted organ 
recipients living longer lives with fewer health complications than those with the same underlying 
condition who did not get a transplant (Hamilton, 2012). However, it was not clear to researchers 
in the preclinical years of hand transplantation that the benefits of graft hands would outweigh 
their financial, physical, and possibly psychological, costs (Lee and Mathes, 1999; Foucher, 1999; 
Jones, 2002). While toxic drugs that impair immune activity may be a reasonable burden for people 
suffering organ failure who would likely die without a transplant, people living without hands 
might not want to risk iatrogenic complications and possibly death for quality-of-life gains in 
functionality and aesthetics.  
When considering these risks, advocates of hand transplantation had to navigate the reality 
that in addition to being risky and possibly life-shortening, people living without a hand or both 
hands have access to aesthetic and bionic prosthetics (although many users abandon these devices 
as not especially helpful or practical in their daily lives) (Kay and Wilks, 2013). Some bioethicists 
voiced further concerns that hand grafts could damage the public image of transplant medicine if 
they ended badly for patients. “The risk associated with extending transplantation to organs that 
are not directly lifesaving,” writes Cleveland Clinic ethicist George Agich, “is that such extension 
might compromise the ethical legitimacy of the entire transplantation enterprise and could 
ultimately adversely affect organ donation” (2003, p. 142). 
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Early hopes for hand transplantation were greatly burdened by memories of a failed hand 
transplant in Ecuador in 1964, in which the patient’s immune system quickly attacked and 
destroyed the transplanted tissue. Advocates of hand transplantation have cited primitive 
immunosuppressants as the reason for the failure of this first recorded attempt: “Despite the use of 
systemic steroids and azathioprine [in 1964 in Ecuador], severe rejection developed 2 weeks after 
the operation and amputation was performed. The development of more efficacious and 
mechanistically driven immunotherapy in the 1980s moved the possibility of successful [hand 
transplantation] closer to reality” (Ravindra, McKinney, Xu, and Ildstad, 2009, p. 3519-3520). 
Although steady advances in immunosuppressant medications were made throughout the 70’s, 
80’s and early 90’s, largely cynical attitudes on the potential for hand transplants persisted as 
animal model experiments did not appear to show promise for human application (Jones, 
Breidenbach, Barker, and Gruber, 1999; Ruppel, 2011).  
By the time hand transplants were again being seriously considered for trials in a human 
patient, life-extending solid organ transplantation and reconstructive microsurgery were both well-
developed fields of clinical care and scientific research, making hand transplantation a project that 
depended not on the development of new tools but on demonstrating the maturity and efficacy of 
existing ones (Barker and Markmann, 2003). HTX researchers in the late 90s began to argue that 
for the right patient, successful hand transplantation was basically a matter of balancing quality of 
life gains in function with the drawbacks of immunosuppression. “Hand transplantation may be a 
landmark for society, but it is not a major surgical or immunological advance,” write plastic 
surgeons and limb transplant researchers Shehan Hettiaratchy, Peter Butler, and W. P. Andrew 
Lee in 2001. “Surgeons have had the technical ability to reattach amputated parts of the upper limb 
for over 30 years. … Similarly, hand transplants do not herald a breakthrough in transplant 
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immunology. [Modern] immunosuppressant drugs mean that rejection can be prevented of even 
very antigenic tissues” (2001, p. 494; see also Kann and Hewitt, 2001). Rather than waiting for a 
major advance in immunomodulatory technology to attempt a human hand transplant, the field of 
modern hand transplantation began when researchers realized that, “[t]he crux of the matter is how 
much immunosuppression can be justified for a non-life-saving-procedure?” (ibid.), which 
effectively reshaped the scientific barrier into a rhetorical one.  
Scientific challenges: Building “proof of concept” for HTX with existing tools 
The first serious public and academic debates on hand transplantation as a clinical 
possibility were initiated by a group of hand surgeons and transplant doctors at Jewish Hospital in 
Louisville, Kentucky, in the late 1990’s. The group, led by surgeons in the celebrated Kleinert 
Kutz Hand Center, were funded by a grant from Jewish Hospital to pursue the next groundbreaking 
innovation in hand surgery and the group chose hand transplantation as their target of exploration. 
In a retrospective chapter for a clinical textbook on hand transplantation, members of the Louisville 
team describe the world’s first successful hand transplant as a goal towards which they began to 
strive inviting the participation of international colleagues and peer communities:  
In June 1996, we organized a team of surgeons comprising hand, plastic, and 
transplant specialties along with members representing transplant psychiatry, 
pathology, tissue typing, hand therapy, and organ procurement. This constituted the 
Louisville Hand Transplant team. In November 1997, the First International 
Symposium on Composite Tissue Allotransplantation was convened in Louisville, 
Kentucky. The goal of this meeting was to discuss the scientific, clinical and ethical 
barriers standing in the way of performing the first human hand transplant (2008, 
p. 215).
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A dominating anxiety among the Louisville hand transplant team, and other limb transplant 
researchers at the time, concerned the biological complexity of the human hand—not its 
psychosocial intricacies or the challenges of sourcing an “external” (visible and social) organ graft. 
Composed of muscle, bone, nerve, blood, and skin, hands as “composite tissues” were thought to 
require higher levels of immunosuppression than internal organs of comparatively more 
homogenous tissue type. Gordon Tobin, a biomedical scientist who worked with the Louisville 
team, retrospectively describes the state of knowledge at that time, “Virtually all investigators 
believed that epithelium [skin] had such great antigenicity that it was insurmountable by 
immunosuppressive drugs” (Tobin et al, 2009, p. 467). Tobin has also said that, “Most of us [on 
the Louisville Hand Transplant Team] were skeptical that [our project] would come to anything in 
the near future. From the 60’s through the 90’s, it was universally believed that skin was too 
antigenic to transplant. The literature was very discouraging. There had been some success with 
mice, but their immune system is so different from ours that no one would take those results and 
think they would be transferrable in humans” (interview with Tobin, 2010).  
The Louisville group perceived that unless they could achieve graft longevity with regular 
amounts of immunosuppression (for instance, the same quantities used in kidney transplants), hand 
transplantation would never be seen as ethically allowable due to the serious side effects of 
transplant medications. Even at therapeutic levels, immunosuppressant drugs can cause 
nephrotoxicity (kidney damage), diabetes, weight gain, are linked to higher rates of some cancers, 
and make transplant patients more susceptible to opportunistic infections and disease (Brenner et 
al, 2002). The effects of a more-aggressive-than-average immunosuppressive regimen on an 
otherwise healthy body were seen as too detrimental to justify a non-life-saving transplant (Tobin 
et al, 2005). Other issues that remained to be considered included the fact that a transplant hand, 
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unlike a heart or kidney, would not be immediately functional, yet would be visible all the time 
(Klapheke, Marcell, Taliaferro, and Creamer, 2000). Years of work-intensive physical therapy 
(four to six hours a day for up to two years) would be required to keep the muscles on a graft hand 
from atrophying in the healing process, and to stimulate communication between the donor hand 
and the recipient’s brain (Bueno et al, 2014; Hartzell et al, 2011). The burden of adaptation and 
compliance would be shared by the patient and their family members, which was difficult to 
envision (interview with Martin Klapheke, 2010). For all of these reasons, the potential benefits 
of a biological reconstructive option such as a transplant hand had to be explicitly articulated and 
compared to existing alternatives.  
In order to demonstrate scientific proof of concept, the Jewish Hospital doctors partnered 
with researchers at the University of Louisville to conduct large-animal limb graft experiments in 
which they deployed standard immunosuppressive protocols to determine the tissue- and life- 
preserving efficacy of contemporary transplant drugs for use in complex “organs” like hands 
(Jones, Breidenbach, Barker, and Gruber, 1999). They also performed an extensive literature 
review. The lead surgeon on the Louisville team, Warren Breidenbach III, worked with colleagues 
in transplant medicine to conduct the review. He has described this process as challenging due to 
the disparity of approaches used by scientists at the time. Breidenbach says, “I couldn’t make any 
sense of [these papers]. Someone would do an experiment with drug A and B, someone else B and 
C… The first person might do it for 60 days and stop, the next maybe 30 days. It was hard to 
synthesize a consistent theme.” However, he says, “[Ultimately] it was shocking—by time we 
finished literature review, it was completely clear that every tissue in the human hand had already 
been successfully transplanted with normal doses of immunosuppression. Many of the articles had 
flown below the radar even though they shouldn’t have” (interview with Breidenbach, 2010).  
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Ethical challenges: Balancing risks and benefits in terms of “quality of life” 
The scientific challenges of hand transplantation were closely tied to the ethics of 
immunosuppression in an otherwise healthy patient. Bioethicists working with the Louisville 
group and attending their conferences grappled with the question of whether it would be morally 
permissible to subject willing candidates to lifelong dependence on toxic pharmaceuticals simply 
to correct an unwanted condition of physical difference (Siegler, 1998; Dickenson and Hakim, 
1999; Simmons, 2000). Concurrent with the literature review and large animal trials, the Louisville 
group hired transplant ethicist Mark Siegler to serve as an outside-observer at several of their 
meetings and to help them identify philosophical and social implications. With Siegler’s counsel, 
the Louisville group developed a strategy for proceeding that included public and professional 
debate as well as rigorous patient selection and preparation protocols (Cooney et al, 2018; Tobin 
et al, 2009). As Tobin has said, “In innovative medicine, being demonstrative and clear allows the 
public and other professionals to weigh in with their critiques and suggestions long before you put 
a patient on the table. It also protects investigators from doing something for their own glory rather 
than for the good of the patient” (interview with Tobin, 2010). Siegler guided the team in their 
efforts to remain transparent and establish the best possible environment for success. Siegler writes 
that in his own estimation, he weighed the question of risk in hand transplantation with the 
principles of beneficence and autonomy: “is improving the patient’s quality of life (as determined 
by the patient) sufficient grounds to allow patients to risk morbidity and mortality? The answer is 
clearly ‘yes’ because such trade-offs are inevitable and are not unique to hand transplantation. In 
fact, people make trade-offs in their everyday life between quality of life (in their terms) and risk” 
(Siegler, 1998, p. 2781). 
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After the Louisville Hand Transplant team established scientific viability and worked 
through the ethical issues with international experts at conferences and in the literature, they began 
looking for a suitable patient candidate. Hundreds of people with upper limb amputations applied 
for the role. The team eventually chose Matt Scott, a New Jersey unilateral amputee and paramedic 
who expressed strong disaffiliation with his brain-controlled prosthesis as too heavy, too 
cumbersome, and not “human” enough—despite his ability to successfully use it. Empirical tests 
of Scott’s candidacy included numerous physicals and extensive bloodwork. The team contacted 
Scott’s insurance company to ensure all of his post-transplant drugs and therapy would be covered 
for as long as the graft survived. Scott was informed repeatedly that the operation had every chance 
of failing, and to mitigate any irrational hopes that might undermine his understanding of those 
odds, Scott was required to appoint a “patient advocate,” defined by the Louisville group as a 
college-educated person with a trusting relationship with the prospective patient who genuinely 
cares for them and who would be willing to scrutinize all aspects of the process including the 
institutional preparedness for a surgery of this kind. Finally, the candidate’s psychosocial health 
was evaluated by a specialist in transplant psychology, Martin Klapheke (Ruppel, 2011; Tobin et 
al, 2009).  
Tobin explains the hand transplant team’s extreme scrutiny of their patient as necessary for 
novel medical interventions that are also dangerous: “These days [identifying the risks and benefits 
of hand transplantation] is easier because we have a good measure of success, but when we were 
first working on this, there was none of that. To Dr. Breidenbach’s credit, he was very, very honest 
with the candidates. He said, ‘I give it about a fifty-fifty chance of [turning black and] ‘falling off’ 
within a year, and you might not have any function at all, and you could die.’ I thought that was 
very straightforward of him not to over-represent the results” (interview with Tobin, 2010). Paul 
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Simmons, an ethicist who worked with the Louisville group, recalls of this process that they placed, 
“a high priority on professional and public discussions” which included symposia in Louisville, 
Vancouver, and Chicago between 1997 and 1999, at which internationally recognized experts in 
hand surgery, transplantation, immunology, and bioethics debated “every aspect of the procedure, 
even before a protocol was submitted to the IRB” (2000, p. 462).  
The predicament of the first hand transplant candidates may have been dire if the treatment 
failed, but it was not likely to have been as severe as the situation faced by the first heart, kidney, 
and liver recipients, due to the non-lethal nature of limb loss as a medical condition. Indeed, “In 
hand transplantation, immunosuppression can be abruptly terminated when a life-threatening 
complication arises, and the hand can be amputated if necessary” (Baumeister et al 2004, p. 102). 
In the case of the world’s first modern attempt at hand transplantation, this was the tragic—albeit 
not fatal—result.  
The first modern hand transplants: Rival efforts in Louisville and Lyon 
The Louisville hand transplant team learned late that they had been in competition to 
perform the world’s first successful hand transplant. In September 1998, an international team of 
surgeons in Lyon, France, carried out the operation on their patient, a businessman from New 
Zealand named Clint Hallam. “As it turned out, the effort for ‘public display’ had the effect of 
notifying the world of the intention to be first with the procedure and thus encouraging others to 
beat them to the draw,” writes Simmons, “Thus, the first hand transplant took place not in 
Louisville, but Lyons, France” (2000, p. 462).  
Nadey Hakim, a member of the Lyon team, writes that his colleagues had been 
contemplating a hand transplant long before the Louisville Hand Transplant team converged on 
the idea: 
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Earl Owen, world-renowned pioneer of microsurgery and a good friend of mine, 
first voiced the idea of a hand transplant more than 30 years ago at a speech at 
Edinburgh University, but it was not until the mid-1990s that he decided it was both 
technically and immunologically possible … Earl was keen to form a team of 
experts in preparation for the procedure, so I suggested we contact Jean Michel-
Dubernard in Lyon, Head of Transplantation and urology at the city’s Edouard 
Herriot Hospital, where Earl had been a visiting professor for 20 years … 
[Dubernard] was excited by Earl’s suggestion and agreed that the proposed forearm 
transplant could go ahead in his department in Lyons. Earl quietly began 
assembling a skilled international team comprised of transplant, orthopaedic and 
hand microsurgeons, anaesthetists, a psychiatrist and a psychologist specialising in 
body image disturbances (Hakim, 2006, p. 1-2 in Hakim, Owen, and Dubernard, 
2006). 
Several members of Lyon group had participated in conferences or followed the 
proceedings published by the Louisville team. Jean-Michel Dubernard agreed with Earl Owen that 
the scientific and ethical justifications offered by the Louisville group and others were sufficient 
to justify an experiment in humans. Together they presented this argument to the Ethics Committee 
of Lyon University and to the Edouard Herriott Hospital’s patient protection board. Both 
committees approved the procedure; Owen and Dubernard finished assembling their team, and 
chose a patient as well as a time to convene for the operation. In a chapter for a book on transplant 
history published in Greek and English, Dubernard reflects on various developments leading to 
the first modern attempt at hand transplantation, “In April 1998, the final decision to go ahead was 
taken. … Earl and I chose September as a suitable month for the operation. Ironically, at a meeting 
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on composite tissue allografts held in Louisville in 1997, John Barker said during his concluding 
remarks that the time had come to ‘just do it.’ The account of this meeting was published in 
Transplantation Proceedings. We received the issue in Lyon in September 1998! Indeed the time 
had really come to just do it” (2011, p. 36). 
However, some aspects of the Lyon group’s inaugural attempt at hand transplantation are 
curiously out of sync with the apparent scrupulousness of the Louisville group in terms of selecting 
and preparing their patient for a deeply invasive and highly visible experimental procedure:  
Earl [Owen] and Clint [Hallam] arrived in Lyon in early September. They stayed 
at the Reine Astrid Hotel where [our team’s psychiatrist] Gabriel Burloux joined us 
and immediately disappeared into Clint’s room. Earl and I waited patiently in the 
lobby but with growing anxiety as nearly two hours passed. When Gabriel finally 
emerged, he gave us the green light. He agreed to take charge of Clint and come 
whenever it was necessary during the pre-and postoperative period. We needed a 
donor as soon as possible, but our procurement area was restricted by Didier 
Houssin to the Rhöne-Alpes region around Lyon (6.5 million inhabitants). The 
regional ABM team was highly motivated, yet I badgered its doctors and nurses 
day in, day out. My routine everyday activities kept me busy but Earl was going 
round in circles. We rehearsed all the steps of the operative procedure on cadavers 
until we knew them inside out. Anxiety was rising. Finally, we decided that if no 
donor came up by the end of September, we would cancel the attempt. … Money 
was a problem. Clint was supposed to arrive with enough money to cover hospital 
costs. He said that he had put it in his suitcase, but the suitcase which was in the 
hold of the British Airways aircraft during the flight from Sydney to London had 
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been lost. I called British Airways several times but was told that no suitcase had 
been registered on his departure from Sydney. Clint admitted that he could not 
muster the necessary funds. He was virtually penniless. We forgave him for lying 
on the grounds that he was so determined to have the transplant, but doubts about 
his behavior nevertheless persisted (2011, p. 36).  
Dubernard was able to secure enough funds to perform the operation by going to a personal 
friend and research sponsor, Charles Merrieux, for help. Almost immediately after Merrieux 
agreed, a suitable donor hand was found, and the international team of surgeons Dubernard had 
assembled for the operation—an all-star cast from France, England, Italy, and Australia—were 
called to come in for the procedure (Hakim, Owen, and Dubernard, 2006; Ruppel, 2011). 
Unfortunately, Clint Hallam expressed displeasure with the outcome of the hand transplant 
and requested removal two years later. At first none of his doctors would agree to perform the 
amputation. Hallam allegedly toured various institutions in the U.S. seeking removal of the graft, 
but finally Nadey Hakim agreed to perform the amputation in London in February, 2001 (Ruppel 
2011). In a quote from a New York Times article called “A Short, Speckled History of a 
Transplanted Hand,” published February 27, 2001, physician and writer Lawrence K. Altman 
editorializes that, “From beginning to end, Clint Hallam's landmark hand transplant embarrassed 
nearly everyone involved. The story began in September 1998 when Mr. Hallam, then 48, flew 
halfway around the world from his home in Perth, Australia, for the operation in Lyon, France. … 
The story ended on Feb. 2 in London. In 90 minutes, Dr. Nadey Hakim amputated the very hand 
that he had helped attach and that Mr. Hallam had sought so desperately but did not do enough to 
keep.” Among the acknowledgements granted Clint Hallam following his tenure as a 
groundbreaking experimental hand transplant patient, he is the first man in history to lose his right 
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hand three times (first in a buzz saw accident, next in a failed replant of his original hand, third 
after losing his transplanted hand)—as originally pointed out in a news article by the UK paper 
The Observer. This bit of trivia is compellingly bizarre and unexpected, but more importantly for 
the argument of my dissertation, it suggests a great deal of suffering on the part of the patient.  
In a personal reflection on his role in various transplant firsts, Jean-Michel Dubernard 
describes his frustration with the behavior of his patient, makes a bizarre conjecture as to the reason 
for Hallam’s eventual disaffection with the hand transplant process, and reflects in a markedly 
wistful tenor that, had Hallam been a better patient, the graft tissue might have survived longer: 
Clint was most cooperative and amiable during the first three months after surgery. 
His wife and children came to visit him at Christmas and returned to Perth in early 
January. Clint was supposed to meet up with them and Earl three days later. Then 
he disappeared. We knew that he was in the United States as he was regularly 
appearing on TV and in the newspapers … Clint had always shown streaks of 
brilliance but his behavior was difficult to understand. When he discovered that 
Denis C., the bilateral hand transplant, [sic] had had an audience with Pope John-
Paul II, he also went to Rome but he failed to meet the pope. He was very 
disappointed. Was this why he discontinued treatment in September 2000? Palmira 
Petruzzo, an Italian vascular surgeon and member of our team, took great pains to 
persuade him to resume the drugs but to no avail. One month after discontinuation 
[of his transplant drugs], the signs of rejection were still only moderate. They 
disappeared rapidly on treatment but so did the patient. In the end, the hand was 
amputated by Nadey Hakim in London in February 2001. According to Jean 
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Kanitakis, our pathologist who examined the graft, rejection could still have been 
reversible (2001, p. 37). 
In his own accounting of the Lyon team’s experiences, Nadey Hakim provides a more 
strenuously passive, yet similarly success-oriented interpretation of the events leading up to and 
following Clint Hallam’s hand transplant (and misses not a beat before claiming that the logical 
next step for their research team would be to attempt an even more challenging and hazardous 
bilateral hand transplant): 
The surgery was successful, and so was the adherence to the immunosuppressive 
regime which has started preoperatively with intravenous anti-lymphocyte serum 
and first doses of the immunosuppressive cocktail of drugs. “My hand’s back,” said 
Hallam on emerging from the anaesthetic. “It’s almost like I lost an old friend years 
ago, and suddenly it’s back.” Congratulations arrived from Jaques Chiraq, the 
French President. Dan Rather, CBS News presenter, stated, “It’s the kind of 
quantum leap in modern medicine that, when it happens, is stunning” … Clint 
Hallam left the hospital on January 1, 1999, assuring us that he would be continuing 
the very satisfactory progress of his transplant and was expected to return to 
Australia for continuation of the protocol. It was now the team’s task to perform 
the first successful double arm transplant—another world’s first!” (Hakim, 2006, 
p. 5 in Hakim, Owen, and Dubernard, 2006).
In the above accounts and in nearly all other early reporting of the Lyon team’s first attempt 
at hand transplant, Clint Hallam’s pain and hardships take a back seat to his criminal identity and 
lack of compliance with his clinicians’ (by definition, ad hoc) hand transplant protocol. While it is 
true that at the time of his hand transplant surgery in Lyon, Hallam was wanted in several countries 
28 
for fraud, denouncement of Hallam’s character by his clinicians (taken up by commenters in the 
media) make the whole scenario appear to be Hallam’s fault, rather than his doctors’ fault based 
on rushed preparation, lack of transparency, and inadequate exit strategy (Campbell, 2004; Ruppel, 
2011).  
Disability studies scholar Fiona Kumari Campbell has written a capacious and profoundly 
critical account of the Lyon group’s public representations of Clint Hallam’s experiences in their 
first hand transplant experiment; Campbell’s is the best synopsis I have found of the media reports 
coming out around this time:  
The Clint Hallam international surgical soap‐opera which played out in the 
electronic and print media during 1998–2000 is an apt example of the ways in 
which contemporary technological practices interface with both popular and 
technical formations of what it means to be ‘dis‐abled’ and ‘nearly‐abled’. … [In 
this case] the contentious nature of the surgical experiment is erased and evaporates 
in media reports to be replaced by the underlying theme of the marvels of medical 
discovery, ‘gift-giving’ (narratives of optimism), and Clint’s ungrateful ‘deviant’ 
response… the experience and insights of Clint Hallam [are] not generally 
addressed and [are] consistently erased (Campbell 2004, p. 444).  
As Campbell points out, it is striking how little energy is expended in the above accounts 
considering the motives, interests, suffering, and even firsthand experiences of the world’s 
first modern hand transplant patient.  
Transplanted six months later than Clint Hallam in January, 1999, the candidate in 
Louisville, Matt Scott, was by most accounts better selected and better prepared than the French 
patient. Scott now possesses the long-surviving hand allograft of over 20 years and frequently 
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appears at meetings to articulate his satisfaction with the outcome—this despite the fact that in the 
days after receiving the transplant hand, tabloid snooping revealed that the donated hand came 
from a man who had been convicted of manslaughter, and whose death occurred via suicide 
(Ruppel, 2011).  
2.2 THE ESTABLISHMENT OF A MEDICAL FIELD: REPRESENTING EARLY 
EXPERIENCES IN HAND TRANSPLANTATION   
Parsing cause and effect in many-faceted procedures like hand transplantation is a nuanced 
task that betrays the inherent subjectivity of data interpretation in medical science. In the rest of 
this chapter I will show how, when recounting the history of hand transplantation in editorials, 
review articles, and other publications, field leaders and observing peers have given fundamentally 
different interpretations of the first successful case of hand transplantation, and why this affects 
both scientific knowledge in the field today and public understanding of the value of hand 
transplantation and other types of VCA.  
The world’s first successful hand transplant 
Today, Matt Scott is unanimously recognized as the worlds “most successful” hand 
transplant patient having enjoyed high satisfaction with his graft for over 20 years. A special event 
at the 2018 American Society of Reconstructive Transplantation (ASRT) publicly honored Matt 
for his efforts and progress and thanked him for ambassadorship in the field. Nevertheless, when 
speaking of the “world’s first successful hand transplant” today, doctors and journalists must take 
pains to clarify whether they mean the Lyon or the Louisville attempt. Frustratingly, in very few 
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of the academic or public-facing texts recounting the history and ethics of hand transplants and 
VCA do authors give an account of how they reconstructed relevant events or awarded primacy to 
successful “firsts.” See, for example, this quote in a paper by hand surgeons Mendenhall, Brown, 
Ben-Amotz, Neumeister, and Levin, which glosses the history of HTX/VCA giving primacy to the 
Lyon group’s 1998 hand transplant, without mentioning the hand transplants that were attempted 
in Ecuador and in Louisville: “Many advancements in VCA have taken place since the first hand 
transplantation was performed in Lyon, France, 2 decades ago” (2018, accessed online). A more 
recent paper acknowledges the Ecuador hand transplant and awards “success” to Matt Scott, but 
completely skips over the 1998 Lyon hand transplant on the way to Louisville in 1999: “in 1964, 
a hand transplant was performed in Ecuador on a sailor who had lost both arms in an explosion… 
However, the patient’s graft was rejected and was explanted at week 3. The field was stagnant 
until the 1980s, when the discovery of calcineurin inhibitors improved immunotherapy and made 
limb transplantation viable. In 1999, a hand was transplanted with longterm success in Louisville, 
Kentucky, reawakening interest in CTA and reconstructive transplantation. By 2009, 53 successful 
hand transplants had been performed worldwide” (Reece and Ackah, 2019, p. 63). According to a 
recent review article by Canadian hand surgeons Noor Alolabi, Haley Augustine, and Achilles 
Thoma, which gives a history of the hand transplant field, 
The first attempted hand transplantation was performed in Ecuador in 1964. The 
transplant survived 2 weeks but was lost to acute rejection … In 1998, the second 
hand transplant was performed in Lyon, France. The patient ultimately lost the 
transplant after 2 years because of rejection secondary to medication 
noncompliance. Following this, the first successful hand transplant with long-term 
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survivability was performed in Louisville, Kentucky, in 1999 (2017, p. 23; italics 
added). 
Of note in the above passage by Alolabi, Augustine, and Thoma, the authors give credit to 
the Louisville group’s work by writing that the “first successful hand transplant” occurred in 
Louisville in 1999—whereas the Lyon transplant is not described as having ever been successful. 
How the authors structure the source of adverse outcomes is also interesting: in their description 
of the historical attempt in 1964, that hand graft “was lost” (passive voice) to “acute rejection”—
clearly a medical cause for failure as immunosuppressants were underdeveloped at the time. The 
Lyon failure, however, is narrated in active voice: “The patient ultimately lost the transplant” and 
there can be no question regarding why: “secondary to medication noncompliance.” (See 
UPMC/Johns Hopkins researchers Jaime Shores, Gerald Brandacher and Andrew Lee 2015 for a 
similar synopsis.) 
Researchers in the Louisville group have published their own versions of the early world 
experience in hand transplantation. In the following quote from a 2009 paper, Tobin and colleagues 
skip mentioning the hand transplant attempt in Ecuador in 1964, award their patient robust 
accolades for his superior results in the 2000s, and account for Clint Hallam’s graft loss as having 
resulted from poor clinical preparation rather than his own “noncompliance”: 
The first 2 hand CTAs provided paradigms defining subsequent world experience. 
The Louisville patient was carefully selected with thorough psychological 
screening, preparation, and family involvement. He was disciplined in 
rehabilitation, in taking medication, and in ongoing monitoring … The single 
exception to the Western experience was the first recipient of the team in Lyon. … 
The procedure went well, but the recipient prematurely left the care of his 
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physicians against advice … Two years after transplantation, he requested 
amputation from members of the original team. … Thus, all hand allograft losses 
to date have come from either poor psychological screening or loss of access to 
immunosuppression, and success correlates with thorough psychosocial screening, 
preoperative education, intense rehabilitation therapy, assurance of ongoing 
medications, and close follow-up” (p. 468, italics added). 
In another paper, the Louisville group offers a more succinct verdict on the matter of Clint Hallam 
and the world’s first successful hand transplant: “It is the Louisville team’s view that failure could 
have been prevented by careful screening and a thorough psychosocial and psychiatric evaluation 
of this candidate” (Brown et al, 2007, p. 359). Notable in the above accounts is how authors 
characterize responsibility for unsuccessful hand transplants. Whereas Alolabi, Augustine, and 
Thoma continue a tradition of blaming the patient, the Louisville group places responsibility in the 
hands of doctor-researchers (failed preparation).  
 One of the most thorough and “objective” regularly published reports on the outcomes of 
hand transplants and other reconstructive transplants is a collaborative update called the 
“International Registry on Hand and Composite Tissue Transplantation” (IRHCTA). In an early 
publication of the Registry in 2006, authors write that, “Of the 23 hands transplanted, all were 
viable at 1 year after transplantation; then 8 graft failures occurred, caused by rejection in a 
noncompliant patient [Clint Hallam] and in the Chinese patients who did not take the 
immunosuppressive treatment” (Lanzetta et al, p. 481, italics added). Perhaps because the authors 
on this review include representatives from the Louisville and Lyon programs, as well as providers 
who started programs in China, Poland, Italy, and Austria, all 23 hand transplants performed up to 
that time are described as having been “viable” at 1 year following the procedure. Although authors 
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acknowledge and seemingly agree that, “8 graft failures occurred,” the source of failure is located 
explicitly “in a noncompliant patient” or in patients’ decisions not to follow medical protocols.  
Interestingly, in our interview for the oral history project that informs my dissertation, Matt 
Scott described to me his ambivalent feelings about the superlative nature of his medical 
achievement and his conflict over the treatment of Clint Hallam by doctors and media 
representatives: “I just happened to be ‘successful’ because [my hand graft has] lasted the longest. 
Honestly, I think Clint, for all his troubles and all his tribulations that he had afterwards, I think 
that he was an incredibly brave soul, whatever his motivations were... I owe Clint a world of 
gratitude for being the first one to get out there and do it, to be the first one to be criticized as 
heavily as he was criticized” (oral history interview with Scott, 2015).  
Establishing a medical field: The evolution of hand transplantation 
In a 2001 paper for The Lancet titled, “Lessons from Hand Transplantations,” several hand 
surgeons with early interest in hand transplantation describe the contentious climate on the topic 
of hand transplantation closely following the Lyon and Louisville cases: “In the aftermath of the 
failure of the first hand transplant, surgeons and patient have traded accusations. He did not comply 
with the therapy, allege the surgeons; my body has had enough, counters the patient. Essentially 
they are both illustrating the same point: immunosuppression for a non-vital, highly antigenic 
transplant is verging on the edge of what is acceptable” (Hettiaratchy, Butler, and Lee, p.495). 
Further complicating the picture of the early global experience in hand transplantation are the 
relatively underreported hand grafts performed in China closely following the Louisville and Lyon 
attempts, in which a change to the Chinese medical system apparently caused loss of access to 
immunosuppressant medications among all the patients; rejection followed inevitably (Tobin et al, 
2009). These early losses, while acknowledged as failures by thought leaders in the field, have not 
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seemed to slow the growth of hand transplantation in terms of discouraging the establishment of 
HTX programs around the world.  
Today over seventy hand transplant operations have been performed worldwide, and they 
have also led to transplants of the face, abdominal wall, penis, and womb (Kollar et al, 2018). 
Nevertheless, hand transplants are still innovative medicine, offered only under research protocols 
in many places, though recently some field leaders have argued HTX has a solid history of success 
to the point where it is no longer merely a “transitional” therapy (as argued by Chim et al, 2014), 
but “is moving from acceptance as an ethical surgical experiment to the standard of care.” 
Contemporary hand transplants advocates write that, “[these surgeries] ‘proved to be better than 
anticipated, now raising the issue of whether hand transplantation is the standard of care … [based 
on the fact that] … Complications were less than originally predicted, the hands obtained good 
function, and long-term allograft survival was demonstrated” (Breidenbach et al 2015, p. 367). 
Shores, Brandacher and Lee essentially agree, although they resist “standard of care” terminology: 
“Hand and upper extremity transplantation has demonstrated sufficient improvement in function 
and quality of life that it should no longer be considered purely ‘experimental’” (2015, p. 357e).  
Unfortunately, despite vaunting claims in the literature and optimistic rhetoric from field 
pioneers in retrospectives and reviews, the actual factors affecting or indicating success in a 
particular case of HTX remain unclear in these papers. After almost 20 years of case studies and 
clinical research, ascertaining the appropriate indications and methods for evaluation in hand 
transplantation are vexing tasks for practitioners; some authors have advocated taking excess 
caution in preparing hand transplant patients before surgery, and zealous care in providing them 
with follow-up for as long as they have their hand graft (Dumont, Sann, and Gazarian, 2017, p. 
150). Many in the field still emphasize the importance of finding the “right” patients to ensure 
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success (which seems to conflict with the idea that hand transplantation could be a “standard of 
care” for any patient population). In a 2010 paper on implementation procedures for VCA in the 
U.S., Linda Cendales, also an early member of the Louisville program, and colleagues write that,
“the importance of patient selection and a multidisciplinary evaluation process cannot be 
overemphasized” (Cendales, 2010, p. 14). Samuel Taylor-Alexander, a medical anthropologist 
who has written extensively on the policy developments allowing for the rapid expansion of hand 
transplantation to other indications, has critiqued the heavy stress placed on finding “ideal” patient 
candidates for these high-cost, high risk reconstructive interventions (Taylor-Alexander, 2014). 
Oral histories of hand transplantation: The need for in-depth firsthand accounts 
It is well understood and widely agreed in the literature on hand transplantation that the 
singular goal of a hand transplant is improving the life of a candidate-patient (Siegler, 1998; 
Simmons, 2000; Dickenson and Widdershoven, 2001; Hettiaratchy and Butler, 2001; Tobin et al, 
2005; Baylis, 2004; Caplan and Purves, 2017). Because hand transplantation necessitates not only 
a serious surgical procedure but a grueling therapy schedule, an invasive pharmaceutical regimen, 
and lifelong commitment to caring for the graft, it would seem impossible to know whether, and 
if so, how, hand transplants enhance recipients’ lives without in-depth firsthand accounts of that 
person’s experiences before and after the intervention. The biologically and emotionally complex 
aspects of receiving and living with organs from another person—especially social organs like 
hands—calls for attention to the feelings of patients about their experiences, not just medical 
monitoring of their adherence to research protocols (Svenaeus, 2012; Neukom et al, 2012; 
Williams et al, 2016; Shildrick, Carnie, Wright et al, 2017).  
In a recent review of VCA ethics, Caplan et al explain the importance of accurate, in-depth 
outcomes reporting to the development of clinically successful VCA programs: 
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Maintaining comprehensive data in standardized, transparent formats will be key 
to long-term viability of the field. VCA has to date been characterized by 
competition among pioneering centers across the globe … This environment 
sometimes rewards self-promotion in data reporting. … While the field has made 
preliminary steps toward aggregating data, much work remains to ensure fairness 
by developing transparent eligibility criteria, uniform sharing of protocols and 
outcomes data, establishing patient centered advocacy programs, and updating 
current laws (2018, online first). 
According to UK hand transplant surgeons Simon Kay and Daniel Wilks, efforts toward data 
collection and transparency of the kind recommended by Caplan and colleagues have not yet been 
robust in the HTX/VCA field: “Of the large number of [hand and face] transplants completed now, 
outcome data of value is to be found in few,” (2013, p. 1457, italics added). Similar observations 
on a lack of helpful outcomes data in the behavioral health literature were published by HTX 
psychiatrists Martin Kumnig and colleagues in a 2012 review paper. Kumnig et al. write that, 
“Despite a thorough analysis of the literature, the lack of relevant published information in the 
psychosocial domain of transplanted patients is a significant limitation … The majority of articles 
do not address the psychosocial assessment in any greater than passing detail, so the conclusion 
that can be made from these highly descriptive, mostly empiric studies in the current literature is 
limited” (p. 425). More recently, the poor quality of outcomes reporting in the hand transplant field 
has been remarked on by HTX practitioners and healthcare policy and effectiveness researchers in 
Canada and North Carolina (Health Quality Ontario, 2016, p. 3; Hedges and Rosoff, 2018, p. 2). 
While there have been some attempts to describe transformations in the health and quality 
of life of HTX patients using self-reported, survey-based methods or thematic analysis of 
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psychiatric semi-structured interviews (Bachmann, 2007; Jensen et al, 2012; Kumnig and Jowsey-
Gregoire, 2016), these approaches do not necessarily perform the essential work of describing 
“what happened” and “what it was like” for recipients and their families before and after hand 
transplant surgery. In a 2012 review titled, “Quality of Life Considerations in Upper Limb 
Transplantation,” psychologist and science studies Salley E. Jensen and colleagues consulted 
approximately 250 academic papers on hand transplantation to determine QoL effectiveness, of 
which 27 were included for analysis in their study having “quality of life” as the main topic. 
However, only 3 of these 27 papers included interviews with hand graft recipients as part of their 
methodology. None of the studies were conducted using open-ended questioning techniques by 
non-program-affiliated researchers, and none of them quoted patients directly regarding their 
experiences. In some cases, no attempt was made to approach experimental participants for their 
point of view even when the stated goals of the research were compatible with doing so. In one 
such study, Slatman and Widdershoven conduct what they call a “phenomenological narrative” 
analysis of the first two hand transplants in Europe. Because the authors, “were not in a position 
to collect information from face–to-face interviews,” they conducted their analysis using data 
collected entirely from news media accounts. Slatman and Widdershoven acknowledge that in 
their phenomenology of hand transplantation, “empirical analysis of embodied self-experience is 
limited” (2010, p. 72).  
Hand transplant textbooks seem to make more space than peer-reviewed journal articles 
for patient perspectives. In The Science of Reconstructive Transplantation, (ed Gerald Brandacher, 
2015), an early chapter featuring exposition on, “The Daily Life of a Hand Transplant Recipient” 
(p. 45) offers an account of HTX challenges and opportunities as told by a patient recipient. The 
article is written in first person and details the process of evaluation and recovery, including day-
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to-day challenges and opportunities and general reflections. It is an interesting and helpful account 
in many respects but limited in its empirical utility as textbook editors do not attempt to describe 
the process of inclusion and development of this narrative (i.e., editorial and authorial decisions 
about preparation and representation including why this narrative was chosen from among other 
HTX narratives).  
In a chapter for the textbook, Hand Transplantation, (ed. Marco Lanzetta and Jean-Michel 
Dubernard), Daniele Bachmann writes on the topic of “Quality of Life in Hand Transplant 
Patients.” Although Bachmann did conduct psychiatric interviews with hand transplant recipients, 
sufficient to yield insights on their motivations and experiences, Bachmann’s chapter spans only 
three pages of the 400+ page textbook in which it is published and does not offer quotes from 
patients, nor long-term retrospective follow-up on how the side effects and complications from 
transplant drugs, and the recovery process, balance against gains of psychosocial considerations 
or manual functionality. Bachmann writes:  
[T]ransplantation of hands changes the patient’s body in a radical way; he does not
get his own hands back (we say “he” because all transplanted patients thus far have 
been men), nor does he return to a previous state. The recipient has to make the 
donor hands his own, and, even with the recovery of motor functions and 
sensitivity, these hands are forever present before the patient’s eyes … The hands 
are also highly charged with meaning in the human being’s imagination: …What, 
for example, did the donor’s hands do before his death, during moments of 
intimacy? The patient’s ability to integrate the transplants is also dependent on the 
reaction of the close family circle, which could display feelings of rejection, of 
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disgust or worry, or, on the other hand, could be quite happy for the patient and 
give him vital support in accepting the transplant (2007, p. 365). 
In this passage Bachmann alludes to several potential avenues of deep concern and interest 
regarding the post-transplant lives of people with hand grafts. Disappointingly, the chapter’s 
conclusion follows soon after revelations that transplant hands change the recipient’s own body in 
“a radical way”; that hand grafts are “highly charged with meaning”; and that the patient’s pleasure 
in owning the hands depends heavily on the acceptance of others. Readers can only wonder at the 
sentiments Bachmann’s patients may have expressed that would lead to such compelling 
statements because the interviews are not published alongside professional analysis.  
Conclusion 
Hand transplants were the ground-breaking surgeries in the field of vascularized composite 
allotransplantation (including transplants of the face, abdominal wall, penis, and uterus, all of 
which are now being performed internationally)—thus arguments promoting positive evaluation 
of early VCA operations can be considered, themselves, successful in eliciting support for what is 
now a well-evolved field of chronic care medicine. As I argue above, hand transplants received 
major coverage in news media even though they represented minimal achievement surgically and 
scientifically—the biggest advance in the field was interdisciplinary coordination and 
reconsideration of ethical norms and this work was accomplished discursively. Because 
distinguishing success from failure in life-enhancing procedures like hand transplantation is a 
complex process requiring several means of interpretation, yet few to no studies of hand 
transplantation have so far used a multi-dimensional, qualitative approach to analysis of HTX 
outcomes, my project could be helpful in recognizing hindrances to clarity and reliability across 
different rhetorical venues and audiences. 
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My oral history research, presented in the next chapter of this dissertation, offers a view of 
hand transplantation from the “bottom up” providing balance and richness to abstract medical 
characterizations of success and adding context to contradictory views among professionals. As 
ethicist Paul Simmons wrote in the early days of hand transplantation, “The benefits of [hand 
transplant operations] do not lend themselves to quantification… [Hand transplant patients] speak 
from experience and weighty matters of importance to them that relate to relations with loved ones, 
intensely personal losses and a sense of what is worth it when an opportunity for restoration 
presents itself” (2000, p. 459-460). The oral history summaries and analysis of interviews with 
hand transplant patients, which I present in chapter 2, help us to think through lingering questions 
of risk and benefit that were the focus of early ethical debates on hand transplantation, such as: 
Will a hand transplant be worth the effort and cost? Under what conditions and for what indications 
are hand transplants most likely to be successful? To whom should hand transplants be offered and 
through what tools should their effectiveness be measured? 
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3.0  AN ORAL HISTORY OF HAND TRANSPLANTATION: NARRATIVE 
REPRESENTATIONS OF EXPERIMENTAL OUTCOMES 
“When we got a moment alone, in [the hospital room following double hand transplant surgery], 
we looked at each other and were like, ‘Wow, these are—beautiful—like, they’re so hot.’ 
[Laughing]…is the only thing we could say because, we had like, mere seconds before somebody 
came in the room, to sort of to acknowledge to each other that, we loved the arms." 
~ Angel Gonzales, partner/caregiver of a double hand transplant recipient 
“I wondered how it would actually feel—how odd is that going to be—to have another man's hands 
touching me? I can tell you that is not a factor at all. From the moment they're on, they're his hands, 
moving those hands and using those hands with his own mind and his own heart. The hand is just 
the physical instrument. Him touching me and him holding me and all that, it's coming from 
Rich—his heart, his emotions. To me, from day one, they were his hands.” 
~ Cindy Edwards, widow of a double hand transplant patient 
In recent decades, narrative methods for research and clinical assessment have gained 
consideration in a range of academic and health sciences disciplines. Investigators and specialists 
with vastly different skill sets, values, and approaches to generating meaning have argued for the 
inclusion of narrative inquiry as a viable means of knowledge generation in their work or research 
(Charon, 2001; Coulehan, 2003; Geisler, 2006; Webster and Mertova, 2008; Woods, 2011; Alnaes, 
2012; Neukom et al, 2012; Brockman, 2013; Cudney, 2014; Peek, 2016; Constant and Roberts, 
2017; Hurwitz and Bates, 2018). In primary and chronic care medicine, in particular, calls for 
attention to narratives and narrative processes have increased in frequency and prominence 
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(Editors, 2007; Sgro, 2016; Charon, 2016; Murphy and Franz, 2016; Shildrick et al, 2017). 
Physician and founder of the “narrative medicine” movement, Rita Charon, has argued that patient 
narratives are not merely ornament to the scientific medical record but an irreducible feature of 
medical diagnosis and decision-making, writing, “Clinicians have always at least implicitly 
understood that the most fertile and clinically salient information we derive about patients comes 
from listening to them talking about their illnesses” (2006, p. 192). Disability scholar and 
sociologist Arthur Frank has similarly stated the importance of evaluating ethical situations in 
healthcare through stories, explaining that, “When other people’s values are stated abstractly, these 
values are compelling only to those who already agree with them. When these values are situated 
in stories, that may not lessen the inherent tragedy, but at least this tragedy can be recognized and 
shared” (2016, p. 21; see also Jonsen and Toulmin, 1988, “Prologue” to The Abuse of Casuistry) 
In this chapter of my dissertation I show how narrative methods can be helpful for 
improving current understandings of the goals and limitations of hand transplantation (HTX) as a 
response to chronic disability of the upper extremity. After introducing several opportunities and 
limitations of narrative inquiry for understanding HTX, I present eight narratives of hand 
transplantation based on my oral history interviews with seventeen hand transplant recipients or 
their closest caregivers. The oral history project contains honest, profound, and deeply intimate 
portraits of the lives of hand transplant patients and their families, before and in some cases long 
after surgery. Their testimony describes a broad range of the functional, aesthetic, and emotional 
ramifications of receiving and caring for a single or double hand transplant; in many ways, these 
personal reflections from the patients’ perspective provide a foil for the empirically oriented, 
progress-driven narratives of hand transplant and “vascularized composite allotransplantation” 
(VCA) articulated by field professionals writing in academic journals (see chapter 1). Far from the 
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currently accepted straightforward, “objective” accounting of outcomes comprising assessment 
practices in the majority of papers on HTX outcomes, where benefits to patients are related in 
detached technoscientific parlance, the multi-dimensional meaning of hand transplantation as a 
quality of life enhancing operation is here illuminated by the life stories of patients, where 
comprehensive notions of “normalcy,” health, and happiness, rather than merely organ function 
and survival, constitute “success.” In the third and final section of the chapter I discuss three 
themes that arose through iterative coding of narrative data, most importantly the idea that claims 
to “success” in hand transplantation should begin and end with patients’ own understanding of 
what these operations afford and mean to them.  
3.1 ORAL HISTORIES OF HEALTH AND MEDICINE: CULTIVATING AND 
SHARING PATIENT PERSPECTIVES 
Long before the expression “narrative medicine” was appointed to describe a methodology 
and a movement in 21st century medicine, psychiatrist and anthropologist Arthur Kleinman was 
among those protesting reductive accounts of human illness and disease that characterized the 
“medical gaze” (Foucault and Sheridan, 1973) of the late 1900s. In The Illness Narratives, 
Kleinman censures strenuously scientific depictions of the physician’s role in these 
conceptualizations as dehumanizing to those seeking care, writing, “The everyday priority 
structure of medical training and of healthcare delivery, with its radically materialist pursuit of the 
biological mechanism of disease … disables the healer and disempowers the chronically ill” (1988, 
p. 9). According to narrative medicine and narrative ethics practitioners, the advantages of patient 
storytelling and its counterpart, critical listening, are practical and immediate: the patient’s 
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experience of illness/disorder becomes a valuable source of knowledge both framing and emerging 
within the clinical setting. Importantly, “narrative medicine” is not aimed at gathering patient 
stories with a view to entertaining and informing the public (especially as representation in this 
vein risks exploiting patients) (Campbell, 2004; Charon, 2006; Shakespeare, 1996; Wiltshire, 
1999).  
Despite apparent enthusiasm for narrative methods in many healthcare circles, the idea that 
patient narratives are more subjective or prone to bias than decontextualized biomedical accounts 
of events and procedures is still widespread among healthcare providers. Rita Charon reminds 
readers that, “‘At the risk of sounding anecdotal’ is the preface to much of the story-telling that 
goes on in medicine, and students or clinicians who take the time to hear patients out are thought 
of as either poorly trained or daft” (2006, p. 192). The extent to which narratives of illness can be 
considered empirical data informing clinical research depends on the goals of the discourse and 
the methods of narrative researchers. For instance, subjective firsthand impressions from patients 
would not be as effective as straightforward numerical measurements for tracking and describing 
certain aspects of postoperative management in hand transplantation, such as kidney function over 
time while on immunosuppressants. Additionally, a single narrative case study published in a 
medical journal or textbook which relates in emotional detail the experiences of a particular patient 
could be informative, but could also be a source of unbalanced representation, distracting from 
other types of stories and experiences. Thus the “situatedness” of narratives in the context of other 
informing data, which may include different historical accounts, academic or scientific studies, 
news articles, firsthand observations, etc., is important to take into consideration when working 
with narrative data. As bioethicist Christine Mitchell has written, “although stories convey ethical 
values and entail ethical responsibilities, they import ethical principles and norms that exist apart 
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from the stories themselves and warrant consideration beyond the tools of narrative analysis” 
(2014, p. s13). Narrative researchers must be clear to outline their approach to collection of data 
and give an account of how they have established internal or external validity in their 
representation of narrators and narrated events.  
Whereas narrative medicine and narrative bioethics can be productive towards knowledge 
generation in the clinical setting without the cases under discussion being widely shared, the 
audiences for medical oral history research are typically external, as the creation of a historic 
document for edification of publics is the primary objective (Yow, 2015). The collection of oral 
history transcripts, and researcher interpretations or summaries, are tasks oriented toward 
publication of narratives or their integration into projects that can transport them beyond the 
academic research context. Many oral histories are archived so that the testimony of narrators can 
be studied in its original form, and some are protected and archived for sharing with a future 
audience (Yow, 2015). In the introduction to the edited volume, Oral History, Health and 
Welfare, Paul Thompson argues that using oral history techniques in any field can bring special 
advantages to researchers: “[Oral histories] allow us to explore those crucial areas of life which 
the written record scarcely touches: the private world of family relationships, for example, and 
all the influences from childhood onwards which go into the shaping of a professional life, and 
the often crucial support of partner and family through adulthood” (in Bornat 2000, p. 3). This 
more-intimate view of events or phenomena can be especially useful to medical humanities 
researchers. Thompson continues, “Oral history can delve into the hidden world of the institution, 
the clinic or the hospital, revealing the daily experience of routines and treatments as told by the 
subjects, clients or patients at the receiving end of services” (in Bornat 2000, p. 4).  
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The hand transplant narratives interpreted in this chapter demonstrate the relevance and 
usefulness of narrative accounts to the clinical process and to scientific knowledge. Despite the 
variation in the narratives below—indeed perhaps because of that variation—examination of the 
experience of living with transplanted hands can help inform scientific and social evaluations of 
the risks and benefits of these procedures. As medical humanities researchers Valerie Kalitzkus 
and Peter F. Matthiessen argue, “Because the language and lifeworld of patients and physicians 
can be so far apart, it might be helpful to have an intermediary… [or a] … facilitator between the 
physician’s and the patient’s world” (2009, 85). As an intermediary or interpreter of patient 
experiences in hand transplantation, oral history is an apt tool, especially given its framing of the 
object of concern within the life narrative of the recipient or caregiver (rather than occurring as 
part of a metanarrative of transplantation or medical science). To discover (for example) how 
power dynamics may have contributed to the deterioration of a clinically necessary relationship, 
or how disappointment after failure to regain a desired function could have weighed on a hand 
transplant patient as they struggled to maintain their responsibilities as part of research protocols, 
can give valuable context and empathic possibility to medical accounts of relevant sequelae. 
As oral historian of lung transplantation Mary Jo Festle has written, oral history interviews 
are especially useful for parsing questions of “quality of life” in medicine and healthcare:  
Although quality of life is by definition a subjective phenomenon, thus far the fields 
of medicine, psychology, and social work have tended to rely upon quantitative 
survey-based data to evaluate it. These are useful and help the field to make 
generalizations about whether transplants are worthwhile, but they also have 
limitations … Oral history interviews nicely complement the quantitative data, 
while at the same time alleviating some of the problems with surveys. Since they 
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are characterized by open-ended questions, oral history interviews allows people to 
provide fuller and more detailed description and to supply their own definitions of 
quality (2012, p. 10). 
Indeed, writes Paul Thompson, “To include a user’s perspective of health and welfare in today’s 
practice of oral history is not simply a question of adding a complementary source to match 
documentary evidence.” Rather, oral histories of health and medicine are, more likely to, 
“challenge and subvert understandings of care and control, the boundaries between health and 
welfare, the location of centres and margins and notions of status and eligibility in all sectors of 
society and conditions of life” (in Bornat, 2014, p. 8).  
Although other qualitative methodologies such as cross-sectional survey research and 
open-ended interviews can elicit story-telling and descriptive statements from research 
participants, only narrative methods are explicitly aimed at understanding the complete picture of 
an event or topic from the “ground level” so to speak. And to understand how a speaker’s life 
history shapes their experiences and their reflections on their experiences. Ideally for highly 
cooperative, dynamic interventions like hand transplantations, a more observationally rich, 
ethnographic methodology than oral history interviewing (incorporating direct observations on 
patient and family routines for care, etc.) might be most revealing in terms of illuminating the 
factors eliciting quality of life effects following transplant of a hand or both hands. However, 
scholars have noted the time-consuming nature of even the most basic narrative inquiry in 
medicine, thus more robustly experiential research may be difficult to support (Kalitzkus and 
Matthiessen, 2009, p. 86).  
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3.2 NARRATIVE REPRESENTATIONS OF HAND TRANSPLANTATION: EIGHT 
ORAL HISTORIES 
The eight narratives of hand transplantation related below are summaries of first-person 
oral history interviews conducted with hand transplant patients and their closest caregivers, 
primarily during the summer of 2015. Participants in the oral history project include single and 
double hand transplant recipients at various temporal distances from their transplant (including an 
interview with Matt Scott, recipient of the longest-surviving hand graft at ~20 years). Oral history 
interviews were carried out using a script of open-ended questions beginning with inquiries about 
the narrators’ early life, and carried out in one-on-one, extensive conversations ranging from 50-
140 minutes per interview. Caregivers and family members were interviewed separately from 
direct recipients of hand grafts which provided additional context, richness, and complexity to the 
accounts. Approximately 10-30 minutes at the beginning of every interview were spent talking 
about the narrator’s childhood and family or vocational background. Framing the topic of 
concern—in this case the outcomes of hand transplants—with discussion of the narrator’s early 
life and interests is typical of the oral history approach and helps anchor recorded testimony more 
strongly in the narrator's own speech and values (Yow, 2015).  
Data gathering for this project commenced in April 2015. I began grounded analysis of oral 
history interviews as they were recorded and transcribed, with early descriptive codes informing 
the development of different and more sophisticated research questions as the project progressed. 
By December 2015, all transcriptions were compiled into a master document (organized by order 
of completion of the interviews) so that as codes evolved and narrative summaries were written, 
relevant portions of narrators’ testimony could be easily referenced and compared using the search 
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function in Word. As links between common ideas or story types began to emerge by comparing 
key points or linguistic structures, preliminary thematic observations could be made. For instance, 
early in the process of conducting interviews, I noticed that on the question of whether hand 
recipients and their families had difficulty accepting the donated “secondhand” nature of their own 
or their partner’s hand graft, almost every narrator described feelings of identification and 
affiliation that were unexpectedly robust. This appeared to me significant because HTX patients’ 
potential emotional disaffiliation from their graft hand(s) was a major concern of early hand 
transplant providers (see first epigraph) and because this phenomenological Q&A emerges 
uniquely within the field of hand transplantation/VCA, since life-extending solid organs work 
automatically without the need for patients’ conscious participation. From the document 
containing compiled interviews and codes I created a codebook in Excel. Managing coded data in 
an Excel spreadsheet was efficient and allowed great flexibility in terms of sorting and visualizing 
codes and their references by topic or life phase. To do this I followed recommendations given in 
a Texas A&M tutorial on qualitative data management published on YouTube: 
(https://www.youtube.com/watch?v=1EzJj6efF_c). 
Other activities informing my grounded theory of hand transplantation include close 
rhetorical reading in the literature on hand transplantation, attendance at two international and one 
national meeting on VCA science and ethics (in April 2015, October 2017, and November 2018) 
and through my ongoing collaborations with clinical providers of hand transplantation conferring 
broad practical knowledge of hand transplant protocols and health policy developments. Clinicians 
and scientists I have formally interviewed to increase my knowledge of hand transplant policies 
and procedures include: plastic surgeon and VCA biologist Mario Solari (UPMC, Pittsburgh); 
transplant psychiatrist Andrea DiMartini (UPMC, Pittsburgh); hand surgeon and VCA researcher 
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Warren Breidenbach III (San Antonio, formerly Jewish Hospital, Louisville); plastic surgeon and 
VCA researcher Curt Cetrulo (Massachusetts General Hospital, Boston); plastic surgeon and VCA 
researcher Scott Levin (University of Pennsylvania, Philadelphia); plastic surgeon and VCA 
researcher Vijay Gorantla (Wake Forest University, Winston-Salem, formerly Jewish Hospital, 
Louisville and UPMC, Pittsburgh); plastic surgeon and VCA biologist Jan Plock (University of 
Zurich, Switzerland); plastic surgeon and hand transplant researcher Daniel Wilks (Leeds 
Teaching Hospital, England); VCA biologist Gordon Tobin (University of Louisville, interviewed 
in 2010); plastic surgeon and VCA researcher Bohdan Pomahac (Brigham and Women’s Hospital, 
Boston, interviewed in 2010); plastic surgeon and VCA researcher Simon Talbot (Brigham and 
Women’s Hospital, Boston, interviewed in 2010); transplant surgeon and VCA researcher Jean-
Michel Dubernard (Lyon University, France, interviewed in 2011); transplant psychologist and 
hand transplant psychiatrist Martin Klapheke (Jewish Hospital, Louisville, interviewed in 2010); 
hand transplant coordinator Brenda Blair (Jewish Hospital, Louisville, interviewed in 2010); and 
immunologist and hand transplant researcher Christina Kaufman (Jewish Hospital, Louisville, 
interviewed in 2010). 
As Charlotte Linde writes in Life Stories: The creation of coherence, “Life stories express 
our sense of self: who we are and how we got that way. They are also one very important means 
by which we communicate this sense of self and negotiate it with others” (1993, p. 1). Nevertheless 
some people do not find it natural to imagine the episodes, events, and sensations of their life in a 
“neat” story-like fashion. Although medical humanities scholar Angela Woods has recently argued 
that, “[We should] not presuppose an orientation towards storytelling or narrative self-
presentation” among subjects of qualitative research, (Woods, 2011, p. 76) my mostly 
chronological script of questions reflecting my needs as an oral history researcher did not leave 
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much room for creative or otherwise non-narrative self-representation by oral history narrators in 
this project. As much as possible, I tried to let narrators speak for themselves and associate events 
creatively in the latter questions of the interview which asked for more “gestalt” or comprehensive 
reflections. For efficiency and readability in the interpretations below, I aimed for a “middle” level 
of abstraction and have added light commentary where I felt some extension would be 
advantageous to parsing key aspects of a narrative.  
Narrative 1: Matt Scott 
Before becoming the world’s first indisputably successful hand transplant patient, Matt 
Scott owned and used an Otto Bock myoelectric prosthetic hand, one of the best brain-controlled 
devices available for non-biological restoration of hand function. During a phone interview in 
October 2010, Scott told me,  
Having a prosthetic just wasn’t the same. Don’t get me wrong—the prosthetic 
served me well. It served me very well. I was able to become a top paramedic in 
my field, (with some adjustments), and I got married and fathered two kids. I was 
successful in the ways we define ‘success.’ But mine was a traumatic amputation, 
you know, and after thirteen years of having a prosthetic, I had grown so dissociated 
with it that I’d come to detest it.” 
Matt lost his left hand on December 23rd of 1985 in an accidental fireworks explosion 
while he and friends were celebrating the holidays. Although the accident was deeply traumatic, 
Matt went back to work as a paramedic the next fall. Matt reported his healing process as difficult 
emotionally and laborious, saying shortly after the accident “[I was] absolutely convinced that my 
life as I knew it was over. I was never going to be a medic again. I was probably going to end up 
on a street corner, selling pencils or something like that, that typical thing. I absolutely believed 
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that in the beginning.” Friends and family were crucial to his eventual transition back into a regular 
schedule of work and life. Matt says, “As time moved ahead and the people around me were 
encouraging and working with me and helping me to rationalize and figure out things—and as 
things became more evident that I could—I think the idea that I couldn’t just became further and 
further from my psyche. It was more of, ‘Now, how can I get back?’ as opposed to, ‘What am I 
going to do to get back?’ I knew what I had to do, and I just went out and did it.”  
Navigating personal relationships was described by Matt to be, in some ways, more 
daunting: “I was a young guy. I was 24 years old. The idea of dating and things like that with a 
hook… I thought, ‘that’s a horrible thing to think,’ but it’s what I was thinking when I was that 
age. I did have that period of depression, but once the prosthesis came, and I saw it was cosmetic, 
by and large, in its appearance, and it opened and closed, and once I learned how to use it and once 
I got fairly adapted and adept with it, things started to look a little bit better.” Matt says his Otto 
Bock prosthetic hand “worked well,” but nevertheless did not feel to Matt that it was ever an 
adequate substitute for the real thing. Matt reports the prosthetic was uncomfortable and annoying 
(he had to have a spare battery with him at all times and to check the device’s charge consistently 
throughout the day). He also remarks that it was unbalanced and heavy, causing occasional 
pressure sores “and things like that.” 
Eventually, Matt says, he was “successful in all the ways we define success.” But the 
feeling of otherness and loss did not disperse over time. Instead, he says, it was the opposite: 
“When I would meet people, I would position myself where my prosthesis was out of their view. 
I would turn my body so that they couldn’t see that. Until some point in time when ... they would 
finally realize that, then I have to explain my life to them and what happened and how I did this. 
It just became a very tedious and angering-type way of living.”  The cumulative effect of these 
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negative social interactions made life difficult to enjoy on a daily basis. “Inside, no, I wasn’t 
happy,” Matt says. “I was probably more angry than anything. As the years went on, I became 
more and more angry. Of course, the anger was inward, but sometimes I directed it outward, and 
was sometimes harsh at times with people, not because of their shortcomings but because I was 
angry with myself.”  
It was many years after Matt’s accident that hand transplants began to be seriously 
considered by doctors as a possible solution to chronic disability of the upper extremity. Matt 
remembers clearly the day he heard about hand transplantation: 
I was in London, England, in all places. I was over there on a little bit of vacation. 
On the day that we were leaving, my dad’s wife came upstairs. She went down to 
the coffee shop and came upstairs with the newspaper and said, “You’re not going 
to believe this.” I said, “What’s that?” She showed me this article in the Sunday 
London Times, I’m pretty sure that’s what it was, about this hand transplant team 
in Louisville, Kentucky. Now, I’m in London, England. I’ve been in the United 
States, I didn’t hear a word about it. I had to go to London to hear about it. It was a 
big, two-page article. I read it, read it again on the plane ride home, and the next 
morning, after waking up, I called Jewish Hospital in Louisville, Kentucky and 
said, “I want to be part of this.” 
Hand transplants were an entirely new option at the time and there was no guarantee a 
biological hand graft would be as functional as Matt’s Otto Bock prosthetic. Matt says he was well 
aware of the risks of participation, “My wife at the time was a registered nurse. I was a paramedic. 
It’s not like we had to learn a whole lot in the way of things, I mean, other than the specifics of 
transplantation, but I understood the pharmacology. I understood the problems that are going to 
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happen. I understood [much of the science of] rejection.” Still, Matt had to seriously consider the 
many potential complications and sources of pain associated with hand transplantation (including 
physical and cognitive side effects of immunosuppression, disruption of life during a long healing 
period, intense post-care treatment, pain, and the constant possibility of graft loss). 
In our interview for the oral history project, Matt describes the hand transplant as a needed 
intervention conferring not functional restoration but what might be termed narrative 
transformation. From the moment he woke up with the graft hand, this element of healing from a 
long-time psychological wound was present: 
When I woke up from the surgery the first time and I looked to my left, my hand 
was gone. It was wrapped up in all these bandages. There was a little bit of 
Betadine, maybe a little bit of bloody drainage there, but the hand was gone. This 
time I woke up and looked to the left and there’s fingers pointing at me. It was like 
it was almost a replay of that waking up in the recovery room 13 years prior. It was 
very weird. Yeah, it was very weird… [The hand] was very heavily bandaged and 
everything, and I see this index finger and middle finger and ring finger pointing 
out at me and I’m like, “Oh, my God!” It was just the strangest, strangest feeling of 
like, “I’ve been here before,”—but the outcome was different. Instead of it being 
gone, it was now back. 
After the hand transplant (and a great deal of media coverage of it), the putatively 
negative—and, for Matt, experientially negative—labels “amputee” and “disabled” could no 
longer be associated with his identity. The positive valuations people seemed to make of Matt after 
learning of his participation in a “miraculous” groundbreaking surgical experiment made a 
conspicuous difference in the way that Matt perceived his own value, particularly as reflected in 
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the eyes of others. The hand transplant also conferred some advantages in terms of function and 
aesthetic restoration—however these have never been the focus of Matt’s reflections on his 
experiences. 
Years after his transplant, Matt met his donor family to thank them for their gift and says 
he feels nothing but gratitude for the opportunity to participate, stating that, “If it fell off tomorrow, 
I’d do it again. I feel like I’ve been healed in a way that would make another amputation far easier 
than the first one.”  
Narrative 2: Rich and Cindy Edwards 
One night in February 2006, a chiropractor from Oklahoma was driving to a hunting trip 
with friends when a brush fire completely overwhelmed his truck. On trying to escape the flaming 
vehicle, Rich’s hands were severely burned, and healed into claw-like stumps that Rich called 
“deranged looking.” Before the accident, Rich had been a well-respected chiropractor with a busy 
practice in his hometown. He had to quit working at his practice and suffered extreme depression 
as a result of his injury. Rich recalls:  
“I lost most of my fingers, 7 of my fingers [in the fire]. My hands were distorted, 
and contorted, but I was still somehow determined that I was going back in to 
practice. That set in depression, for the first time in my life. I was extremely 
depressed for years… I still had hope that I could find somebody who could fix my 
hands, get them limber, and movable again, instead of clenched up into kind of a 
fist. We found what, we thought, was the most outstanding one, which was at Duke 
University. He did 5 or 6 surgeries, and my hand was actually worse off than it was 
before he even started. I was very unhappy about that.” 
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After disheartening experiences with traditional reconstructive methods, Rich and his wife, 
Cindy, turned to doctors in Louisville, Kentucky to discuss hand transplantation. Rich had never 
tried prosthetics, and prosthetic rejection had been a stipulation of candidacy in the early years of 
the Louisville hand transplant program; however the lead surgeon at the time of their consultation, 
Dr. Breidenbach, thought Rich might attain better-than-average results due to the fact that his 
hands had never been amputated, and some length of the existing nerves could potentially be 
preserved and transplanted into the graft hand, reducing the amount of time for recovery following 
transplant. Although Rich was initially rejected as a candidate by the first psychiatrist in Louisville, 
he was eventually reevaluated and approved for transplantation. 
 Unfortunately, Rich’s desire was not to regain some function from his new hands, (which 
was likely), but to regain enough function to be able return to his chiropractic practice (which was 
not). Transplanted hands do not work as well as a “normal” hand; even an excellent outcome with 
a hand graft will never attain the same level of dexterity, sensation, and strength as the original. It 
may have been a collectively conditioned response, or an indication of the importance of 
understanding the limitations of these surgeries, that when I first began researching hand 
transplants in 2010, almost every member of the team I interviewed in Louisville observed, “Our 
patients aren’t going to be concert pianists, you know.”  
 As years passed post-transplant, it became more and more clear to Rich and Cindy that the 
much-desired result of returning to work after hand transplantation would remain out of reach, and 
Rich’s depression again became debilitating. While experiencing some return of function and 
sensation was deeply meaningful to Rich and Cindy (for example, being able to hold hands 
together and to pray, more bathroom autonomy, among other affordances), his spirits continued to 
plunge. At the end of the summer 2015, Rich visited a shooting range near his home and killed 
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himself. Cindy mourns the loss of her life partner and is conflicted when describing whether she 
thought hand transplantation had been the best option for their family. 
“Rich couldn't live like this, like the way it was [after the fire]. People were always 
staring at his hands. Children were always staring and pointing. Even though he 
can't do hardly anything with his hands right now, at least they look mostly 
normal… I don't recall really hoping that he'd go back to practice or believing that 
he would. He did. He was hoping and believing. I didn't necessarily bank on that, 
but I was hoping he be able to go back emotionally into the practice. We had an 
associate doctor that was carrying the practice for us while he ... After our accident, 
we had to hire a doctor to carry on the practice. I thought, ‘Well, if he could go back 
in and just oversee and work with the patients and all this, even if he couldn't put 
his hands on them and adjust…’ That was my hope for him, but, because he 
physically couldn't do it, emotionally and mentally, he just actually was defeated. 
He was just defeated by it and didn't want anything to do with the practice, didn't 
want to go back in if he couldn't do it. He pretty much didn't want anything to do 
with it. That was hard. That was an expectation that we never achieved. I was also 
hoping that he would be able to do more with his hands, and he just can't. He just 
can't do more. I mean, he can't. They told us he wouldn't be able to button buttons. 
Okay, I accept that, but he just won't… I wish, just sometimes, just very, very little, 
that Rich would have prosthetics instead because, then, he wouldn't have to take all 
those medications.” 
Rich’s death was not widely reported in the media, and there has not been, to my 
knowledge, a clinical case report published on Rich’s outcomes. While suicide approximately five 
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years after a self-styled “life-enhancing” operation may not look like success to some, Cindy has 
stressed repeatedly in interviews that the hand transplant was better than no change at all. 
Intriguing to me, in conversations with Rich and Cindy, both partners have mentioned a 
shift in their values regarding healthcare which was both necessitated and facilitated by the hand 
transplant process. Before the accident, Rich and Cindy said, they were: “Chiropractic, not 
medical.” Both partners were suspicious of medicalized tendencies toward unnecessary high-tech 
intervention, and both believed in the power of the mind or spirit to heal the body. Rich had even 
been dismissive of people claiming to suffer depression in the past (an attitude he regrets following 
his own experiences). For all of the above reasons, Rich and Cindy were not organ donors. Their 
philosophy of health and medicine changed greatly after the hand transplant experience. First, the 
high level of compliance and cooperation necessitated by hand transplant recovery made it 
necessary to “buy in” to traditional western medical values of transformation and scientific 
progress—this was not, they reported, difficult as the hand transplant was such a unique, exciting, 
and emotionally moving prospect. Second, the extraordinary “gift” of the hands elicited feelings 
of wanting to reciprocate, and persuaded them of the value of other types of transplants—both 
Rich and Cindy quickly became strong advocates of organ transplantation and donation, and Cindy 
donated Rich’s hand grafts to medical research after his death.  
Narrative 3: Angel Gonzales and Will Lautzenheiser 
Double hand transplant patient and former quadruple amputee Will Lautzenheiser was an 
early-career professor of filmmaking in Boston before a virulent streptococcus infection in fall 
2011 necessitated amputations of all four of his limbs. Will’s recovery process included noting 
and critiquing the ways in which socialized expectations and aesthetic ideologies seemed to 
mediate his experience of disability in public spaces. Will also found solace in humor: as a former 
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English major, Will enjoys laughing about the inescapable presence of hand metaphors in the 
English language and has even performed standup comedy in which his jokes often moved toward 
the tension of his appearance by acknowledging and commenting on his experiences as an 
amputee.  
Will’s partner, Angel Gonzales, is a thoughtful and reflective Brooklyn native of 
intimidating self-knowledge, with an apparent talent for nurturing peace and health in challenging 
circumstances. Will and Angel had been dating for a less than two years before Will’s sudden 
illness and the amputations that followed from it. Angel stayed to help Will through the healing 
process, and describes the decision as second nature: “I’m not ... interested in running away; I’m 
interested in the difficult aspects, if that makes sense. The difficult to me is more interesting. 
That’s...more of my character.”  
Will and Angel worked through months and years of readjustment involving prosthetics, 
care assistance, and modifications to their apartment allowing Will to perform a range of daily 
tasks for himself. Life had attained a degree of normalcy when doctors in their hometown of 
Boston offered Will the opportunity to participate in an experimental double hand transplant. 
Angel describes his reaction to the offer as mixed, and in some ways he was bluntly skeptical. 
Growing up in Brooklyn, Angel says, he was immediately looking for the “catch” and describes 
his reservations:  
For all purposes [Will was] was healthy, he just didn’t have arms and legs. So these 
medications introduced a whole new set of things that might happen which will not 
necessarily facilitate life. You know, the skin cancers, diabetes, you know all kinds 
of maybe kidney problems—so in that sense I’m like, “You really need to consider 
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this.” And, I kind of, wasn’t just, jumping on board with it, but, I was also not 
gonna say, “Well you can’t have arms” you know; I wanted it to be his decision. 
Will received a double hand transplant in October 2014. In the recovery period, Will and 
Angel worked diligently to keep the hand grafts healthy. Their daily schedule, and many aspects 
of their life together, had to change following surgery. Of special concern to the couple was the 
temporary loss of all their work finding some equilibrium at home between Will’s needs and 
Angel’s ability to offer care, since Will’s hands would be in hard casts for months, and then useless 
“dead weights” while the nerves slowly regenerated (function for hand grafts and hand replants 
returns slowly as nerves regrow, about a millimeter per day). Fortunately, the double hand 
transplant has not been a problematic development as Angel once worried; rather, the couple 
reports being truly delighted by the new hands, even before they were functional.  
Both Angel and Will use the analogy of caring for an infant to describe the early period of 
living with the hand transplant. Angel said of this time that they were constantly on guard for signs 
of infection and rejection, but that the excitement of their new situation and its potential made the 
uncertainty more bearable: 
To me it was, I guess, the closest I’ll ever be to ...having a child? So it was kind of 
like, these sort of instinctual things come with it ... you know [with a hand 
transplant] some people suffer from pain and, you know, stay up all night so, [Will’s 
transplant hands] were very quiet babies. [Laughs.] So um, it kind of, it came 
natural, in that sense? It didn’t seem foreign, you know what I mean, that I could 
help them along and try to kind of, discover or, figure out, together what would be 
best and how we could help the arms grow. It wasn’t so much like, “this is where 
you know you can sense your feelings and what can we expect,” just we’re 
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constantly watching them ... I think when Will has fully regained sensation, or if he 
fully regains sensation, uh, and proprioception—so that he doesn’t have to think 
about where his arms are—that will be the sort of, the day that the baby’s grown 
up!  
In a similar vein to the undetermined sense of value and development that Will and Angel 
placed on the hand grafts, Will describes the process of coming to know or fully own his new 
hands as one of watchful awareness of emerging significance. Morphologically, Will’s 
transplanted hands have undergone subtle aesthetic transformations, and these alterations of form 
and function have been the focus of much semiotic speculation. He describes a pattern of 
continuous discernment early on in which he was attempting to differentiate between the physical 
qualities of his hands that might be consequences of his own actions and care, versus those that 
may be from the lifestyle of his donor, versus those that might indicate underlying biological 
processes (including signs of rejection and infection). Will describes his experiences of coming to 
“own” his new hands as an emotional and rewarding learning process: 
I have a couple of scars that weren't things I had earned. I saw them on the hands, 
and I thought, “Well, that's fascinating. I wonder how my donor acquired them.” 
Everyone has scars on their hands, but generally, you know where you got them. 
You've got stories related to them, and this is one of these weird cases where I 
literally don't know where my hands have been, which is funny.  
When I was in Phoenix [giving a talk for a transplant conference], I unwittingly 
learned a lot about my donor, because I was talking as part of a panel that presented 
this donor case, and I was a patient sort of representing one of the beneficiaries. 
This donor actually benefited 10 different people with 11 different organs ... One 
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thing I learned is that my donor practiced karate, and I only imagine that maybe 
some of the scars that came, I think some of the scars that came around his hands 
must be from that. I don't know, of course, but it's possible. 
There’s an interesting transition. Several weeks after, I noticed, of course, that the 
hands were rough, were calloused, and I noticed several weeks after my transplant, 
I was home for a while, that the skin began to slough off my hands. The callouses 
began to wear away, basically. The skin underneath was sort of fresh and pink and 
soft and all this ... There are ways that you can build strong hands, and build 
callouses up on your hands, and whether [my donor] did that or not, I don't know. 
But that work was going away, and it was represented in a more—not necessarily 
the hands of an academic, because my hands weren't all that soft, I don't think—I 
don't know. I took that as a, “It's okay. It's all right for me to think of these as mine.” 
At the same time, of course, I can't feel everything in them yet, and the nerves are 
only slowly going down, and I don't have total appropriation in them. There's a lot 
about them that still feels not quite mine. I don't think I'll ever lose—as much as 
they feel increasingly like mine—I don't think I'll ever lose the sense that, in a way, 
I owe something to someone with them. I don't think that's a bad thing. That's not 
negative. It just makes me realize, it's a reminder that I need to be grateful, and not 
just for this. I'm happy with that. 
Narrative 4: Dave and Karen Savage 
Dave and Karen Savage live in Bay City, Michigan, near where Dave grew up, and where 
they both enjoy residing in close proximity to their extended family and adult children. Dave 
describes his childhood in Michigan as peaceful and enjoyable, drawing (for emphasis) an implicit 
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comparison between the values characterizing those simpler times and our contemporary 
landscape: “Back then it was easy growing up. You went around, did whatever you wanted to do—
if you wanted to go out, there was nobody lurking around in the shadows, ya know? It was a good 
time.”  
Dave and Karen met in their 30’s after they had both been married with kids of their own, 
and long after Dave suffered a traumatic injury to his dominant right hand in a machine press 
accident. Dave, a quiet person whose economical style of speaking leaves some work to the 
listener’s imagination, describes the accident as a “plain and simple” event resulting from the 
confluence of two factors. The first factor Dave characterizes as material or environmental insofar 
as, “some of the devices that were there for safety just weren’t on the machine,”—a fact both Dave 
and the corporate insurers who covered the accident attributed to oversights by the company Dave 
continued to work for the rest of his professional career. The second factor Dave narrates as his 
own failings of attention and knowledge at the time, “You’re young and you’ve got a job and …ya 
know, there are safety rules that are involved in it and you don’t know ‘em all.” 
At the time of the accident, Dave knew immediately that his hand would have to be 
amputated. Dave says, “[the machine press] just smashed it … You could tell [my hand was 
unsalvageable] just by looking at it.” Although Dave (like many narrators) uses second person 
when recalling many events, including the loss of his hand, he recounts the time period directly 
after the injury in first-person terms, emphasizing (somewhat surprisingly to me) the lack of 
disruption to his life that the loss represented and his own agency in managing his post-traumatic 
experiences. Dave says: 
“When I woke up after the surgery, first thing is my wife was standing there with 
my draft notice. Uh, so if that would’ve came a day earlier, the accident would’ve 
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never happened because I wouldn’t’ve went to work. But then, I looked around and 
I seen where I was at and I said, ‘I ain’t staying here.’ So, ya know, I worked a deal 
to get out of there and all I needed was a pair of shoes. So my father-in-law lent me 
his shoes and I got up and walked out and went to the other hospital… Um, like I 
said it’s hard to explain. I lost [my hand] in an industrial accident and uh, life went 
on from there!” 
Dave also revealed his humor in this bit of narration. I asked him what inspired his decision 
to switch hospitals following such a major, seemingly traumatic surgery, and he said: 
DS: They couldn’t put me in a private or semi-private room. They put me in a 
twenty bed ward. And everybody was in that ward from crazy people on up. So, I 
didn’t wanna be there. 
EH: Ok, and how long were you in the second hospital? 
DS: The second hospital? Oh, gosh I dunno probably about two weeks, maybe. 
EH: Wow, and that was just caring for the wound itself or did you receive other 
types of treatment? 
DS: Yeah, it was just caring for the wound, waiting for all the swelling to go down, 
stuff like that, ya know—the other reason I wanted to go to that hospital is ‘cause 
my mother worked in the kitchen.  
EH: Nice.  
DS: So I knew I’d eat good. (Laughing) 
Dave describes life post-amputation as being much the same as life before, with a few 
modifications. At the time of his injury, Dave’s first wife was pregnant; although he does not 
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indicate this special family status as a reason for wanting to return to work, he says that the loss of 
his hand did not diminish his ability to do so, “I might’ve been off work seven, eight months at the 
most? I was going crazy—I wanted to go back to work. When they called me and asked me if I’d 
come back to work, I didn’t even hesitate. I didn’t even have my prosthetic yet, when I went back 
to work.”  
When Dave and Karen met in the mid-80’s, Dave was still using a simple cable hook 
prosthetic to help manage daily tasks. He says of the device that, “sometimes it helped [and] 
sometimes it got in the way.” Dave and Karen both observed that the serious limitations of using 
the hook when interacting with other people was the most frustrating aspect of its manifestation as 
a “replacement” for his lost hand. Sometimes these interactions were upsetting and isolating. Karen 
describes the feeling in sharp recollection: “Dave helped me get off the ground a youth football 
program, and he was one of the coaches. Our son [Gus] did a lot of the demonstrations …because 
Dave couldn't throw a football, or catch the ball in a way the kids would be instructed to catch it. 
… That bothered him because he was there to be a coach and be there to help them, and I think it 
bothered him a lot that the kids would shy away.” 
Although Dave was an amputee for over 30 years before having the opportunity to 
participate in hand transplantation, the long period of posttraumatic recovery and adjustment did 
little to diminish his interest in being made whole again through some kind of intervention. “[Dave] 
never wanted to think of himself as being handicapped,” says Karen. However, the loss never felt 
justified, and it was hard to fully accept. Karen says, “If certain safety factors would have been 
enforced—if the company would've done what it should've done to guarantee all their workers’ 
safety—this probably never would've happened to him. I think anybody would resent having been 
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pushed into working in a situation that wasn't safe and now he's got to deal with it the rest of his 
life.”  
Dave never stopped thinking that someday—not supernaturally, but possibly within his 
lifetime—he would have two hands again. He believed in the power of science to provide a path 
to restoration. Dave says, “like one guy was trying to figure out why certain animals could grow 
their limbs back. Ya know? And thinking they could apply that to humans, and I dunno whatever 
became of that.” Karen remembers exactly when that distant possibility became a close reality: 
“Dave was pretty functional, but ever since day one with me, he always said, ‘If 
there's another way to get another hand, I'm going to try it.’ We joked about the 
idea that, yeah when we get to heaven, we're going to have perfect bodies, God is 
going to give us perfect bodies, and you'll have your hand back, and I'll be skinny, 
and we would make a joke about it. That's kind of how it was with us from the 
beginning. Then, one night on TV they had an article about Matthew Scott and his 
hand transplant, and I saw that and I looked at Dave and his eyes were like, ‘Wow— 
I have to check on this,’ and he said to me, ‘How will we ever find out about this 
guy? How do we do that?’” 
The next day, Karen says, she, “got busy with the TV, with local newspapers, and got a 
contact information for the person who did the interviews, and then that person that did the 
interviews gave us contact information for the hand transplant program in Louisville.” After a long 
period of evaluation and negotiation with the insurance company that covered his initial accident, 
Dave was listed as an experimental patient for the Louisville hand transplant program. Jewish 
Hospital, which hosts the program, agreed to cover all costs except the follow-up 
immunosuppression, which Dave would have to take for the rest of his life. Karen describes the 
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exciting decision to try for the hand transplant as being heavily mediated by reminders of what 
could happen if the transplant went badly: 
“[The doctors] wanted us to be totally aware of what it would do, what it possibly 
could do. It was a big concern to the point of, ‘Maybe we shouldn't do this’—
because maybe all these drugs are going to hurt you in the long run, and there won't 
the benefit we're expecting out of the transplant. The other part of it, when you 
think about it, is hand transplantations—if a person's going in, and they're having 
liver, or heart, or lung transplants, you've got to have that to live. A hand transplant 
is something you're going to have to improve your quality of life, but you can get 
along without it.” 
Dave and Karen waited what seemed to them a long time for a hand graft to become 
available. Dave says he waited through, “like four false alarms there” which were stressful and 
discouraging. However, after the a match was made and the transplant surgery accomplished, Dave 
and Karen both describe being amazed by their instant affiliation with the new hand. Dave again 
emphasizes a feeling of continuity or normalcy rather surprise or transformation on waking up 
after surgery: “I didn’t feel any different. I looked down and I saw it there, and right away ... 
everything was mine! Ya know and as far as my wife she felt the same way!” Karen agrees, “It 
was immediately his hand.” 
For many years, the transplant conferred both functional and psychosocial benefits, 
sufficient to be worth the work and effort needed to maintain it. Dave says, “when you first get [a 
hand graft] you know it’s all great and you know, you put all this hard work in with the physical 
therapy and all that … at first everything was great!” However, minor complications and difficulty 
68 
managing transplant drugs caused more and more stress and discomfort as the years went by. From 
Karen’s point of view, the changes to their quality of life were not always good ones: 
ER: How did life change after the transplant? 
KS: He's grumpier.  
ER: Really?  
KS: Yep. A lot of times he's not feeling really good. I tend to blame it on the 
medicine.  
ER: Was it like that from the very beginning? 
KS: Let's see. It's kind of hard for me to say because at first, when he first had the 
surgery, you got your surgery recovery time. You know, where you're not feeling 
good because you just had surgery, and all this stuff is healing up, plus he's on all 
the new medicine where he doesn't feel good because his stomach's upset from 
taking all this medicine. That lasts a long time. Once the hand starts looking better, 
and he starts feeling better, it kind of eases up, but it never goes away. 
Dave acknowledges that there were numerous challenges. In managed complication after 
managed complication, he discovered firsthand that high levels of immunosuppression would 
protect the graft hand but harm his own health, and vice versa. By the time of our oral history 
interview approximately ten years after his transplant surgery, Dave was easily animated when 
talking about the long-term challenges of hand transplantation, especially in terms of post-
transplant medications: 
“[At one point] they changed [all of my drugs]. Uh, I started out with Prograf and 
Cellcept? Something like that, and since then, they’ve taken me off Cellcept and 
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they put me on what's-it-called, Rapamune. And of course the Rapamune does the 
exact same thing that the Prograf does. So they had me taking both of them at the 
same time, and in the meantime the Prograf is screwing my kidneys up, and uh—
so now they’ve taken me off the Prograf, and now I’m on a drug they call Myfortik. 
And I take that four times a day. And then I take Rapamune. Ya know uh it’s two 
milligrams a day. And I’m still on the steroids. And I was supposed to be well off 
the steroids.” 
Despite a long period of satisfaction in which doing small hobbies and having a human 
hand again conferred high satisfaction, over time the deteriorating quality of his clinical 
relationships, personal health, and the graft itself have soured Dave’s experience. He described 
several times throughout our interview the frustration that came with not knowing why his drug 
regimen was being changed or why doctors wanted to do a particular procedure: 
“I mean they’ve been doing this off and on throughout the whole, whole thing! Ya 
know they’d call up and they’d change [my drugs], and uh, say you were gonna go 
I for surgery or something. They’d have you stop taking a certain drug and go back 
on the other drug, ya know ‘cause one drug slows down the healing process. Ya 
know and this is what I’ve been trying to tell ‘em about [my damaged, bleeding] 
fingertips! Ya know you’ve got me on a drug that slows down the healing process! 
Can you just take me off that and put me on something else for a while? And ya 
know it’s just like—I get no response. That’s my biggest frustration: I get no 
response. … It got so bad, that I went down there in June, and when we sat down 
to talk, the first words out of my mouth I told them, ‘I am ready for it to come off.’ 
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Annd I think it just shocked them. ‘Cause all the sudden they wanted to do this, and 
they wanted to do that.” 
Because Dave’s hand transplant came as part of a research grant and his continued care is 
covered under Louisville’s funding, if Dave wants a second opinion at another institution, he has 
to pay for it out of pocket (which he can’t do). The experientially proprietary nature of Dave’s 
relationship with the Louisville program has thus been a major source of dissatisfaction with the 
hand graft that has little to do with the phenomenology of the hand, itself (about which Dave still 
has positive feelings). Dave says, “I really am I am very frustrated. ‘Cause I feel I’m getting no—
I, I feel like I’m going backwards. You know what I’m saying?” 
While a few of the doctors who brought Dave into the Louisville study remain there, most 
have gone on to start new reconstructive transplant programs at other institutions. As we talked, it 
seemed to me that deteriorating clinical relationships were as much a source of stress for Dave and 
Karen as the complications of the hand transplant aftercare (which include, for them, yearly trips 
to Kentucky for checkups, and winters spent in an RV in Arizona to protect the hand graft from 
the cold). Dave frequently compared his (more positive) experience working with the doctors on 
the original Louisville team to that of his experiences working with newer, in his opinion more 
aggressively experimental, doctors. Karen has a similar outlook:  
“The treatment that Dave got at that beginning, right after his surgery with that 
particular team of doctors and nurses was most excellent. You couldn't ask for a 
better group of people. As time has gone by, a couple of the doctors have left the 
program, and each time one of the doctors leave … Each time one of the doctors 
leaves, the new doctors coming on board, it seems like they don't have the 
ownership of the program that the previous doctor did.”  
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Ultimately, Karen says, she would not want Dave to choose the hand transplant if given 
the choice to make over again. At this time, Dave still has his hand graft although the function and 
appearance of the hand have gone down dramatically. He says, “if I could work my hand, the way 
I should be working it, I could probably get 50-55 percent function out of it. Ya know, but the way 
it sits right now, basically all I can do is hold something between my thumb and finger. My index 
finger. That’s it! Somebody hands me a receipt I can grab it—well heck, I could do that with a 
hook!” 
It is unclear what kind of exit strategy has been prepared for Dave and Karen by the 
Louisville hand transplant team. Although Dave’s hand graft has been described as in a state of 
non-salvageable, slowly progressing “chronic rejection,” and although he has been recently 
diagnosed with metastatic squamous cell carcinoma,1 diabetes and kidney problems that are 
complicated by his immunosuppression, Dave is deeply conflicted about the idea of losing the 
hand graft. In scientific presentations to the VCA community, Dave’s doctors say that they want 
to respect his wishes in terms of keeping the graft as long as possible because “he is attached to 
it.” 
Narrative 5: Vasyly Rohovvy 
Vasyly Rohovvy is a bilateral hand transplant recipient currently living in Austria, although 
he is originally from Ukraine and was living in Ukraine when an accidental blast injury resulted 
in the loss of his eyesight and both hands. When I interviewed Vasyly, he was visiting the 
University of Pittsburgh for a conference on eye transplantation; his sister and personal caregiver, 
1 As reported by Louisville team member Tuna Ozyurekoglu on Thursday, November 15th 2018 at the 6th 
biennial American Society for Reconstructive Transplantation (ASRT) meeting: http://www.a-s-r-
t.com/2final2018MeetingProgramScheduleweb.pdf; confirmed via email 27 November 2018. 
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Elena, was traveling with him. Vasyly wore dark glasses as we sat on a patio near the Cathedral 
of Learning in Oakland. He was cheerful, having been a keynote speaker at the conference the 
night before, and spoke excellent English with a strong Slavic accent.  
Vasyly considers himself a lucky person despite the many considerable challenges he has 
faced. He says he had a “very happy childhood” which he attributes to a lack of access to drugs 
and alcohol on the streets in the USSR when he was growing up. Nevertheless, Vasyly understands 
that, “there was disadvantages and advantages, so to say, in USSR. For children it was a good 
childhood,” he says. “For my parents it was not so good, because, I don't know how to say… In 
that time, they say that there was no freedom. I don't know what does it mean, ‘freedom.’ There 
was no slavery, but I don't know. My father was happy, so to say, when USSR fall. My mother 
was not happy.” 
The accident occurred when Vasyly was eighteen years old and studying IT. He describes 
the event: 
“I was going home with my dog and about 600 meters from my home I saw a car 
and inside the car I saw a bag. I saw that someone had forgotten it. I wanted to find 
out what it is in that bag, if it's money. I stopped and picked it up and I tried to open 
it. That didn't work and then I yanked harder. I lost my eyesight on the spot. I 
couldn't realize, of course, what happened to me. I tried to rub my eyes and only 
then I understood that I have no hands. I was scared and I ran to my home, looking 
for help, but I took a wrong direction. I ran to another side, so to say. I ran and hit 
cars, walls, trees, I don't know what else, and fell down and stand up, but because 
so big blood lost, after the next fall I couldn't stand up anymore. I was lying on my 
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back and thought that I was dying, but suddenly something in my head began to 
scream, ‘Call for help, do something, don't sleep!’” 
Vasyly says that the snow on the ground that day helped the ambulance to find him quickly 
after a bystander dialed for emergency help. A week later, Vasyly’s parents rented a car and took 
him from his hometown to Kiev (about 300 kilometers away). At that time, doctors were able to 
save his right eye, but nevertheless, Vasyly says, “I didn’t want to live. I didn't know how to live 
without hands, with burned face, with very poor eyesight. I stayed at home by myself and didn't 
want to see anybody.” Vasyly’s sister, Elena, was instrumental to his recovery via hand 
transplantation, “My sister started looking for clinic that could help me. She went to the internet 
café and she looked for a clinic that can get my hands back, so to say. In a few months she found 
in an article about the hand transplantation in France. We found a teacher and she helped us to 
translate a letter from Russian to French and we sent that letter to France, Lyon.” 
After Vasyly and his family identified hand transplantation as a potential route to to 
restoration, they negotiated with programs in several different countries to achieve candidacy. He 
describes the process of evaluation and waiting for a hand:  
“Of course, it wasn't possible for us to get an appointment [in Lyon, not being] a 
resident. We tried to do it, to find money ourselves, but the French doctor didn't 
want money, they want involvement of Ukraine government. We couldn't do that 
and after that my sister found a clinic in Germany, in Munich. We went to that 
clinic, I passed all medical checkups. It was 3 years after the explosion. I didn't 
have German citizenship and therefore they couldn't find money for surgery. I was 
waiting for the answer about 2 years from Germany. They didn't answer to us and 
my sister went once again to Germany and took all my all medical results and 
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brought them to home. She found another clinic in Austria in Innsbruck. We sent a 
letter to the director of the clinic in Innsbruck. He answered us and said we can 
come to Austria, to Innsbruck. In 4 months in 2005, my sister and I came to 
Innsbruck. I passed all medical checkups once again and then was waiting for the 
results… About 11 months I waited for a donor and in May 2006 I received a call 
from the clinic that they have hands for me and after that I was 17 hours in surgery.” 
Vasyly knew that the hand transplant would mean that his life “will be forever connected 
with my doctors and with the clinic.” He describes himself as being a tireless worker for the health 
and functionality of his hand grafts and an eager participant in the process, despite the downsides 
of taking transplant drugs: “After the hand transplant I did the therapy, every day from Monday to 
Friday from 8am till 5pm. I take immunosuppressants and there are a few side effects.” 
Vasyly had severe phantom pain after the explosion, which fortunately resolved after the 
hand transplant. Although his eyesight is now totally gone following complications in a repair 
attempt, Vasyly says that the aesthetic, human appearance of his new hands is highly valuable to 
him. “I was very afraid that I will get big hands. I asked my doctors to find for me good hands. I 
had very long fingers … I asked my sister, as I said, to tell me how do they look like and she said 
‘No worries, they fit you perfectly.’” His function is also good following extended efforts in the 
hand therapy clinic in Innsbruck: “I did the therapy for 3 years. I know there is very few patients 
who did therapy for so long as me. I learned a lot of things that I took for granted before the 
explosion. To eat. I had to relearn everything, to dress myself, to eat with fork, spoon, to open a 
bottle.” 
Although early on the management of transplant medications was difficult, insofar as, “It 
was very difficult to take a lot of pills—about 20, 25 pills. Of course, I felt sick.” However, Vasyly 
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says that, “nowadays I take 3 pills in the morning and 3 pills in the evening” which is very 
manageable. The special advantages of hands over prosthetics are clear to Vasyly. “Feeling 
sensation is very important for me, because if you cannot see, you only have one connection with 
the world. Fortunately, my hands can feel rain, sun, wind and I can feel almost human being if I 
touch your hand, I can tell—I feel.” At this point Vasyly invited me to test his sense of touch and 
sensation. I reached out to shake his hand. “Your hands are a little bit cold... Cold finger as I 
imagine.” He was right, my hands are often cold.  
Nevertheless, Vasyly reminded even at the end of our interview that, “Hand transplant, it 
is not a miracle. [I knew] I will not get my old hands. I will get new hands and these hands will 
cause pain, there is a lot of work to do and a lot of things depends on me, not on my parents or on 
my doctors, only on me.” One aspect Vasyly discussed at length is the idea of reasonable 
expectations as a factor to success. “I didn't have very big expectations. Therefore, I wasn't 
disappointed. Before the hand transplantation I met other hand transplantation patients. I saw what 
they can do with their hands and I talked to them. I think it's very important for everyone who 
wants to get new hands to talk to people who already have them.” Vasyly has gone on to marry a 
woman he knew before his injury, has a daughter, and continues to receive some day-to-day care 
from his sister Elena.  
Vasyly recognizes that aspects of his life have been extraordinary, where his hand 
transplant experiences represent a necessity for his welfare and hard work. “We were just an 
ordinary family from Ukraine. [My doctors] told me I had only one solution, they told me that 
don't give up, one day you will get your hands.” But no amount of relevant preparation, he 
emphasizes, can ensure success with a hand trasnplant. Vasyly says, “I'm very lucky.” 
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Narrative 6: Sheila Advento 
“We all have meningococcal agents at the back of our throats, as I understand it,” says 
Sheila Advento, trying to describe the source of a viral infection that, several years ago, almost 
killed her. Although meningococcemia is non-threatening among people with a healthy immune 
system, for some reason, Sheila was susceptible at that time, and from what she thought was an 
average cold or flu, her health deteriorated rapidly. By the time Sheila was rushed to the hospital 
for acute nausea and fatigue, she was gasping for air and had to be induced into a medical coma to 
save her major organs from failure. Unfortunately, the illness resulted in severe necrosis of all four 
of Sheila’s limbs, and she left the hospital a quadruple amputee.  
Sheila Advento was born in the Philippines but came to the United States as a young child. 
The potentially disruptive or disorienting immigration experience was mitigated by early 
introduction to American culture via school. Sheila says, “Maybe a month after arrival, I went to 
school right away, so I got adjusted almost immediately.” Plus, “It's mandatory that we learn 
English in my country, as well as any other country really. We watched a lot American movies 
and stuff.”  
Sheila was an independent person supporting herself and going to school before she got 
sick. It was difficult to transition to a life where all of her personal needs had to be met by another 
human: 
“I cried a few times, but I was also under antidepressants, so that helped me. I was 
in the hospital and then also I was in rehab. Especially when I was in rehab, I felt 
like I was confined in secure place, in a secure bubble. Where they do the exercises, 
occupational therapy, physical therapy, and doing things that I eventually got 
accustomed to and knew what to do because I was in this bubble. It wasn't until I 
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was discharged that things started clicking, how difficult life is as an amputee. I 
was getting really depressed, and I didn't know how to handle things emotionally. 
I was frustrated a lot, I took it out on people. I didn't know how to calculate the 
frustration into my life. I didn't know how to handle anything. I just wanted to be 
independent, and it was hard to ask for help, is was so hard to accept help. I didn't 
want to pity myself, I didn't want anyone to pity me. It was all these heightened 
emotions that I'm not familiar with that just came into the picture. … [Before], I did 
everything on my own. I got dressed on my own, I did my makeup and my hair on 
my own, did the laundry on my own. Then all of a sudden all that's gone.” 
Eventually, Sheila and her family hired a personal assistant, but things started looking up 
especially after Sheila came across an article about hand transplantation. Sheila says, “I reached 
out to the facility. I reached Dr. Lee, who was there at that time. He almost immediately responded 
back. I sent him pictures, and we just exchanged communication to the point where I was invited 
to do the screening.” 
Compared to other narrators on this project, Sheila’s evaluation and waiting period for hand 
transplantation were rather fast (completed within a year):  
“For about a week I did all the necessary screening process that they required. That 
includes psychological testing, a lot of blood work, seeing multiple doctors, and 
meeting with a transplant team. Then eventually, it wasn't that long after, I got 
approved for a transplantation. I thought that I may have to wait years. That was a 
reality I was thinking about, that I would have to wait years for a donor. had a safety 
bag on the side, just in case [and] I only waited nine months. I remember I actually 
had a day off of work and I was just watching TV. I got a call and I was told that I 
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needed to travel right away, because I had a donor waiting, so my mother and I 
traveled to Pittsburgh. We took a plane to Pittsburgh.” 
At the time of our interview, Sheila was completely satisfied with her experiences as a 
hand transplant recipient. Despite what she describes as a “grueling” the post-operative therapy 
and medication regimen as well as some debilitatingly severe headaches in the early phase, Sheila 
described her experiences in positive terms, emphasizing the gradual return of function and 
sensation in her hands as a thrilling and pleasurable, unfolding experience. “I'm able to do so much 
more. It's exciting for me. For instance, I'm able to grab somebody's arm, I'm able to hold 
somebody's hand, I'm able to hold my boyfriend’s hand. It's a nice feeling. Not having hands, 
eventually you lose the intimate feeling… I feel like my sensations are back. It's just very exciting. 
Everything is so exciting for me.” 
As part of my evolving oral history protocol, I asked as one of my final questions for 
narrators how their relationship with their clinical providers has evolved over time. At the time of 
our interview Sheila Advento was happy with her outcomes and with the quality of her care from 
the team at UPMC (although by the time of our interview the program had migrated to Johns 
Hopkins University). However, as recently as November 2018, one of the lead surgeons on 
Sheila’s team has reported that Sheila is in renal failure and in need of a kidney transplant. He also 
admitted that Sheila is now seeking care outside of their program (Shores et al, American Society 
for Reconstructive Transplantation, Chicago 2018). Sheila attended the meeting where these 
results were presented; however, she was not invited to speak publicly about her experiences. She 
did personally confirm this distressing, ongoing outcome to others and her lost faith in the 
transplant team at UPMC/Johns Hopkins (see chapter 3 for more on the rhetoric offered by field 
professionals at this meeting). 
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At one time, Sheila’s uncomplicated answer to my then-standard question about clinical 
relationships did not merit much further consideration. With the above information, this is no 
longer true, and for many reasons which I will discuss at length in the next two (concluding) 
chapters, I find Sheila’s narrative of hand transplantation to be one of the most disturbing accounts 
of biomedicalization of physical disability in the hand transplant literature.  
EH: Do you feel like you have a good relationship with your doctors? 
SA: Yes, very good. …They're easy to talk to. They check up on me. They call or 
send text messages, just to check up, to follow up. I think that's wonderful, because 
not a lot of doctors are like that. 
EH: Yeah. Why do you feel like the relationship with your doctors is so strong? 
SA: I think, because they want the best for me, regardless of the hand. With the 
hand transplant they want to make sure that I'm doing okay, they want to make sure 
that I'm healthy… What my progresses are and what the changes are, so forth. I 
update them also, a lot. 
EH: Yeah. 
SA: Just the fact that everybody wants the best for it, with their hand transplant. 
EH: Do you feel like their interest is really about you? 
SA: Yes, definitely. 
Narrative 7: Josh Maloney 
“I remember them cutting my clothes off to check, make sure the rest of my body wasn't 
wounded and me trying to stay calm. As far as I know, I never went into shock. I never screamed, 
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I never cried, I never passed out,” says former Marine and hand transplant patient Josh Maloney 
recalling the day he lost his dominant right hand. It was the second day of a two-day convoy 
training exercise and Josh was one of the leaders.  
On that day they were using shot boxes, which Josh describes as “basically a big four-foot-
long by six-inch thick steel tube filled with compressed air and baby powder, to simulate an IUD 
going off.” Unfortunately, the box they were using was faulty, and instead of sending current on 
command, it was sending current all the time—so when one of the Marines skipped protocol and 
plugged the wires into the box without first checking that the charge box wasn’t active, it 
detonated. Josh says that when the explosion went off, everything happened, “fast.” “Diaz had his 
knees around my neck keeping my head straight. I had Marines with my arm out and I kept asking 
him, ‘I know I'm messed up, but do I still have fingers? Is my arm gone? Somebody tell me 
something.’ Nobody would tell me anything. I remember—it was January 31st, 2007, it was cold.” 
Josh kept his head throughout the life flight: “I laid there telling jokes trying to keep 
everybody else calm. One, I knew if I lost my cool, as cold as it was and as injured as I was, I 
would probably die if I allowed my heart to race, to go into shock or anything. Marines are a 
special breed. I knew my guys would take care of me, but anything they could use to make fun of 
me later, they would.” 
The oldest of four children, Josh says that throughout his life, he has had a strong sense of 
himself and his goals for life. Of his early and lifelong desire to be a Marine, he explains, “I always 
thought, watching war movies …I bought into—and I still do to some degree—that patriotic 
rhetoric. [As a career, it seemed] you get to play with cool stuff. I wanted to be a pilot, and then I 
realized how much math was involved and I was like, ‘No, I'm good.’”  
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Once his family realized Josh was serious about joining the military after high school, since 
several family members had been sailors many of them assumed Josh would also join the Navy. 
Josh narrates, “I was already the black sheep for going in the Marine Corps. Then, [my family] 
wanted me to get a trade when all I wanted to do was blow things up. I was an 18-year-old kid. 
Think about the future or you're going to give me high explosives? I'll take the high explosives.”  
I met Josh for coffee at a Starbucks near Moon, Pennsylvania, about 30 minutes from 
Pittsburgh, to conduct our interview on his experiences as the first recipient of a hand transplant 
at the University of Pittsburgh Medical Center (UPMC). By that time, Josh had undergone a self-
requested amputation of the unilateral hand graft, having found the therapy and Rx protocols too 
burdensome to justify for his lifestyle long-term. Josh continued: “I take things as they come and 
don't really think about it beyond that. [I’m that] type of person. I don't care. In a lot of ways, I can 
take some subjects and think deeper on it, but things that happen in my everyday life, I don't.” 
Patti Maloney, Josh’s mother and also a narrator for the oral history project, says that, 
“along with Josh not having strong opinions on anything, (as I say facetiously)—as he came into 
his own through being in the Marines and everything he became very strong-headed.”  
Josh sincerely enjoyed and never regretted his career path into the Marines, despite being 
deployed twice to Iraq. Of that time, Josh recalls a comfortable relationship with duty and 
routine—“You didn't have to think. You didn't have to worry. You just did what was in front of 
you”—and amusing stories, “I remember being stopped on a security halt and an Iraqi vehicle went 
by that must have had dinner in the back, in the trunk, chicken. The chicken fell out because it was 
tied to a milk crate and it came undone. You have seven Marines fully armed chasing the 
chicken…”  
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I asked Josh whether he might be performing some optimism for the sake of the interview, 
at least in terms of his war memories. He answered, “No—I remember the bad things more often 
than the good. It was just—it was one of the scariest moments of my life. I turned nineteen in Tikrit 
on the air field that's outside Saddam's palace. It was scary as hell, but it was also some of the most 
fun I've ever had in my life.”  
Patti says that despite reservations from the rest of the family, “Josh loved being in the 
Marines. After a couple years when he came back to visit, on one of those—I just looked at him 
and he wasn't that skinny little kid that went off, he was this big guy… I can literally remember 
the moment when I was standing there looking at him thinking, ‘Wow has he grown up and 
changed.’ Just that whole wow, he's no longer my little boy kind of thing.” 
In the hospital after the accident, Josh says, he didn’t seem to fully appreciate the disabling 
nature of his injury, inquiring about his professional capacities rather than his health, “I came out 
of surgery, the first time after they made sure I was okay, and my platoon was still around me, they 
had all driven up to the hospital. I remember acting like, ‘When can I get back to work?’ Was the 
first words I said to anybody. I just wanted to go back to work. Then, I don't remember much after 
that.” Josh was transferred from the first hospital to Walter Reed, “where they did more surgeries 
and helped me heal up.” After mixed experiences at Walter Reed, Josh and his family negotiated 
his care back to Pittsburgh, where he was treated at UPMC and eventually, heard about hand 
transplantation. He says, “I started dating a girl whose aunt worked for UPMC at Mercy and that's 
how I heard about the transplant program. … She actually handed me a flyer than had been 
circulating through UPMC. We were at a family dinner and I actually called that number that night 
and left my information. I got a call back the next day.” 
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The evaluation process Josh describes as relatively straightforward, despite having little 
idea what to expect when the graft hands finally arrived. “They walked me through it all,” he 
remembers, “I had to get all the blood work and the psychological testing. To me it was all pretty 
easy because—being a Marine, to me, it was like, ‘Okay that's the next mission. This is what I 
want, this is what I want to do’ [even though] there was nobody that had done it before me that 
could walk me through the process and tell me what to expect. I knew going into it that I was the 
guinea pig.” 
According to most hand transplant experts and Josh’s own clinicians, he had an excellent 
functional outcome in the early post-operative period of about two years. “Therapy was painful,” 
Josh says: “It was worth it but it was painful.” He quickly started seeing returns on his investment 
and recalls using the graft hand as an exciting experience. “I was getting really good with it. Really, 
really good. Way more than Vijay or anybody else thought I would ever get because I pushed 
myself. Then I started trying to... I got arrogant and stupid and thought that after a year of therapy, 
it was just going to stay that way that I didn't have to maintain it. I took advantage of it and I 
stopped paying attention and functionality went down.”  
The more disappointing aspect of the hand transplant long term, says Josh, was the 
aggregate effect of all the work and worry that had to be managed on a day to day basis. The 
contingencies of life grew, yet his hope of returning to a combat role was not coming any closer 
to fruition. Josh says he grew weary of the constant surveillance and the experience of hand 
transplant patienthood. He also experienced episodes of acute rejection that were unpleasant and 
in some ways, off-putting to others. Patti Maloney remembers the long arc of Josh’s relationship 
with his graft as being affected negatively by complications of immunosuppression and the 
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transplant lifestyle: “[He was experiencing a lot of rejections and] I think it was in that time that 
Josh had just reached that point in his mind like he wanted to not have to be a slave to the routine.” 
In retrospect, Josh thinks, “I did it for the wrong reasons. I did want to get back into the 
military, thinking that that would be my shot to get back in [to the military]. I kept thinking about 
that the whole time the process was going on for it.” Patti thinks that ultimately the hand transplant 
amounted to a role Josh played that he also grew out of in a timely fashion: “Josh was … the first 
one [at UPMC]. That's an awesome responsibility and I think he tried to live up to that for as long 
as he could and then he just didn't want to be that person anymore.”  
Narrative 8: Joe Kinan and Carrie Pratt 
Joe Kinan and Carrie Pratt are an impressively committed, seemingly truly cohesive, 
couple who met many years ago at an international conference for burn survivors. Carrie, a native 
of Ferndale Washington with an easygoing demeanor and sharp powers of observation, suffered a 
serious burn injury when she was just a baby and has been attending support groups for burn 
survivors most of her life. Joe, a victim of the infamous 2003 New Jersey Club Fire, is now the 
first hand transplant recipient at Massachusetts General Hospital’s emerging VCA program, and a 
soft-spoken person of amazing willpower.    
Carrie’s description of her early life highlights her strong sense of independence and self-
knowledge following a childhood in which bullying was an occasional feature. “I always wanted 
to be a nurse. But, uh, the four years in college was more than I could stomach. After not enjoying 
high school too much. I just had a different learning style and I was told in college it would be 
different but I just...wasn’t willing to give it a try—I wanted to start working right away, so, I 
passed on that and went to beauty school instead.” Joe who made his career in men’s clothing 
before the fire, like Carrie found work gratifying and a source of independence.  
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The couple met approximately ten years ago. Carrie describes that time period and the 
importance of the community that brought them together: 
“I was, um, in a bad marriage at the time, and my husband was also a burn survivor, 
and so the first year I came to World Burn was an extremely emotional experience 
for me. Just because of where my life was at home and just meeting all of these 
amazing people, strong amazing people, and Joe was, in the group with so many 
other new faces and he was just, um, happy go lucky and joking… When you look 
at him you would expect him to be um, like a little bit more… on guard or worried 
that he’s gonna be judged. But that’s one thing that I learned on that first day was 
that everybody there, if they’re being there they’re comfortable with themselves 
not necessarily outside of the conference but at the conference everybody comes 
out of their shell and they talk and joke and it kind of brings them back to who they 
used to be before their accident. I was introduced to him by the director of my 
foundation that I was there with, she had just run into him and she...brought us over 
and said, ‘You have to meet this guy he’s absolutely incredible,’ and he just started 
cracking jokes about his appearance right off the bat and I just thought, ‘This guy 
must have been through hell, and he’s been through so much, and he—he still has 
this light about him and he’s still so positive.’ Uh, and we became friends after that 
conference. We didn’t talk a whole lot but we would email a couple times during 
the year, and then we would see each other at the conferences during the year, and 
over the years of our friendship we would talk more often. Once I got divorced he 
kind of became my sounding board for everything I had been through and, you 
know because he wasn’t a big talker he listened, which was really nice to have 
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somebody listen, and not judge you. So. And it wasn’t until, we were in Galveston 
Texas, five it’ll be five years ago this October uh, at a conference, that, something 
was just different between us. And I’d been divorced for, a year and, um, we 
decided that we would have a long distance relationship which was a little scary 
but, we made it work. Yeah, so we’ve been friends for nine, going on nine years I 
think.” 
At some point during the development of his friendship with Carrie, Joe’s plastic surgeon 
in Boston introduced to him the idea of hand transplantation and invited him to consider being 
evaluated for their program. Because the extent of Joe’s burn injuries caused the loss of all of his 
fingers, at that time Joe was able to do very little for himself: “I figured out how to get myself a 
glass of water. Just little things. I did eventually get a device, I made it myself actually with a 
friend of mine, that did work good in order to hold a fork so that I could feed myself. But getting 
dressed was an obstacle, shoes, pretty much everything. I did figure out how to hold my 
toothbrush…” After being offered the possibility of a hand transplant, Joe says, “I went home and 
thought about it and I called Carrie, who was just my friend at the time, and asked her what she 
thought about it. Then after her conversation I thought about it some more, ‘Do I want to be on 
medicine for the rest of my life?’, things of that nature.” Carrie says that the idea of constant 
medications was especially hard to get used to, especially for Joe: “Joe’s never been drunk in his 
life, he’s never taken illegal drugs, he’s never been high never smoked a cigarette, like he was—
straight as an arrow, clean—when it came to bodybuilding the only supplements he ever took was 
protein powder…” 
After the hand transplant, Joe and Carrie say they purposely remained in state of watchful 
awareness rather than emotional investment. Carrie describes that time:  
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“We really didn’t have any expectations which, I think, is a good thing. Um, I kind 
of compare it to, you know when you have a new baby you—are hoping that it’s 
healthy, and that you don’t have any health issues, and that your child’s gonna be 
different than any other child. Whatever that is, um, but you can’t expect your kid 
to be born, and to be a certain way that you have imagined in your head, and I guess 
that’s kind of...what we did with his hand. He got this hand, and it was—a hope—
that he would be able to do things that he couldn’t do with the stump that he was 
left with. And none of it was immediate, at first the biggest milestone was being 
able to pick up a marble, um, and that was like two months in. And that was a huge 
deal.” 
According to both narrators, there was a long and surprisingly arduous period of adjustment 
before Joe got any real function and benefit out of the graft hand. Carrie says, “I would say the 
first three months were pure hell. It was...horrible. Um, and if that was something—that somebody 
could have told us before the transplant I think it would have made the transition a little easier? 
But nobody knew.” Along with grueling therapy and nerve pain, Joe endured near-constant 
vomiting and nausea for over a year before his body adjusted to the medications.  
One interesting and especially rare outcome of the hand transplant for Joe and Carrie is the 
rich familial relationship they have developed with the family who donated Joe’s graft hand. 
Because Joe and Carrie’s donor was a high school senior who died in a freak accident, it was easy 
for them to triangulate between demographic information they were given about the hand donor 
and the local news covering the tragic death. When Joe and Carrie first met the family, Joe says 
their connection was, “strange in a good way.” He explains that it, “Seemed like friends that you 
hadn't seen for a bunch of years. We sat down and started talking. …I didn't know what to expect 
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and I wasn't trying to expect too much. Since then they have asked and we've accepted that [our 
newborn daughter] Hadley—if she could be considered their granddaughter—because her son's 
hand is on me so his DNA is inside of me now. They asked if she could be part of the family.” 
Although it may seem surprising to outsiders, phenomenologically and biologically Joe 
and Carrie say it makes sense for the donor family to participate in their life in this intimate way. 
Carrie describes their connection in strongly affective language:  
“We know in our minds that having this hand on his body had nothing to do with 
[our getting pregnant] because all the transplant medication Joe was taking should 
have, for all intents and purposes, made him sterile—even if he hadn’t had a 
vasectomy. But it didn’t. Um, so like, I’ve said, and Mary [the mother] says it too—
it’s like this little person is supposed to be here. We don’t know for what reason, 
but um, it makes Mary feel better to think that Troy had something to do with it. 
It’s not like, Joe took on Troy’s DNA profile because he didn’t. But, there’s some 
part of Troy in Joe that’s now Joe. The hand belongs to Joe, it’s his hand, um—but 
I think it makes Mary feel better, thinking that there’s some part of Troy… in 
Hadley. And when we told [our doctor] this he kind of laughed and he said hey, 
‘Anything’s possible.’ You know? Not that it’s her biological grandchild by any 
means. But, um, that we don’t know if we would have had her before. So, 
anything’s possible, but she feels like this—this is her grandchild and we’re 
perfectly fine with that. We love them to pieces, we absolutely love spending time 
with them, we were at their house last weekend, um—there was a big memorial 
softball tournament in Troy’s memory and so Joe along with the family got to throw 
out the first pitch. Troy used to be the pitcher, at his high school, so... that was really 
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special for all of his friends to see, and all of his family, and, for his parents most 
of all, to see, um, Troy’s hand doing what it used to do, which is, pitching, which 
... was pretty cool.” 
Joe and Carrie are still navigating together the many challenges and opportunities of human 
hand transplantation. When asked what they would change or do differently if given the 
opportunity, Carrie says her only regret so far is the lack of adequate preparation and inability to 
accurately imagine the intensity of the early post-operative period, concluding, “I’m glad it took a 
whole year for us to get through the process. Um, being able to ask questions that we thought were 
pertinent to the surgery, the one thing that we did hold back on was—and Joe expressed this to me 
later—was, ‘I’m afraid to ask too many questions because I’m afraid they’re gonna say, we 
changed our minds, you’re not a good candidate for this.’” Carrie emphasizes the extent of this 
mistake anecdotally: “[Our doctor] Curt said, ‘That’s the stupidest thing ever, you could ask us 
anything and there was nothing that was gonna change our mind about you being the first patient 
at MGH to do this.’ Um, so it’s—I think that would be one of the things I would tell patients is, 
‘Don’t’ be afraid to ask every question that’s on your mind.’” 
3.3 ORAL HISTORY OF HAND TRANSPLANTATION: THEMES AND CONCEPTS 
Based on the interviews with hand transplant patients and their caregivers, I present several 
thematically organized “gestalt” insights pertinent to understanding what counts for success in this 
field, and how success has been achieved through the mental and physical work of patients and 
those who support them. Taken together, the narratives illustrate that in hand transplantation, 
compliance is a collective achievement of medical providers, caregivers, and patients rather than 
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the sole burden of the hand graft recipient. Second, physical sensation, manual and psychosocial 
function, and the health of a hand transplant are deeply related categories of the HTX experience 
and should be treated as such in scientific measurements of efficacy in hand transplantation. 
Finally, insofar as “success” is achieved in HTX, it can only be defined by the conceived desirable 
outcomes of the hand transplant as envisioned by the patient and their family.  
“Compliance” is a collective achievement 
Researchers in the field of hand transplantation make much of the process of patient 
selection and the need for strict adherence to immunological protocols and hand therapy 
guidelines. When guidelines are not followed, patients can be charged with “noncompliance,” 
which effectively brands clinical interventions as personal failings if the treatment ends badly (see 
chapter 1 for discussion on noncompliance issues in the first modern case of human hand 
transplantation).  There has, however, been little work to understand longitudinal compliance and 
its challenges from the viewpoint of patients and their caregivers who carry out the work from day 
to day (Kumnig and Jowsey-Gregoire, 2016).  
In addition to engaging in hand therapy and medication management for the rest of their 
lives or the lifespan of the graft, patients and their caregivers must perform the real work of forging 
and maintaining the relationships that make hand transplants possible. From the start, hand 
transplants involve a host of actors and actants—a huge network of laborers are needed not only 
to organize and perform the transplant medically, but also to help the patient care for the hand 
graft, to guard against outside threats, to interpret signs (e.g., of infection or progress), and to help 
shape new meanings in response to contingencies. As Angel Gonzales describes in his oral history 
interview:  
91 
“[My partner’s arms]...were basically dead weights, in these casts, and swollen and 
just, needed constant maintenance—you know, we had to unwrap the arms, wrap 
the arms, uh, multiple times a day, massage them, work them out it was just a 
regime of things that, basically by the end of the day you were glad that the day 
was over!”  
Because in the short term of hand transplantation, functionality will go down before it goes 
up, for bilateral HTX patients especially family caregivers or attendants have to be willing to put 
in as much work as the patient. These care activities may or may not be aspects of the recovery 
process that they relish or even expect.  
In hand transplantation, for almost all aspects of the preparation, surgery, and aftercare, as 
the saying goes, “it takes a village.” In their seminal 1977 book on architectural evolution and 
livability, A Pattern Language: Towns, Buildings, Construction, authors Christopher Alexander, 
Sara Ishikawa and Murray Silverstein write, “when you build a thing you cannot merely build that 
thing in isolation, but must also repair the world around it, and within it, so that the larger world 
at that one place becomes more coherent, and more whole; and the thing which you make takes its 
place in the web of nature, as you make it” (p. xiii). Recalling the surprisingly wide and robust 
circle of effect the hand transplant had on his social relations, Matt Scott said, “’I started to realize 
that this is not just me. This is everybody around me. Everybody around me who knows me, even 
my friends will go, ‘Hey, you’re friends with that guy who got the hand, right?’… It spread that 
far out that it affected more than just me and my small nucleus. It went far around me.’” Matt 
Scott’s experience was unique due to the way his experience of celebrity patienthood contributed 
to the social effects he describes—nevertheless, hand graft recipients across my oral history 
interviews have remarked on the local, rather than individual, effects of these types of transplants. 
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Whether clinical, familial, or collegial, the relationships supporting the substantial work of 
hand transplantation are crucial to patients’ thriving. Instances during which the shared nature of 
“compliance” in hand transplantation can be especially visible are those in which HTX recipients 
were considering exit strategies. Josh Maloney recalls, “I was afraid to disappoint [my doctors] 
when I told them that I wanted to have the hand removed. When the functionality started dropping, 
I felt like I was disappointing them. I felt bad because of it. … I finally just said, ‘I think now is 
the time. I've given it everything I can, it's not getting any better.’” Even in the less intensive 
rehabilitation processes of solid organ transplantation, care providers typically consider it part of 
their job to check in on their patients, to motivate them in completing care protocols, and to 
communicate consistently about health events. As organ transplant clinicians Williams, Low, 
Manias, and Crawford argue, “A quality partnership with frequent interaction between the health 
professional and patient is necessary to support medication adherence… Post-transplantation, 
patients require repetition, reassurance and re-enforcement long-term by staff trained in adherence 
counselling within a supportive healthcare system as taking multiple doses of different medication 
every day is taxing” (2016, p2252 and p2260).  
Jan Plock, a plastic surgeon and burn care physician in Zurich who is starting a VCA 
program in Switzerland, was a resident at UPMC, Pittsburgh, when hand transplants were being 
performed and treated there. In a Skype interview Plock says he observed loose obligations to 
patients among some HTX doctors (compared to the personal commitments held by counterparts 
in solid organ transplantation) and the high cost for patients when their care team was unreliable 
or constantly changing:  
“What I see in other transplant centers is that the centers really have a very strong 
connection to their patients, and I think there are huge differences in the different 
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U.S. centers. For example, the [Brigham and Women’s Hospital] team seems to 
have a very strong communication with their patients; other teams who did a very 
low number or a few patients have this quality. Then there are other teams where 
there is only one surgeon who has this quality of relationship with the patient so the 
team can’t handle that relationship, it is more of a personal commitment … 
Observing the situation at UPMC the only thing I can really say is the patients were 
not happy with the situation, and the situation is that their doctors, the surgeons 
who had transplanted them, were not there any more. The hospital was the 
providing institution so they were bound to this hospital and the doctors that were 
there were not the ones that had initiated the process. And this is a really neutral 
statement because nobody could do anything about it [at UPMC]. They didn’t know 
or had not known before [that the program was moving to Johns Hopkins]—the 
situation just changed.”  
Because many hand transplant recipients live a long distance from their center of care 
(especially in the U.S.) maintaining therapeutic relationships can be particularly challenging. 
Many narrators expressed dismay recalling how many trips they had to take for yearly checkups 
and to manage complications—trips which were made at their own expense, a fact which caused 
bitter feelings in some cases. Other recipients have found the necessary migrations of hand 
transplantation to be enjoyable on some level, “I have since come to think of Louisville as a home 
away from home,” said Matt Scott describing his regular visits there. For HTX patients who 
experienced the phenomenon of their original clinicians leaving for new opportunities or to start 
VCA programs in other places, advocating for their own interests with newer doctors who did not 
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know them from the beginning of their treatment was uncomfortable and problematic (see 
narrative 4, Dave and Karen Savage for quotes on this effect).  
Function, sensation, and sensitization: Irreducible issues 
In conversations with friends, family, or colleagues about my research on the history and 
ethics of hand transplants, Luke Skywalker’s robotic hand is a cultural touchstone of frequent 
reference. When discussing tradeoffs between hand transplants and prosthetic technologies, I 
sometimes mention Luke’s sophisticated bionic hand as a foil: we’re not there yet. Often, the 
catwalk on the cloud planet is recalled because most of us have trouble conceiving of the loss of a 
hand—and Luke is a rare protagonist who dramatically and visibly suffers this fate in a major 
motion picture. As an aid to imagination of the amputation or transplantation of human hands, I 
find STAR WARS imagery intriguing because Luke’s loss is so theatrical yet so quickly made a 
non-issue through advanced biotechnology. Luke’s device is dexterous, strong, touch-sensitive, 
and always functioning. Following the scene in which Luke is fitted with the prosthetic, audiences 
are able to forget the loss ever occurred and thereafter must be reminded through staged gestures 
and meaningfully panned shots that the movies’ hero is in fact an amputee. 
The functional, aesthetic, and overall therapeutic differences between transplant hands and 
prosthetics are a key source of interest and speculation for hand transplant doctors, candidates, and 
recipients—as well as ethicists, payers and policy makers who work to determine the best care 
options for their communities within the limits of available resources. As pointed out by hand 
transplant providers, prosthetics are often rejected by their users for reasons that include their 
awkward social nature, their heavy weight, and the fact that they must be taken off frequently (Kay 
and Wilks, 2013). Matt Scott describes his bionic hand: “It had its limitations. It was battery-
powered, so that was always something of concern is that I always had to have a spare battery or 
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two with me, making sure that if the battery power started to wane, I had something to quick pop 
in and pop out. It was uncomfortable and it was unbalanced. It was heavy, particularly on the distal 
end, where the hand is, because that’s where all the robotics were.” 
While the spectrum of function for hand transplants is broader than for prosthetics 
(including return of touch sensation, warmth, and “human”-ness) hand transplants do not 
necessarily work better than prosthetics to improve their users’ quality of life. A hand transplant 
unlike a prosthetic is a constant presence on the body both affording and constraining that person’s 
action and movement through the world. Narrators for my oral history project almost unanimously 
experienced functional gains with a hand transplant that were impossible with the prosthetics they 
had tried, yet these gains were made within the parameters of the post-transplant lifestyle, 
including restrictions on diet, lifestyle, budget and freedom to travel in the short or long term. 
While hand transplants and bionic prosthetics both require extensive learning and rehabilitation 
periods before they are useful for even the most basic tasks, many who pursue hand transplantation 
after using bionics emphasize that the work needed to maintain a hand graft and the demands of 
post-care protocols were far more intense than any physical therapy they had previously 
experienced.  
Because hand transplants can bring dramatic functional returns but are also biological gifts 
from another person, gains can be set back by immunological complications. “Sensitization 
describes the acquired ability of the immune system to react to [foreign tissue] by producing 
antibodies and developing memory cells,” write VCA biologists Klein et al in a paper on the 
science of rejection in reconstructive transplantation (2015, p. 247). During a rejection episode, a 
hand transplant can swell and grow painful, develop spots or lesions, itch, and burn. Of course, the 
social and manual function of hand grafts go down during rejections, as the graft(s) might be too 
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swollen or hurting to use, and the aesthetic presentation of rejection can be off-putting to others 
(as one family caregiver described, “You come to the point that [you want to ask] ‘Is your, is that 
hand dying?’ It's not right, let's put it that way. It's not getting the right blood flow—or, is it in 
rejection?”  
Following a rejection episode, a transplant patient’s immune system is likely to be more 
sensitized to their graft, and any fluctuation in medications could result in further rejections 
(especially alterations made intentionally to deal with systemic bacterial or viral infections where 
turning down immunosuppression is necessary for recovery) (Krezdorn and Pomahac, 2017). Even 
long after rejection episodes, effects can be felt in the subtle loss of dexterity and sensation that 
can occur with them (possibly because of swelling or attendant vasculopathy [hardening blood 
vessels]). “I would say the first couple years were the best results he had,” recalls Karen Savage 
at the end of our oral history interview. “Dave was using his hand for everything. Then each time 
that he's gone through one of these episodes where there's swelling and pain, he comes out of the 
episode, but with less function on his hand.” Josh Maloney recalls similar struggles:  
“I was getting really good with [using my graft hand]. Really, really good. Way 
more than Vijay [Gorantla] or anybody else thought I would ever get because I 
pushed myself. Then I started trying to ... Okay, I'm going to go back to school and 
I'm going to get a job, [so] I got arrogant and stupid and thought that after a year of 
therapy, it was just going to stay that way that I didn't have to maintain it. I took 
advantage of it and I stopped paying attention and functionality went down. Then, 
I was outside more and I was going to [technical school] working on cars for school 
and started having more rejection issues, and more and more rejection issues. The 
meds kept getting stepped … Eventually, it just got too much.”  
97 
When Josh and his family has seen “the writing on the wall” as he says and he exited the program 
with a second hand amputation, Josh nevertheless felt that the hand transplant experience “taught 
me what I can make myself do and what I'm capable, mentally. I always say it, but I don't think I 
quite believed it until during and after the transplant that disability is a state of mind. I'm wearing 
my prosthetic now, but I can still do most everything that everybody else can do with two hands. 
I've just learned to adapt.”  
For others, even if the donated nature of hand grafts can cause fluctuations in health or 
frustration in terms of the transplant lifestyle, hand transplantation is an operation that can return 
life-giving function unparalleled by other reconstructive options. Sheila Advento explains the real 
joy she feels in having her graft hands: “just the fact that I'm able to do so much more. It's exciting 
for me. For instance, I'm able to grab somebody's arm, I'm able to hold somebody's hand, I'm able 
to hold my boyfriend’s hand. It's a nice feeling. Not having hands, eventually you lose the intimate 
feeling.” 
“Success” begins at conception 
Imagining what a hand transplant will be like, and what it will represent in terms of a 
change to the life course of a person and their family—including aspects of lifestyle, value, and 
identity—is a process requiring several intertwining avenues of deep concern. Patients and 
caregivers must work to discern whether a hand transplant will be affordable for their family and 
whether the biological risks (including lifelong reliance on and weakness from toxic 
immunosuppressive drugs, surgical complications, and possible graft-related illness) will be worth 
the psychosocial benefits that may or may not follow as a result of the hand transplant. For bilateral 
amputees, the calculus is especially precarious: if the transplant fails, they could lose valuable time 
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learning how to use their prosthetics, or they could be set back in their ability to wear prosthetics 
for months or years due to an additional healing period before getting fitted for a second pair.  
Having time to imagine all the possible outcomes of hand transplantation and associated 
challenges was an important factor in long term success according to several narrators. As Carrie 
Pratt notes above, “I’m glad it took a whole year for us to get through the process. Um, being able 
to ask questions that we thought were pertinent to the surgery...” Still, Carrie along with many 
other narrators in the oral history project expressed a sense of frustration regarding the gap between 
how difficult they imagined the HTX recovery process being and how difficult it actually was 
(hard to the point of unmanageable). Matt Scott says the daily labor of the transplant and the 
necessity of being away from home for several months post-transplant for therapy and observation 
was the hardest part, “I knew that there’s going to be work, but I didn’t realize how much work it 
was going to be. I don’t think that I had an understanding—and I’ve reported this back to the team 
as well—the people who are coming in, they have to understand what they’re getting into. Beyond 
medication and beyond the therapy it’s just it’s going to be hard, hard work, and I don’t think I 
was ready for that. Psychologically, I wasn’t ready for it.” Many narrators recall with pride or a 
sense of self-satisfaction the hard work they put into the hand therapy and how this work showed 
through in their evolving ability to manipulate the world around them. Vasyly Rohovyy narrates, 
“It took a lot of time, as I said, three years. I did the therapy for three years. I know, there is very 
few patients who did therapy for so long as me. I learned a lot of things that I took for granted 
before the explosion. To eat. I had to relearn everything, to dress myself, to eat with fork, spoon, 
to open a bottle.”    
In the above narratives, patients described hand transplant successes and their level of 
satisfaction in relation to what they had conceived, prior to transplantation, as likely desirable 
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outcomes. For example, Josh Maloney describes having hoped to regain a combat role in the 
military after hand transplantation and, failing this outcome, he stopped going to hand therapy 
every day; requested re-amputation of the graft quickly followed. Josh reflects, “Truthfully, I did 
it for the wrong reasons. I did it to get back into the military, thinking that that would be my shot 
to get back in. I kept thinking about that the whole time the process was going on for it.” A similarly 
powerful yet erroneous conjecture about what kind of life would be possible with new hands led 
to dissatisfaction and disaffiliation in the case of Rich Edwards. For a short period, hope itself 
seems to have been a telos of Rich’s hand transplant treatment, an end in itself conferring 
reinvigorated purpose to his shared life with Cindy, from which new meanings could have—but 
unfortunately did not—arise. Because their hand grafts were unable to take on new meanings after 
years of grueling therapy did not afford the hoped-for outcome, the semiotic calcification of these 
HTX as “unsuccessful” in specific endeavors led graft loss for Josh and even more severe 
consequences for Rich (depression and suicide).  
 Software engineers are familiar with the problem of overdetermination of methods and 
endpoints in designing and implementing new technologies. The following passage from a paper 
describing parallels between engineering and evolutionary biology sketches concepts that are 
relevant to the unfolding contingent, iterative, and enmeshed technologies of hand transplantation: 
[W]hile human engineers are certainly goal oriented in the short run and nature is
not, their guesses as to what a new device might eventually be used for often fall 
flat … adherence to a strict linear approach to design has often been identified as 
the key reason for the frequent failure of large-scale software projects, which some 
estimates put at over 50 % of projects. It is common, for example, for precise 
requirements to be unclear at the beginning of a project, and many complex design 
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problems often don’t come into view prior to implementation (Calcott, Levy, 
Siegal, Soyer, and Wagner, 2015, p. 54-55). 
This description of an “iterative” design process in highly interactive technological disciplines is 
similar to challenges associated with demanding, constantly unfolding, medical interventions like 
hand transplantation.  
One recurring theme in my oral history interviews that I found fascinating and instructive—
voiced on separate occasions by patient families who did not know one another—was the 
metaphorical comparison to their experiences as caretakers of hand grafts to the processes of 
attending, working through, and cautiously observing the development of a baby or child. Angel 
Gonzales gave the analogy in buoyant, but also serious, terms: 
“I didn’t see [the work of HTX rehab] as frustrating, because I mean, this kind of 
thing is exciting—to me it was, I guess the closest I’ll ever be to ...having a child? 
Haha, so it was kind of like, I dunno these sort of instinctual things come with it. 
… I think when Will has fully regained sensation—or if he fully regains sensation, 
uh, and proprioception, so that he doesn’t have to think about where his arms are—
um that will be the sort of... the day that like, the baby’s grown up! [Laughing]” 
Carrie Pratt offered the “baby metaphor” to illustrate what it’s like to both hope for an outcome 
while also holding that hope in tension with the knowledge that it could be otherwise, “I kind of 
compare it to, you know when you have a new baby you—are hoping that it’s healthy, and that 
you don’t have any health issues, and that your child’s gonna be different than any other child. 
Whatever that is, um but you can’t expect your kid to be born, and to be a certain way that you 
have imagined in your head.” 
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Conclusion 
Building on the traditions and insights of oral history, grounded theory, and narrative 
medicine, this chapter provided eight oral histories with hand transplant recipients and their 
partners or family caregivers. The interviews illustrate the unending nature of the hard work of 
hand transplantation, but also the unique joys and capacities for life and self-transformation that 
HTX can provide well-prepared and cared for patients. In the last section of this chapter, I 
highlighted three themes that run across these oral histories: first, that compliance is a collective 
achievement of medical providers, caregivers, and patients. Second, that physical sensation, 
manual and psychosocial function, and the health of a hand transplant are deeply related categories 
of the HTX experience and should be treated as such in scientific measurements of efficacy in 
hand transplantation. Finally, that “success” is determined by the conceived desirable outcomes of 
the hand transplant as envisioned by the patient and their family. 
Regardless of how hand transplant patients might envision an intervention like hand 
transplantation in terms of restoring their quality of life or a specific function, outcomes in this 
field will always be a complicated palimpsest of pre-existing associations and novel, as-yet-
uncategorized sensations. For this reason, anticipating that a hand transplant will allow for the 
return of a former lifestyle or career may be impractical or a dangerous recipe for disappointment. 
When assessing quality of life outcomes in hand transplantation, patient-centered must mean 
patient-defined—even if the imperfect, intuitive definitions given by patients means working with 
a vocabulary that is possibly resistant to standardization. I argue in closing this “keystone” chapter 
of my dissertation that the goals of a hand transplant are emergent, not predetermined: patients do 
not reach a discreet destination or point of full recovery but will rather see gains and losses in 
psychosocial and manual function over time due to complications from drugs, rejection episodes, 
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or the limitations of the post-transplant lifestyle. In the next chapter I discuss the scientific, ethical, 
and human costs of failing to recognize the unfolding contingent nature of success in hand 
transplantation. 
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4.0  THE RHETORIC OF “SUCCESS” IN HAND TRANSPLANTATION 
“‘To the pain’ means the first thing you lose will be your feet below the ankles, then your hands 
below the wrist, next your nose and then your tongue. The next thing you lose will be your left eye 
followed by your right. Your ears you keep, and I'll tell you why: So that every shriek of every 
child at seeing your hideousness will be yours to cherish. Every babe who weeps at your approach, 
every woman who cries out, ‘Dear God, what is that thing?!’ will echo in your perfect ears. That 
is what ‘to the pain’ means: it means I leave you in anguish, wallowing in freakish misery, forever.” 
~ Westley, The Princess Bride 
“We know that Mary Shelley’s hero, Frankenstein, [sic] was made of pieces of human bodies sewn 
together. The first time a patient sees his newly grafted hand, the sight is rather awful. Stitches, 
threads, the swelling of the hands and the additions, the possible different colours of the skin … 
The unnamable is there. The perception is traumatic and revives the idea of the lifeless coming 
back to life.”  
~ G. Burloux, “Hand Transplant and Body Image” 
in Lanzetta and Dubernard, 2007, p. 378 
After over twenty years of human research and clinical trials, there are no commonly 
accepted rules or conventions characterizing how and when “success” is attained through hand 
transplantation (HTX). In the early years of the field, outcomes of single case studies were 
published promptly and with preening self-congratulation by clinical professionals directly in 
charge of or involved with the events (see chapter 1). The outcomes reports on the first hand 
transplants in Louisville and Lyon confirm the “success” of these procedures in terms of a technical 
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(early surgical and immunological) result and many of these reports were immediately and 
uncritically cited by peers as showing proof of concept for further hand transplants and for the 
diversification of hand transplants to other conditions (collectively called “VCA”). Regrettably 
few of the scientific and ethical debates on hand transplants’ effectiveness feature discussion on 
whether the interventions successfully returned the “quality of life” (QoL) gains that figured so 
prominently in preclinical ethical debates.  
In the preceding chapter of my dissertation I argue that the under-appreciated and often, 
uncirculated narratives of hand transplantation from patients’ point of view can offer visceral 
complications to decontextualized representations of results given in scientific review articles and 
case reports. In the first section of this chapter I show how “successful” outcomes in hand 
transplantation are produced by stakeholders through a series of rhetorical gestures in which 
empirical findings from preselected scientific and psychosocial assessment tools take the place of 
“commonsense” conclusions and firsthand observations of patient participants. As I will show in 
my descriptive analysis of these medical texts, having read and imaginatively entered (Yow, 2015) 
the vicariously rich imagery and personal language of the oral history narratives, gestalt traces of 
these account will—I hope—settle like a lens upon the mind’s eye when re-encountering clinical 
voices in chapter 3, helping to bring certain features of medical storytelling into relief. These sense 
impressions from patient narratives of hand transplantation, far from being “merely” descriptive 
or emotional edgings to scientific accounts are, I argue, pertinent tools for interpreting the given 
information in many academic-professional contexts—which might otherwise be “sanitized” from 
their resonances—since patients’ own subjective experience of their QoL is both the occasioning 
and the ongoing clinical and ethical justification for hand transplants.  
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In part two of chapter 3 I think through the concepts of medicalization, biomedicalization, 
and the social model of disability to unpack how such dehumanizing rhetorical conventions have 
come to characterize outcomes reporting in this field of human subjects research. To do this work, 
I bring voices from bioethics, disability studies, and science and technology studies (STS) together 
with my own data and observations to argue that “success” is a misnomer in complex biomedical 
interventions like hand transplantation and claims to success a problematic distraction from 
patients’ lived reality which involves complicated tradeoffs of health for quality of life that are 
never fully resolved. There is a recognized need for more robust integration of STS concepts 
regarding largescale developments in medical science and practice, with insights from disability 
studies on how those developments affect populations “on the ground.” In a call for papers for the 
2019 meeting of the international Society for Social Studies of Science (4S), organizers write that 
such integration is needed and timely: 
In STS, for all the considerations of the posthuman, critical conceptualizations of 
disability remain rare. The research, then, emerging from these fields has largely 
run in parallel, with few or fleeting intersections. If the conceptual and political 
points of reference in these fields are characterized largely by disjunctions, the same 
cannot be said for their subjects of interest. From studies of biomedical technologies 
such as pharmaceutical and bionic devices to studies of the senses and ways of 
being in the world, the subjects and objects of concern in critical disability studies 
and STS overlap significantly (https://www.4s2019.org/accepted-open-panels/ 
“Beyond the Prosthetic Imaginary: New Intersections between STS and Disability 
Studies).  
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Because hand transplantation makes transformations to bodies from the inside out requiring 
the enmeshed participation of several biotechnological disciplines and processes, this approach of 
wholesale transformation (changes sustained at the cellular level), rather than localized restoration 
represents, I argue, the “biomedicalization” of human hand loss. Consequently, the increased 
degree of surveillance and self-transformation attending HTX must be taken on board in 
evaluations of effectiveness. I conclude this chapter and the argument of my dissertation by 
explaining why, when efforts to transform the human body are rebuffed by organic complexity (in 
the form of rejections, infections, and other biological complications) iterative evaluative work is 
needed to illuminate tradeoffs for patients in the long term.  
4.1 “SUCCESS” IN HUMAN HAND TRANSPLANTATION: CONTEMPORARY 
PERSPECTIVES 
Hand transplants were the groundbreaking surgeries in VCA, and accordingly many of the 
ethical and technical arguments justifying hand transplants to peer researchers and the public can 
be considered, themselves, successful in eliciting support for what is now an international field of 
chronic care medicine. The first hand transplants in Lyon and Louisville were figured as surgical 
successes in media reports as early as days after the operations (see chapter 1). Following only six 
months after transplanting Clint Hallam (who notoriously requested amputation of the graft two 
years later) the Lyon team writes, “We have confirmed the technical feasibility of limb 
transplantation” (Dubernard et al, 1999, p. 1318). After just one year, the Louisville group 
published similar conclusions, “Our results and those of the first human hand transplantation, 
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performed in France, show that early success in hand transplantation can be achieved with the use 
of currently available immunosuppressive drugs” (Jones et al, 2000, p. 472).  
After over twenty years of human trials, success claims in the field of hand transplantation 
are no more sophisticated in terms of their empirical significance than they were in the early, 
fevered years of human experimentation and “proof of concept” studies. Because straightforward, 
dispassionate representations of illness events are a stylistic convention in medical reporting, one 
is obliged to read beyond the lines—imagining the human experiences on the ground being 
represented by the abstract statements—to appreciate why some articles’ recitation of relevant 
sequelae feels wrongly unreflective or inauthentic in terms of proving the effectiveness of hand 
transplant interventions.  
Consider the following study from a hand transplant research program at Duke, University 
in Durham, North Carolina, which argues for the efficacy of a novel immunosuppressant drug in 
caring for HTX patients preceded by an unelaborated yet seemingly well-populated list of 
complications from the hand transplant aftercare and experimental immunosuppressive regimen:  
At [post operative month] 4 the patient experienced an increase in serum creatinine 
of 1.3 mg/dL and a tremor that resolved with a reduction in the tacrolimus dose. At 
[post operative month] 6 the patient reported increasing fatigue and fever. The 
results from routine screening for viruses were within normal limits. He was 
admitted to the hospital and medication- induced neutropenia was diagnosed… 
During his 8-month belatacept infusion visit the patient presented with round 
erythematous, nonblanching macules …. At 1 year the patient reported mouth 
ulcers and new, asymptomatic skin lesions localized to the allograft (Cendales et 
al, 2018, p. 1805). 
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Despite these reported complications in the short term, in the conclusion of their paper, Cendales 
et al write that, “We have shown that hand transplantation can be performed using a de novo 
belatacept- based treatment in a CNI- free regimen, providing sufficient prophylaxis from 
rejection, reversible rejection when occurred, and reduced side effects, the latter particularly 
important” (2018, p. 1806). Revealingly, the authors do not mention the fact that their patient 
resides extremely far away from the transplant center but was personally responsible for getting to 
and from his monthly appointments. Cendales et al write: “Per protocol the patient resided locally 
for 3 months and returned to his local residence in month 4. Thereafter, the patient returned to our 
center monthly for his belatacept infusion until the end of the study period at postoperative month 
(POM) 18” (p. 1805, italics added). These are significant details because in traveling to these 
mandatory monthly appointments, the patient—who lives in Laredo, TX, on the border with 
Mexico—had to travel a distance of over 1,400 miles to Durham, North Carolina for these 
experimental treatments. One might commonsensically wonder what other tradeoffs have been 
experienced by this patient in terms of the hand transplant when we have no firsthand feedback 
from him on the gains and burdens he has experienced in any publication or presentation by 
Cendales’s group so far.  
Regrettably, the example related above is not an isolated case of abstract representation of 
patient experience at the service of “progress” in the hand transplant field. At every conference I 
have attended on VCA (three so far), the need for consistent outcomes reporting has been 
emphasized by field leaders but no strategies have been agreed upon for filling empirical gaps. 
There is an International Registry of patient data but it is not complete or up to date lacking insights 
from many programs and patients. Furthermore, patients who have lost their hand grafts are not 
followed at all, and complications, including patient deaths, are not discussed in the media with as 
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much regularity as successful surgeries or milestones.  Even when outcomes are published in a 
timely fashion and a patient followed over time, manual function (grip strength, etc.) and the 
clinical management of immunosuppression or rejection/infection are discussed, but not the factors 
contributing to patients’ quality of life post-transplant. Thus, the impact of managed complications 
and the post-transplant lifestyle (including travel to and time spent in the hospital and at 
appointments, or the temporary loss of manual and social function during recovery from surgery 
and from infections/complications) are not considered—after 20 years of hand transplantation we 
can find out almost nothing about patients’ lives from the literature and even conferences are thin 
on this aspect. 
As Judy Segal writes in Health and the Rhetoric of Medicine, “The most salient narrative 
of medical history is the narrative of progress, the narrative that says, ‘We used to have things 
wrong, and now we have them right, or are on the road to having them right’” (2008, p. 21). When 
clinical researchers push success narratives, publishing and discussing primarily quantitative 
“scientific” variables from their experiments without considering complicating on-the-ground 
participant perspectives, a dangerous loss of focus on research subjects’ personal interests in the 
outcome of experimental interventions can occur. This is emblematic not just of one-off case study 
representations of success in hand transplantation but also of the “top-down” rhetoric from 
contemporary field leaders. In a recent feature-length article on hand transplant outcomes by 
science journalist David Dobbs, the tendency of hand transplant thought leaders to present 
outcomes in terms of their own needs and not their patients’ is strongly highlighted. Dobbs 
interviewed me for his article on modern hand transplant outcomes and I encouraged him to attend 
a scientific meeting on the topic. Dobbs acquired a media pass for the 2018 conference of the 
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American Society for Reconstructive Transplantation (ASRT), giving the following reflection on 
representations of patients’ experiences by surgeon-scientists at the meeting:  
[S]uccess was the theme of the conference that day, and [Gerald] Brandacher [head
of the ASRT] underscored that idea in his opening speech. Just as solid-organ 
transplants had moved 30 years earlier from doubt to acceptance, he said, so 
reconstructive transplants were poised to do the same. Challenges remained. Now 
that many patients had been on immunosuppression for years, Brandacher noted, 
they were suffering more renal complications and chronic rejection of the grafts. In 
his opening talk at the conference, Brandacher acknowledged that the VCA field 
had not resolved all its issues. But his main message was one of success and the 
need to move forward. Most of the day’s talks followed this lead. The last speaker 
of that afternoon’s long opening session, a bioethicist, in fact, ended by crying, “Let 
us plow forward with this incredible field!” 
(https://www.wired.com/story/devastating-allure-of-medical-miracles/) 
As demonstrated above and in previous chapters, when doctor-scientists create 
opportunities for their patients and also frame how those opportunities will be managed and 
assessed, professional considerations in the literature may travel farther and farther from the site 
of the patients’ and their families’ ever-evolving needs in relation to their own health and even the 
health of the hand graft(s). As Stefan Timmermans and Marc Berg warn in their 2003 book on 
evidence-based medicine, The Gold Standard, “the emphasis on following standard procedures, 
based on scientific evidence, could leave precious little room for patients to influence the course 
of their own care trajectories. Moreover, an emphasis on objective evidence might direct the 
physician’s attention even more to laboratory tests and other objective measures of the patient’s 
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condition, and belittle even more the importance of the patient’s own story and experiences” (p. 
118). If, as Timmermans and Berg argue, representing patients’ experiences in such unrealistically 
calculated ways is contrary to medical knowledge and possibly ethics, why have reductive 
quantitative methods for assessing medical outcomes become the seemingly “natural” vocabulary 
for doctors relating case studies to their peers (especially in a field like hand transplantation where 
the stated goal of the treatment is subjective improvement to patients’ quality of life)? 
To illustrate how such ungrounded, seemingly out-of-touch vocabularies have come to 
dominate clinical discussions of outcomes in this and other fields of medical science, the next 
sections explore the concepts of medicalization and biomedicalization as they relate to the 
evolution of treatments for hand loss in the 20th and 21st centuries, turning first to disability scholars 
for a critical framing of key developments and processes.  
4.2 HAND LOSS, PHYSICAL DIFFERENCE, AND THE “SOCIAL MODEL” OF 
DISABILITY 
In the above epigraph, a French psychoanalyst and participant in several of the world’s first 
hand transplants, Gabriel Burloux, invokes images of Frankenstein’s monster to emphasize fears 
of psychological rejection in early hand transplantation (in Lanzetta and Dubernard, 2007, p. 375). 
Notable in Burloux’s chapter, the ontological state of being “pieced and sewn together” is the 
speculative source of horror—a somatic fact eliciting revulsion from others or from oneself. Since 
I started writing this dissertation project, images of Frankenstein’s monster have entered my 
mental and visual field of view with increasing regularity as 2018 marked 200 years since Mary 
Shelley first liberated her “hideous progeny.”  
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For me, Shelley’s haunting depiction of scientific tragedy is made more unsettling because 
the story’s horrific ends emerge not from defects in the monster-protagonist’s nature or character 
but as an outcome of the unearned abuse and “othering” the creature endures from every person to 
whom he appeals for the most basic of human needs: care. Here is the creature approximately mid-
way through the novel, begging his creator for a chance at life, which he characterizes as life with 
seemingly any amount of affection in it: 
“I learned from your papers that you were my father, my creator; and to whom 
could I apply with more fitness than to him who had given me life?” … he 
continued, “If any being felt emotions of benevolence towards me, I should return 
them a hundred and a hundredfold; for that one creature's sake, I would make peace 
with the whole kind! But I now indulge in dreams of bliss that cannot be realised. 
What I ask of you is reasonable and moderate; I demand a creature of another sex, 
but as hideous as myself. The gratification is small, but it is all that I can receive, 
and it shall content me. It is true we shall be monsters, cut off from all the world; 
but on that account we shall be more attached to one another. Our lives will not be 
happy, but they will be harmless, and free from the misery I now feel. Oh! my 
creator, make me happy; let me feel gratitude towards you for one benefit! Let me 
see that I excite the sympathy of some existing thing; do not deny me my request!” 
(Shelley, 1994, p. 99-100 & 105, quoted from Dover Thrift Editions, republication 
of the third edition of Frankenstein (chapters 16 & 17); italics added). 
This pitiful appeal follows several chapters of acute emotional suffering by the creature in which 
his gestures of friendship and bids for inclusion in human society are met with fear, revulsion, and 
physical violence by individuals and whole communities. The creature has learned to care for 
113 
himself but longs to be cared for, in turn—the same way he has observed (from afar) human 
families caring for each other throughout his solitary travels.  
Much has been made by literary scholars of the negligence of Doctor Frankenstein in his 
abandonment of his living creation. As an archetype, or foil for, differing concepts of scientific 
progress, an overlooked feature of Mary Shelley’s groundbreaking novel are the less dramatic, yet 
richly narrated character-building events in which the unnamed creature’s tremendous capacity for 
human connection are demonstrated through his eloquent words and compassionate behaviors. 
What clearly prevents this individual’s personhood from evolving fully, in Shelley’s depiction, is 
his lack of an acceptable degree of human appearance or an advocate of “normate” status (Garland-
Thomson, 1997, p. 8) who could translate his physicality as not-monstrous, but different. As 
science and technology scholars Megan Halpern and colleagues write in an article that reinterprets 
Frankenstein for interdisciplinary readers, the Victorian horror story that pervades so much of 
contemporary bioethics and technoscience discourse is about, “what it means to care for, or fail to 
care for, one’s creation,” as much as it is “a cautionary tale about the evils of scientific hubris.” 
Halpern et al conclude of their study that, “[Shelley’s novel is] a parable about the dire 
consequences of care’s absence … [and it] … cautions us against abandoning our creations to the 
world; in order to protect both the creation and the world, we have to take part in the discourse and 
deliberation about how it is taken up and integrated into its social contexts” (Halpern, Sadowski, 
Esrich, Finn, and Guston, 2016, p. 49-50 & 55). 
Burn survivors, people with congenital deformities, and others whose physical appearance 
has been a source of exclusion or abuse by society often gain critical resources for life through the 
advocacy of a friend or family member or through laws that have been advocated which protect 
their rights to equal treatment (Davis, 1995; Schweik, 2009; Johnson, 2010, p. 474; Kafer, 2013, 
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p. 30; Dolmage, 2017). Victor Frankenstein could have served as such an advocate for his abused
creation—much the same way Dr. Treves defends difference in the acclaimed film, The Elephant 
Man—but for no reason given other than the creature’s “monstrous” physicality, he does not.  
Frankenstein’s sentient creature is in considerable company as a fictional sufferer of human 
intolerance for physical difference. In the majority of narratives where disability and disfigurement 
are pictured, the storylines of disabled characters—typically not main characters—follow a 
predictable course in which restoration of form or function is a goal for which the afflicted strive 
(often aided in their pursuit by wealthier, healthier “normate” characters). In her 1997 book, 
Extraordinary Bodies, disability scholar and professor of English and bioethics Rosemarie 
Garland-Thomson laments the limited range of depictions of disability in modern culture. The 
representations that largely make up our (western) perceptions of disability and physiological 
difference, Garland-Thomson argues, are misleading and unsatisfactory. She writes, “From 
folktales and classical myths to modern and postmodern ‘grotesques,’ the disabled body is almost 
always a freakish spectacle presented by the mediating narrative voice. Most disabled characters 
are enveloped by the otherness that their disability signals in the text” (p. 10, italics added). Even 
for those whose affective adaptions to their physical difference is not as conspicuous as (for 
example) the use of a wheelchair or prosthetic, many dis/abled people describe moments in which 
strangers have noted their difference and called attention to, or been unsettled by, its presence. As 
bioethics scholar James L. Benedict explains in his 2017 book on the ethics of informed consent 
in VCA, “The field of VCA arose in part because major tissue deficits of the face or upper 
extremities deprive persons of at least some of their ability to control the world, to savor the world, 
and to reveal themselves to others” (p. 195). As Rosemarie Garland-Thomson affirms above, a 
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person’s authentic self remains painfully invisible to others when their identity is “enveloped” by 
a quality of alien appearance or experience.  
In Embodied Rhetorics: Disability in Language and Culture, scholar of disability and 
social justice Rod Michalko further illustrates the difficulty of living in a society where bodily 
norms are presumed or required, “There is always a sense of the uncommon with me even in the 
most commonplace happenings. My blindness is constantly with me. It goes wherever I do. I am 
always ‘with it’ and ‘in it.’ My blindness is always ‘with me’ and ‘in me.’ Moreover, my blindness 
is always ‘marked’ in public. Smokie is always with me. He is in his harness and, for most, this 
signifies me as blind” (p. 202, “Putting Disability in Its Place” by Rod Michalko and Tanya 
Titchkosky in Embodied Rhetorics edited by James Wilson and Cynthia Liewicki-Wilson, 2001). 
Michalko joins scholars such as the blind writer and art historian Georgina Kleege in noting not 
just how visible their lack of vision is to others, but also the seemingly intentional ignorance 
practiced by many sighted writers and thinkers when portraying the experiences of the visually 
impaired. Kleege is both droll and lacerating in her re-presentation of the “hypothetical blind man” 
of philosophical thought experiments: 
The Hypothetical Blind Man has long played a useful, although thankless role, as a 
prop for theories of consciousness. He is the patient subject of endless thought 
experiments where the experience of the world through four senses can be 
compared to the experience of the world through five. … One of the most striking 
features of the [Hypothetical Blind Man] is that he is always assumed to be both 
totally and congenitally blind. Real blindness, today as in the past, rarely fits this 
profile (2005, p. 180 and 287). 
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According to Kleege, depictions of what it’s like to be blind in the thought experiments of western 
philosophy are so inaccurate as to be farcical. Spectators of blindness across all types of texts—
but especially academic philosophical texts—recognize and cognize blindness as a category or 
experience of embodied lack, Kleege argues, despite the fact that they have no notion of and 
indeed, no tools with which to comprehend blindness as a lived continuum of sensations, many of 
them experientially “positive” (see also Paterson, 2016: Seeing with the Hands: Descartes, 
Blindness, and Vision). 
Due to the shallow nature of popular portrayals of dis/abled people in popular culture, 
disability studies scholar Lennard Davis has argued that many forms of dis/ability are deceptively 
“familiar” to those who do not have them. “The first assumption that has to be countered,” Davis 
writes, “is that the ‘normal’ or ‘able’ person is already fully up to speed on the subject. My 
experience is that while most ‘normals’ think they understand the issue of disability, they in fact 
do not. When it comes to disability, ‘normal’ people are quite willing to volunteer solutions, 
present anecdotes, recall from a vast array of films instances they take for fact” (2017, p. xvi). 
Another source of wrong assumptions regarding the needs and proficiencies of people with a 
particular condition of difference are the supposedly sympathetic or supportive activities which 
celebrate difference through simulatory activities. As Alison Kafer argues in Feminist, Queer, 
Crip, asking students to, “spend a few hours using a wheelchair or wearing a blindfold so that they 
can ‘understand’ what it means to be blind or mobility-impaired” are activities which, “focus on 
the alleged failures and hardships of disabled bodies (an inability to see, an inability to walk) [and] 
also present disability as a knowable fact of the body.” Kafer continues, “There is no accounting 
for how a disabled person's response to impairment shifts over time or by context, or how the 
nature of one's impairment changes, or, especially, how one's experience of disability is affected 
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by one's culture and environment. Wearing a blindfold to ‘experience blindness’ is going to do 
little to teach someone about ableism, for example” (2013, p. 5 Kindle edition).  
According to Kafer and many other disability scholars, the phenomenal realm of dis/ability 
includes not just diminished access to spaces and activities that “normal” people enjoy—it also 
entails the endlessly disruptive and hurtful experience of being othered or to have one’s condition 
of difference become the locus of one’s identity in the eyes of others. Often enough, dis/abled 
persons are not just “enveloped by” disability, but reduced to it: “disabilities surface to explain 
everything or nothing with respect to [disabled persons’] portraits as embodied beings” (Mitchell 
and Snyder, 2000, p. 50). As Garland-Thomson has observed, “Cultural dichotomies do their 
evaluative work: this body is inferior and that one is superior; this one is beautiful or perfect and 
that one is grotesque or ugly. In this economy of visual difference, those bodies deemed inferior 
become spectacles of otherness while the unmarked are sheltered in the neutral space of normalcy” 
(1997, p. 7-8).  
While normate people can be both effectively “invisible” and “unknown” in public, 
dis/abled people are both conspicuous and (as Davis argues) illusorily “familiar.” Misconceptions 
about the needs and experiences of people with disabilities miss the reality of what makes certain 
conditions more or less difficult to live with on a daily basis. For instance, aspects of hand loss 
that are impossible to appreciate from a non-intimate perspective include the exhausting daily work 
of navigating a new life role or trajectory and a different orientation to others in even the closest 
of personal relationships. The paradoxes of applying for disability while struggling to adopt a 
positive dis/abled identity can be frustrating and alienating; having to ask for care and depend on 
others encourages humility and bond-building in addition to providing limitless daily sources for 
relational friction and feelings of disempowerment. As Sheila Advento describes the difficult 
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process of learning to rely on others for many of her daily needs, “It was so hard to accept help. I 
was getting really depressed, and I didn't know how to handle things emotionally. I was frustrated 
a lot, I took it out on people. I didn't know how to calculate the frustration into my life. I didn't 
know how to handle anything. I just wanted to be independent, and it was hard to ask for help, is 
was so hard to accept help … I did everything on my own—then all of a sudden all that's gone.”  
With the above voices of dis/ability in mind, one can perhaps appreciate why people doing 
the work of living with disability in our society describe feeling fatigued by conversations about 
their differences, while at the same time having to constantly engage in political and personal 
arguments for their right to be included, educated, valued, and of course, allowed to live 
(http://disability-memorial.org/).  
The “social model” of disability 
The “social model of disability” is an envisioning of disability and disfigurement which is 
in many ways the direct opposite of that assumed by modern medical professionals. Disability 
scholars and activists have robustly challenged the view that, “unusual embodiment is inherently 
inferior” (Garland-Thomson, 2002, p. 7). Scholars and activists whose views of disability are 
informed by a social/relational model rather than a “medical model” argue that, “the ‘problem’ is 
not the person with disabilities; the problem is the way that normalcy is constructed to create the 
‘problem’ of the disabled person” (Davis, 2017, p. 3). Writing on what she terms a 
“political/relational” model of disability, Alison Kafer locates disability not in individual 
deformities but “in built environments and social patterns that exclude or stigmatize particular 
kinds of bodies, minds, and ways of being….[as well as] in inaccessible buildings, discriminatory 
attitudes, and ideological systems that attribute normalcy and deviance to particular minds and 
bodies” (Kafer, 2013, p. 6 Kindle edition). James Wilson and Cynthia Liewicki-Wilson give a 
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similar perspective in Embodied Rhetorics: Disability in Language and Culture, insisting that, 
“Transforming disability … entails more than just including the disabled. True transformation 
would permeate the entire social order and generate changes in economic organization, ethical 
thought, educational practices, the organization and design of social space, and the interactions 
and habits of people in all aspects of daily living” (2001, p. xii).  
Despite the above liberatory views of dis/ability in society, there is a somewhat 
contradictory thread in some of the disability studies literature that seems to demand an unmodified 
embrace of the “dis/abled” identity category in ways that may feel forced or inauthentic to some 
people. For instance, even the raucously affirming disability advocate Alison Kafer concedes that 
despite finding joy in communities of disabled people and valuing her own experiences as a 
dis/abled person, she does not want to become more disabled than she presently is (Kafer, 2013, 
p. 4 Kindle edition). Kafer acknowledges that a paradox exits in “…the possibility of
simultaneously desiring to be cured of chronic pain and to be identified and allied with disabled 
people” (ibid, p. 6). We may also recall that burn survivors Joe Kinan and Carrie Pratt—also strong 
advocates and activists on the part of people with disabilities or physical differences—signed up 
for a risky and potentially burdensome experimental treatment for a chance to gain more 
independence and functionality in their lives (see chapter 2). Social models of disability that invite 
positive participation in dis/ability as an identity category also suffer in the sense that disabilities 
can be more dynamic than other cultural markers—conditions of disability or chronic illness wax 
and wane throughout the life course, taking on different meanings and statuses. As Rosemarie 
Garland-Thomson writes in Extraordinary Bodies, “The physical impairments that render 
someone ‘disabled’ are almost never absolute or static… Some conditions, like multiple sclerosis 
or arthritis, are progressive and chronic; others, such as epilepsy, can be acute. Even seemingly 
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static disabilities like amputation affect activities differently, depending on the condition of the 
rest of the body” (1997, p. 13, italics added). 
In their 1988 book on the lifetime management of chronic illness, Unending Work and 
Care, sociologists of science Juliet Corbin and Anselm Strauss summarize these learned social 
reactions to and associations about disabilities that, “Having a chronic illness or disability may 
well be acquainted with having a failed body. Illness aside, whatever one chooses to do, physically 
or mentally, usually assumes that one has a functioning body capable of carrying out the desired 
activity” (p. 7). Indeed, the first doctor I interviewed for my master’s project on hand transplant 
history called the phenomenon of losing a limb “upper extremity castration” to indicate his 
understanding of a unique category of relational impotence stemming from hand loss. In my oral 
history narratives (see chapter 3) the physical difference of upper extremity loss is experienced by 
many narrators as embodied inferiority. Several hand transplant recipients or one-time candidates 
for hand transplantation have made comments such as, “I’m ‘on disability’ but I’m not ‘disabled’.” 
Most of my narrators with unique arms or hands saw themselves as, and wanted to be seen as, 
autonomous, strong, capable, unique, even fun, people—and most naturally wished to signal their 
self-sufficiency and sense of social value to others. Unfortunately many experienced difficulty 
signaling their own normalcy, self-sufficiency, and vitality to others when they lost their hands 
because for strangers, this lack signals a person as impotent or (apparently to some) incompetent.  
Angel Gonzales relates the frustrating arc of his and his partner’s relationship with the 
outside world following the latter’s quadrilateral amputations: 
I think people respond to the [transplanted] arms in a way that is … different … 
from the way that they respond to someone who has all four limbs gone, you know 
what I mean? Like they can almost accept that he’s in a wheelchair because he has 
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no legs, but you know they kind of freak out when he has no legs and no arms 
they’re like “whaaoouo” you know? But now that he has arms it’s a little bit easier 
to be out in public , not that we cared either way it’s just—for the sake of other 
people, it’s easier to be outside, with the arms. Um, you know what I mean, like, 
they seem to respond less to him um, in this pitying way or in this kind of freaked 
out way where they would come and address me about his condition. You know [in 
those cases] it’s like, “He’s right in front of me,” or you know what I mean um, that 
would happen if we would go shopping at Trader Joe’s and I would be like, uhhh, 
“He’s right there!” (laughter) ..."I would just kind of shrug and give them a quick 
answer and keep moving, um, which is actually something a [physical therapist] 
taught us. 
For Rich and Cindy Edwards, the responses of strangers to the sight of Rich’s injuries and 
the loss of face, so to speak, that he felt in public based on other people’s staring was one of the 
hardest aspects of trying to navigate life following burn trauma. Cindy narrates, “Rich couldn't 
live like this like the way it was. People were always staring at his hands. Children were always 
staring and pointing. Even though he can't do hardly anything with his hands right now, at least 
they look mostly normal.” As I was completing the descriptive codes for my oral history 
interviews, the code “Other People”—referring to instances in which narrators recalled  
Rosemarie Garland-Thomson has pointed out that acts of staring can be an inward journey 
as well as an outward gesture, when starers are made self-aware and an engaged rather than 
individual experience unfolds via this recognition:  
Triggered by the sight of someone who seems unlike us, staring can begin an 
exploratory expedition into ourselves and outward into new worlds. Because we 
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come to expect one another to have certain kinds of bodies and behaviors, stares 
flare up when we glimpse people who look or act in ways that contradict our 
expectations. Seeing startlingly stareable people challenges our assumptions by 
interrupting complacent visual business-as-usual. Staring offers an occasion to 
rethink the status quo (2009, p. 6). 
Responses of society to disability and embodied difference are also plastic and dependent 
on circumstances, having historically been determined by prevailing social attitudes on the moral 
status of a marking differences (including questions of heritability and the circumstances leading 
to acquired conditions) in making decisions on how to care for or otherwise manage the presence 
of non-normate individuals. As a group of medical ethicists and psychiatrists write concerning the 
public “acceptability” of novel forms of reconstructive transplantation following hand transplants, 
Sarwer et al write that, “Perception of personal sacrifice and accountability for facial trauma plays 
a role in public endorsement of face transplant. Transplant to ameliorate injury sustained secondary 
to military service garners nearly universal support. Victims of disfiguring accidents receive 
substantial support as well, though transplantation is valued more highly for ‘blameless’ accidents 
than for accidents partly resulting from the victim’s own actions” (p. 28-29). 
In a related example, a surprisingly charitable attitude towards individuals with 
inadvertently acquired physical disabilities in Nazi Germany inspired a proliferation of assistive 
technologies for that population even as the same administration sought to end the existence of 
people whose difference was considered both unwanted and “innate.” Historian Robert Jay Lifton 
writes, explaining how superficially progressive resources for the treatment of people with certain 
disabilities aided Nazi narratives that their doctors were ethically and scientifically administering 
medicine: 
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[A]t the same time that they developed a policy of sterilizing or killing people
considered unfit for a society of the strong, the Nazis boasted of spectacular results 
and humane employment arrangements for people who had lost hands or limbs, 
especially in combat. In these ways, most doctors could continue to view 
themselves as authentic physicians, whatever the degree of Nazification of their 
profession (1986, p. 40). 
In western cultures where restoring the so-called “usefulness” to society of disabled 
persons is considered a good, strategies for mitigating disability directly by healing/restoring the 
bodies of affected persons are praised for their power to remove a source of unwanted difference—
even as more discernibly eugenics-informed erasure of disabled persons has lost public and 
professional approval. Today the trope of astonishing restoration of disfigured bodies to healthy 
norms can be encountered in nonfictional settings as diverse as TV journalism, scientific papers, 
direct-to-consumer prescription advertising, and the rhetoric of holistic and religious healers. As 
Kafer has restated from a selection of science news articles: “Thanks to new developments in 
medical technology, we are ‘soon’ going to be living in an era when ‘brainpower will let the 
paralyzed walk, [and] allow the mute to speak.’” She adds matter-of-factly that, “Enabling ‘the 
paralyzed’ to walk is one of the most common expectations for [medical] technologies” (2013, p. 
107 Kindle edition).   
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4.3 HOW DID WE GET HERE? MEDICALIZATION, BIOMEDICALIZATION, 
AND HAND TRANSPLANTATION  
As western medicine advanced in the 20th century, the processes referred to by science 
scholars as “medicalization” entailed the scientific measuring, sorting, mending, disciplining, and 
instructing of patients and communities under the authority of emerging scientific standards and 
field-specific best practices. As STS scholars Clarke, Mamo, Fosket, Fishman, and Shim describe 
these transformations: 
Historically, the rise in the United States of Western (allopathic) medicine as we 
know it was accomplished clinically, scientifically, technologically, and 
institutionally from 1890 to 1945. This first ‘transformation of American medicine’ 
was centered not only on the professionalization and specialization of medicine and 
nursing but also on the creation of allied health professions, new medico-scientific, 
technological, and pharmaceutical interventions, and the elaboration of new social 
forms (e.g., hospitals, clinics and private medical practices) (2009, p. 50). 
The “medicalization of society” has been theorized and documented by sociologist Peter 
Conrad, who explains, “The main point in considering medicalization is that an entity that is 
regarded as an illness or disease is not ipso facto a medical problem; rather, it needs to become 
defined as one” (2000, p. 182-184 Kindle edition). Disability scholar and literary theorist Arthur 
W. Frank has called this phenomenon, “the modernist expectation that for every suffering there is
a remedy” (2013, p.80 Kindle edition). Early hand transplant ethicist Mark Siegler, arguing on 
behalf of a clinical attempt at hand transplantation, exemplifies this point of view when he writes 
in 1998 that, “The public expects that previously untreatable medical and surgical conditions will 
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yield in time to scientific research and that novel treatment developed by clinical scientists will be 
introduced into practice with a minimum delay” (1998, p. 2782).  
 “The consequences of this master narrative,” Frank goes on to say, “are complex.” Of 
course, physical and cognitive disabilities of all kinds have become the objects of much 
medicalized attention, little of which has been objectively or even superficially oriented toward 
the benefit or well-being of the communities targeted for interventions. Media and disability 
studies scholar Fiona Kumari Campbell has lamented that among the insults and injuries of 
medical science toward people with disabilities is the apparent lack of interest shown in generating 
healthcare products and services that respond authentically to dis/abled individuals’ actual needs. 
Campbell argues that, “Medical practices, organized around the medical model, presume that the 
doctor’s task is to diagnose diseases, to discover their causes and symptoms, and design treatments. 
Any knowledge standpoint of the patient [on this model] is sloughed off” (2003, p. 443). In a 
similar vein of critique, Alison Kafer scornfully reviews medically driven efforts to normalize 
physical and cognitive difference in her 2013 polemic, Feminist, Queer, Crip, writing that the 
medical model of disability, “frames atypical bodies and minds as deviant, pathological, and 
defective, best understood and addressed in medical terms. In this framework, the proper approach 
to disability is to ‘treat’ the condition and the person with the condition” (p. 5, Kindle edition). 
Kafer reminds readers that normalizing “treatments” for disability and physical disfigurement have 
been justified “on the grounds that such acts will lead to better futures for the disabled person 
and/or for their communities” and she reminds readers that such efforts have included: “everything 
from sterilization to institutionalization, from bone-lengthening surgeries to growth attenuation” 
(ibid, p. 29-30). 
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The healthcare processes of “biomedicalization” have arisen alongside those of 
medicalization in recent decades as a more networked, information-driven orientation to 
biomedical research and delivery, facilitated by 21st century advancements in data science and 
biotechnology. As STS scholars Adele Clarke, Janet Shim, Laura Mamo, Jennifer Fosket and 
Jennifer Fishman write in their 2003 article theorizing biomedicalization, “Biomedicalization 
describes the increasingly complex, multisited, multidirectional processes of medicalization, both 
extended and reconstituted through the new social forms of highly technoscientific biomedicine” 
(p. 162).  Unlike traditional western medical approaches which produced their effects through the 
discovery and disciplining of molecular and behavioral activity, according to Clarke and 
colleagues, “The historical shift from medicalization to biomedicalization is one from control over 
biomedical phenomena to transformations of them. … [Biomedical] innovations and interventions 
are not administered only by medical professionals but are also ‘technologies of the self,’ forms of 
self-governance that people apply to themselves (p. 167).  
I believe it is via the criteria of ‘biomedicalization” not “medicalization” that hand 
transplantation is mostly accurately characterized and critically viewed. Whereas traditional 
“medicalized” treatments for upper extremity loss or injury have aimed to return discreet aesthetic 
or psychosocial function(s) at the site of injury, the radical transformation of a patient’s care 
trajectory necessitated by hand transplantation—where a candidate essentially moves from 
“healthy” amputee to post-transplant “patient” indefinitely—requires individual and community 
“buy-in” on a level that is unprecedented by even the most invasive brain-controlled prosthetics.  
Because prosthetics necessarily come on and off (an annoyance remarked on by almost all 
narrators for this project) their use or disuse does not command a change ontologically or even 
nominally to the user’s Self or how they think of themselves. By contrast, hand transplantation 
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involves protracted somatic and behavioral changes which are experienced by recipients and their 
families as genuine transfigurations of their identity and/or lifestyle. During a 2008 panel on 
transplantation innovation at the Clevelend Clinic, Dr. Thomas Starzl (considered by many to be 
the “father” of modern organ transplantation), described related phenomena succinctly when he 
said, “Putting a new hand or face on someone is astounding.  It changes the morphology of the 
brain, which can be observed with functional magnetic resonance imaging.  It changes the soul, if 
that is what you want to think of when talking about the brain” (Cooley et al, 2008, accessed 
online). This approach of wholesale transformation rather than localized restoration is consistent 
with the processes of biomedicalization as through hand transplantation, recipients’ lives are 
profoundly enmeshed with the evolving biotechnologies and “self” technologies of immunological 
monitoring, graft rehabilitation, and maintenance for as long as they have their hand graft. Such 
robust alterations of routine and self-understanding have been recognized as challenges in 
selecting “ideal” patient candidates (Taylor-Alexander, 2014) for hand transplantation as 
prospective patients are judged based on their ability to withstand and participate fully in the 
transformation, hybridization, and collaboration needed to make a hand transplant work.  
Viewing HTX procedures and outcomes through the concept of biomedicalization gives us 
tools for understanding which support activities and rhetorical strategies might produce or 
undermine a person’s quality of life through hand transplantation. In a biomedicalized society, 
novel constructions of wellbeing coalesce around emerging and pre-existing concepts of illness 
and the “multiple” or entangled body (Mol, 2003; Shildrick et al, 2017) as, for instance, online 
communities of people identifying “with” or “as” a particular medical condition form to equip 
themselves with rapid-cycling knowledge about their condition, and to develop tools for collective 
bargaining on available treatments. Adversely, biomedicalized approaches can entail a greater 
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requirement for surveillance or more invasive access to personal data by medical experts, and can 
create uncertainty/precarity which is experienced as a risk state by participants.  
As can be witnessed in the oral history chapter of my dissertation (chapter 2), the new layer 
of stress, labor, and “precarity” added to the lives of hand transplant caregivers by these procedures 
is a repeating feature, even when narrators ultimately expressed satisfaction with the hand 
transplant. “Uncertainty, referring here to doubt about how to act, is a well-known challenge in 
healthcare. … Medical uncertainty has a deep moral and existential dimension: it provokes 
fundamental questions about whether lives are worth living, about balancing potential with risk, 
and about weighing danger against benefit,” Write Stefan Timmermans and Mara Buchbinder 
citing Renee Fox’s ideas on this topic. The authors continue, “Fox emphasized that uncertainty 
could not be dispelled with scientific or technological advances. She drew attention to the recursive 
nature of uncertainty: while technologies may address some forms of uncertainty, they seem 
bound, inevitably, to uncover previously unrecognized forms of uncertainty or to produce new 
ones” (2012, p. 13, italics added). Because “uncertainty is inevitable whenever new technologies 
produce previously unavailable knowledge about patients” (p. 14), the passage by Timmermans 
and Buchbinder could be easily be applied to describe the situation encountered by hand transplant 
patients: these surgeries may create more uncertainty than they dispel about whether life will be 
“worth living” after the intervention. The threat of rejection—which must be constantly monitored 
and protected against—and the specter of life-threatening complications from immunosuppressant 
drugs attend all gains to lifestyle and self-description following hand transplantation. (Despite 
these factors, efforts at dispelling uncertainty in the VCA field so far have not included efforts to 
ask patients why and how the surgery worked to transform their lives; as above the “gaze” of most 
papers in the literature has been on measuring duration and function of grafts, identifying 
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molecular processes of immunomodulation, and classifying variables of acute and chronic 
rejection.)  
Conclusion 
 This chapter offered a rhetorical reading of representations of hand transplant outcomes in 
medical literature, demonstrating the emphasis on preselected criteria for effectiveness and 
declarations on how protocols for managing rejections and infections were sufficient to allow the 
hand graft to continue. This narrow view of success is in sharp contrast with the patients’ accounts 
offered in the previous chapter, as well as insights from STS and disability studies. The chapter 
ends by calling for more authentic methods of representing patients’ experiences and for 
connecting the “success” of medical experimentation to actual factors impinging on patients’ 
quality of life. 
Recognizing the range of meanings and values attributed to a hand transplant, and the new 
sources of meaning and value afforded by a hand transplant in the lives of recipients and their 
families, enables diverse stakeholders to understand how very personal, subjective factors must be 
accommodated in quality of life assessments both prospectively and post-transplant. Physicians 
and ethicists working to improve the process of hand transplantation operate blindly when they 
cannot accurately envision the factors contributing to past successes and failures; qualitative and 
quantitative approaches are needed to understand outcomes in this and other fields of 
transplantation (Shildrick et al, 2017). Of course, if narrative or other phenomenologically oriented 
methods are to be deployed more systematically across the hand transplant field, patients should 
have a say in determining how their feelings and experiences are emphasized in medical 
representations and how their personal reflections are “sliced and diced” so to speak, as data. Thus, 
in closing and in the next and final chapter of my dissertation, I argue that more research on the 
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ethics of representing others in academic medical journals (either as persons or as abstractions) is 
needed.   
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5.0 CONCLUSION 
“Never turn your attention off, and always show respect for what people choose to tell you. This 
was the first reason I listened; the second reason was that the stories were beautiful and well-told, 
and I knew that there’s no beauty without meaning (aesthetics is not merely ornament and 
appreciation; it is a form of knowledge).”    
~ Alessandro Portelli, The Death of Luigi Trastulli 
Ten years since I began studying the history, outcomes, and ethics of human hand 
transplantation (HTX), my understanding of the value of these surgeries has been informed by 
conversations with amputees, hand transplant recipients and their caregivers, doctors and 
researchers in hand transplantation/reconstructive transplantation, and crucially, by my readings 
in academic disability studies. My final conclusion based on the arguments and observations 
presented above is that hand transplants are ethically complicated, lifelong interventions that 
require, above all else, a team of care providers who are committed as their first priority to the 
health and well-being of their patient recipients, not to advancing the science of the field or their 
own professional interests.  
In this dissertation, I have shown that where outcomes of experimental operations are 
reported in the detached parlance of objective science, discerning the lived experiences of patient 
participants can be nearly impossible. I discussed how hand transplants received major coverage 
in news media even though they represent minimal achievement surgically and scientifically—the 
main development making HTX possible at the turn of the 21st century was interdisciplinary 
coordination and reexamination of transplant ethics and this work was accomplished discursively. 
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This is important, I argued, because almost all of the rhetorical heavy lifting giving rise to HTX 
relied on the promise of “beneficence,” or the idea that HTX present an opportunity to improve 
the quality of life (QoL) of a vulnerable population of care seekers despite the known burdens of 
immunosuppression and steroids.  
The very notion that “quality of life” could be a site of intervention for organ 
transplantation has been called “a quiet revolution in organ transplant ethics” by prominent 
bioethics scholars. Nevertheless, twenty years after the first speculative discussions on the risks 
and benefits of hand transplantation, the specific nature of these tradeoffs in human experience are 
still unclear. As I revealed through my interpretation of HTX oral histories in chapter 2, the nature 
of quality of life effects after hand transplantation are far more challenging, person-specific, 
complicated, and drawn-out than medical case studies and reviews represent. Because for 
bioethicists and surgeons it has always been a narrow question of balance whether hand transplants 
are permissible, the specific nature of quality of life tradeoffs for HTX patients should not be going 
unexplored in this field, since patient-centered policies and procedures in hand transplantation 
cannot be developed without access to qualitative data which take into account the large-scale 
impact of these surgeries on patients’ lives.  
Finally, in chapter 3 in undertook a close rhetorical reading of representations of HTX 
outcomes in medical discourse showing how clinical stakeholders depict hand transplant outcomes 
as “successful” through a series of gestures that include recitations of preselected criteria for 
effectiveness and declarations on how protocols were deployed to efficiently manage 
complications like rejections and infections. However—as I show through my discussion of theory 
in disability studies and STS following the rhetorical analysis in section 1, the lived reality for 
patients “beyond the lines” of these texts could be very different from the sanitized progress-
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oriented depictions of HTX professionals. More work must be done, I argued, to determine more 
authentic, accurate methods for representing subjects of medical experimentation, especially in 
treatments that seek to improve patients’ quality of life. 
The ethical dimensions of my dissertation are significant and urgent. The hand transplant 
field has evolved and expanded rapidly without robust knowledge of what has happened to, or is 
going on with, existing patients. The exceptionally limited number of recipients (N= <100) means 
the hand transplant field suffers from shortage of data as a fundamental problem. Indeed, the value 
of direct, peer-to-peer consultation with knowledgeable “people like me” is a recurring theme 
across my oral history interviews, yet because competitive research programs are geographically 
and intellectually siloed, a central meeting place for information exchange (intellectual 
perspective) and affective connection has not been organically facilitated. Efforts to rehabilitate 
hand transplantation will, in my opinion, begin with serious international conversations on the 
ethics of representing patients and other vulnerable stakeholders (either as persons or as 
abstractions) in this field, guided by a patient advocacy and support network.  
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